Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3005229	s-alfa-2	g/l (g/l)	10200	22682	0.00%
3005229	s-alfa-2	— (—)	1806	2372	100.00%	Distribution not available
3005229	s-alfa2	g/l (—)	890	1427	100.00%	Distribution not available
3005229	alfa2-glob	g/l (—)	682	2715	100.00%	Distribution not available
3005229	s-a2glob	g/l (—)	410	876	100.00%	Distribution not available
3005229	s-alfa-2-fraktio	g/l (g/l)	307	369	0.00%
3005229	alfa-2	g/l (—)	113	347	100.00%	Distribution not available
3005229	alfa-2-glo	g/l (—)	85	96	100.00%	Distribution not available
3005229	s-alfa2-globuliini(valetietues-prot-fr)	g/l (—)	60	82	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Finngen Rheumatological endpoints

2831

7069

2.34

323.31

2.1

2.3

7.47

7.17

g/l

14.02

2586

6377

Heart failure,strict

2105

5899

2.65

321.20

2.2

2.3

7.62

7.36

g/l

8.25

1908

5210

Gout

1309

3672

3.36

317.84

3.1

2.4

7.63

7.33

g/l

6.98

1201

3253

Influenza and pneumonia

3363

9434

2.33

307.65

3.0

1.9

7.58

7.24

g/l

19.90

3057

8490

Autoimmune diseases excluding thyroid diseases

3440

8179

2.36

307.65

1.9

2.4

7.40

7.32

g/l

1.79

3166

7306

Osteopathies and chondropathies

2106

7960

2.57

307.65

2.9

2.1

7.55

7.39

g/l

3.75

1835

7146

Second line medication for Crohn's disease

2291

7897

3.05

307.65

5.0

1.7

7.48

7.33

g/l

3.53

2138

7102

L04AX Other immunosuppressants

2265

7703

3.10

307.65

5.0

1.7

7.48

7.33

g/l

3.58

2114

6923

Systemic connective tissue disorders

1745

5108

3.69

307.65

1.8

2.3

7.79

7.41

g/l

12.94

1577

4532

Bacterial infection, other or unspecified

2609

6946

3.48

307.65

3.2

2.0

7.83

7.30

g/l

34.50

2380

6128

ILD medications

4185

7734

3.05

307.65

2.9

1.6

7.45

7.24

g/l

9.62

3840

6874

Metabolic disorders

3158

8163

2.44

307.65

2.4

2.1

7.50

7.27

g/l

9.16

2874

7330

Inflammatory bowel disease treatment related agents

3972

8870

2.59

307.65

2.0

2.3

7.55

7.24

g/l

19.47

3633

7919

Infections, IBD-co-morbidities

617

612

7.64

307.65

4.2

2.1

7.43

7.03

g/l

4.25

565

555

ILD medications: prednisolone, methylprednisolone, prednisone

3986

7706

3.00

307.65

2.2

1.6

7.51

7.24

g/l

14.60

3640

6846

Pneumonia, organism unspecified

3047

9148

2.41

307.65

3.0

1.9

7.64

7.25

g/l

24.72

2758

8222

ILD medications: immunosuppressive drugs

2828

6769

4.12

307.65

4.4

1.6

7.46

7.23

g/l

8.66

2652

6044

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

489

345

26.91

307.65

18.5

1.5

7.05

7.65

g/l

6.51

478

297

Other systemic involvement of connective tissue (FG)

1281

3098

4.42

307.65

1.7

2.4

7.75

7.27

g/l

14.68

1147

2731

Chronic kidney disease

2198

4536

5.40

307.65

2.3

2.2

7.70

7.39

g/l

11.38

2038

3948

Polyarthropathies

2727

5878

3.17

307.65

2.4

2.3

7.66

7.27

g/l

21.30

2514

5280

Renal failure

2970

6334

4.60

307.65

2.5

2.1

7.69

7.38

g/l

15.69

2734

5555

Renal tubulo-interstitial diseases

3804

8962

3.33

307.65

2.4

2.2

7.64

7.27

g/l

27.71

3465

8009

Other bacterial diseases

3773

8783

2.83

307.65

2.7

2.0

7.63

7.21

g/l

32.17

3452

7835

Other soft tissue disorders, not elsewhere classified

3007

7661

2.37

307.65

2.2

2.3

7.37

7.35

g/l

0.35

2751

6860

Glomerular diseases

994

2538

4.32

307.65

2.6

2.3

7.92

7.35

g/l

17.30

930

2297

Aplastic and other anaemias

2882

6547

4.53

307.65

2.4

2.2

7.39

7.49

g/l

1.84

2598

5771

Fever of other and unknown origin

2194

5999

3.41

307.65

3.6

2.1

7.58

7.31

g/l

8.28

2027

5366

Dialysis, with operation codes

778

1532

5.77

307.65

3.8

2.1

7.53

7.26

g/l

3.36

732

1381

Multiple myeloma, including Hilmo

716

597

19.76

307.65

15.7

1.4

7.03

7.53

g/l

7.77

699

522

All chronic kidney diseases

3084

6134

4.47

307.65

2.3

2.1

7.70

7.31

g/l

24.47

2859

5419

Primary_lymphoid and hematopoietic malignant neoplasms

1760

3569

5.68

307.65

8.0

1.4

7.07

7.49

g/l

18.12

1683

3139

Polyneuropathies and other disorders of the peripheral nervous system

1520

3306

5.26

307.65

2.3

2.2

7.10

7.46

g/l

12.29

1375

2945

First line medication for Crohn's disease

3828

7607

2.81

307.65

2.9

1.5

7.46

7.22

g/l

11.03

3529

6762

Heart failure, not strict

3025

7575

2.85

307.65

2.4

2.2

7.63

7.31

g/l

15.82

2760

6767

Other systemic involvement of connective tissue

1308

3954

3.56

307.65

1.8

2.3

7.74

7.43

g/l

6.79

1172

3510

Implicit bacterial Sepsis

1879

5798

3.05

307.65

2.7

2.1

7.70

7.39

g/l

9.84

1670

5143

Other anaemias

2755

6243

4.65

307.65

2.4

2.2

7.39

7.49

g/l

1.70

2482

5491

Pneumonias (Asthma/COPD co-morbidities)

3303

9573

2.39

307.65

3.0

1.9

7.61

7.25

g/l

22.32

3010

8603

Examination and observation for other reasons

2055

4079

3.02

307.65

2.3

2.1

7.27

7.41

g/l

2.70

1892

3704

Persons encountering health services for specific procedures and health care

3323

9160

2.23

307.65

2.6

2.0

7.43

7.31

g/l

3.59

3070

8176

Acute renal failure

1203

3088

4.29

307.65

2.8

2.1

7.74

7.35

g/l

10.12

1101

2709

Bacterial infection, other or unspecified

2763

7204

3.46

307.65

3.1

2.0

7.82

7.28

g/l

37.36

2525

6359

All kidney diseases

3942

8841

3.19

307.65

2.4

2.1

7.60

7.23

g/l

27.13

3619

7905

All pneumoniae

3314

9596

2.38

307.65

3.0

1.9

7.61

7.25

g/l

22.87

3019

8625

Other bacterial diseases

3739

9059

2.90

307.65

2.8

2.0

7.67

7.23

g/l

33.75

3421

8090

Oral corticosteroids

3895

8817

2.72

307.65

2.1

2.3

7.60

7.24

g/l

24.59

3569

7870

Pain in limb

2724

7550

2.49

307.65

2.1

2.3

7.39

7.35

g/l

0.52

2485

6761

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4969

8449

4.33

307.65

2.4

2.1

7.33

7.40

g/l

1.72

4532

7545

Tramadol

2693

6475

2.64

307.65

2.3

1.9

7.51

7.21

g/l

13.39

2428

5810

Other and unspecified anaemias

2739

6201

4.67

307.65

2.4

2.2

7.39

7.49

g/l

1.73

2467

5454

Implicit Sepsis

3073

8762

2.67

307.65

2.4

2.1

7.51

7.34

g/l

5.22

2730

7895

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

644

1126

6.88

307.65

3.2

2.2

8.35

7.45

g/l

23.80

586

1001

Anaemias

1002

592

11.81

307.65

2.4

1.2

7.28

6.92

g/l

4.34

935

550

2999

7653

2.45

307.65

3.1

1.8

7.60

7.27

g/l

16.51

2733

6859

Malaise and fatigue

2035

5388

3.19

307.65

2.1

7.49

7.34

g/l

2.84

1803

4788

General symptoms and signs

3349

6766

2.55

307.65

2.4

2.0

7.39

7.29

g/l

2.03

3052

6076

Multiple myeloma and malignant plasma cell neoplasms

717

678

16.97

307.65

15.7

1.5

7.03

7.49

g/l

7.24

700

603

Condition for Implicit Sepsis (Organ dysfunction codes)

3011

8805

2.50

307.65

2.4

2.1

7.48

7.33

g/l

4.03

2692

7938

Other and unspecified polyneuropathies, also in other diseases

1405

2905

5.61

307.65

2.0

2.2

7.10

7.46

g/l

11.13

1267

2585

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

913

633

27.34

307.65

6.9

1.2

6.95

7.55

g/l

11.52

850

553

Bacterial Sepsis

2124

6283

3.06

307.65

2.9

2.1

7.68

7.39

g/l

9.74

1895

5586

Implicit Sepsis

2958

8510

2.74

307.65

2.5

2.1

7.54

7.35

g/l

6.47

2622

7642

Multiple myeloma

489

345

26.91

307.65

18.5

1.5

7.05

7.65

g/l

6.51

478

297

Liquid cancers, helper endpoint

2798

4806

5.77

307.65

6.2

1.2

7.04

7.53

g/l

35.61

2622

4230

Condition for Implicit Sepsis (Organ dysfunction codes)

3064

8606

2.54

307.65

2.4

2.1

7.45

7.32

g/l

3.29

2757

7768

Implicit bacterial Sepsis

2015

6150

3.00

307.65

2.7

2.1

7.69

7.39

g/l

10.00

1789

5463

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3234

9664

2.35

307.65

3.0

1.9

7.62

7.25

g/l

23.35

2946

8686

Autoimmune diseases excluding thyroid diseases, strict definition

3318

7905

2.36

307.65

1.9

2.4

7.40

7.32

g/l

1.76

3053

7057

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2999

7653

2.45

307.65

3.1

1.8

7.60

7.27

g/l

16.51

2733

6859

Heart failure and antihypertensive medication

1002

1708

4.07

296.88

2.1

2.4

7.64

7.08

g/l

13.79

918

1522

Disorders of lipoprotein metabolism and other lipidaemias

2726

7675

2.27

295.65

2.2

7.59

7.29

g/l

13.23

2473

6866

Unspecified kidney failure

645

1355

5.40

294.98

2.5

2.1

7.61

7.38

g/l

2.45

595

1184

Abnormal findings on examination of blood, without diagnosis

1874

6971

2.59

291.85

2.6

2.3

7.71

7.33

g/l

14.23

1710

6260

Erysipelas

2371

8043

2.32

285.55

2.1

2.0

7.63

7.24

g/l

20.27

2152

7147

Nutritional anaemias

1902

7662

2.50

278.90

2.0

2.2

7.53

7.43

g/l

1.57

1678

6804

Glomerular disorders in diseases classified elsewhere

678

1553

4.90

278.41

2.6

2.2

7.96

7.35

g/l

13.23

632

1416

Oedema, not elsewhere classified

1218

4017

3.15

278.10

2.2

2.1

7.55

7.38

g/l

2.50

1097

3571

Septicaemia

1616

5871

2.70

275.05

3.0

2.0

7.58

7.30

g/l

7.71

1453

5163

Asthma, unspecified (mode), excluding more controls

1570

4364

2.78

273.72

2.0

1.8

7.53

7.21

g/l

9.89

1427

3921

Other heart diseases

1239

2564

3.25

272.85

2.3

2.0

7.38

7.00

g/l

9.24

1148

2350

Codeine

2647

6623

2.22

266.94

2.1

1.9

7.44

7.20

g/l

8.62

2405

5952

Hypertension, essential

2191

5294

2.41

266.40

2.2

7.53

7.07

g/l

25.16

2019

4767

Iron deficiency anaemia

1655

6550

2.61

265.95

1.9

2.3

7.57

7.44

g/l

2.01

1456

5815

Other and unspecified iron deficiency

1367

5006

2.88

265.70

1.9

2.2

7.61

7.45

g/l

2.62

1208

4447

Nephropathy related operations

687

1651

4.66

265.10

3.8

2.2

7.54

7.35

g/l

1.83

650

1493

Explicit Sepsis

1647

6138

2.62

264.64

3.0

2.0

7.58

7.37

g/l

4.74

1482

5460

Autoimmune diseases related-to ILD

2641

10900

2.13

264.59

2.0

2.2

7.55

7.31

g/l

9.14

2422

9759

Heart failure, strict

2280

7267

2.31

262.06

2.1

2.3

7.62

7.42

g/l

5.28

2063

6409

Gout, FINNGEN

1309

4758

2.93

258.54

3.1

2.2

7.63

7.33

g/l

7.33

1201

4210

Certain infectious and parasitic diseases

2752

6483

2.17

257.23

2.5

1.8

7.46

7.20

g/l

10.23

2530

5766

Care involving dialysis

502

959

6.00

256.40

2.5

2.0

7.58

7.29

g/l

2.67

469

872

Pure hypercholesterolaemia

2441

7396

2.22

255.41

2.2

7.63

7.30

g/l

14.85

2207

6609

Hypertensive diseases (excluding secondary)

1320

2593

3.04

251.71

2.2

2.0

7.42

6.98

g/l

13.22

1228

2369

Reimbursement for rheumatic diseases

1944

8556

2.35

251.31

1.7

2.3

7.70

7.33

g/l

15.62

1797

7619

Codes for special purposes

1808

7737

2.42

251.11

2.7

2.1

7.52

7.34

g/l

3.75

1634

6940

Provisional assignment of new diseases of uncertain etiology

1806

7726

2.42

251.01

2.7

2.1

7.52

7.35

g/l

3.73

1633

6929

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3354

9441

1.98

249.13

2.0

2.3

7.37

7.38

g/l

0.05

3104

8401

All-cause Heart Failure

2223

7175

2.28

248.44

2.1

2.3

7.63

7.43

g/l

5.26

2011

6324

Asthma, unspecified (mode)

1632

4955

2.56

242.36

2.0

1.8

7.53

7.23

g/l

9.20

1481

4447

Hypertensive diseases

2133

5334

2.31

238.35

2.1

2.2

7.49

7.06

g/l

21.43

1972

4801

Implicit viral Sepsis

1160

4127

2.97

238.32

2.8

2.1

7.43

7.40

g/l

0.21

1036

3672

Osteoporosis

1175

3920

3.00

238.24

2.2

2.1

7.57

7.55

g/l

0.11

980

3458

Hypertension

2129

5333

2.31

236.87

2.1

2.2

7.50

7.06

g/l

21.78

1968

4801

Opioids

2661

6657

2.12

236.83

2.4

1.8

7.42

7.20

g/l

7.65

2417

5984

Medical observation and evaluation for suspected diseases and conditions

1927

4130

2.45

236.08

2.2

2.1

7.38

7.41

g/l

0.30

1712

3744

Diseases of arteries, arterioles and capillaries (FINNGEN)

843

1630

3.76

230.90

2.3

2.2

7.79

7.05

g/l

20.28

775

1472

Diseases of oesophagus, stomach and duodenum

3123

9775

1.95

230.50

2.1

2.2

7.37

7.35

g/l

0.22

2796

8825

Other arthritis (FG)

1060

3658

3.03

229.08

2.2

2.4

7.79

7.19

g/l

20.73

974

3289

Dental caries

972

3061

3.21

228.69

3.7

2.1

7.38

7.39

g/l

0.04

893

2783

Other septicaemia

1407

5424

2.61

225.77

2.7

2.0

7.59

7.31

g/l

6.59

1263

4764

Covid-19 confirmed case

1398

5634

2.60

224.07

2.8

2.1

7.60

7.39

g/l

4.14

1256

5019

Diverticular disease of intestine

2394

7435

2.12

221.42

2.5

2.2

7.44

7.39

g/l

0.67

2148

6667

Asthma, excluding more controls

1980

4534

2.33

220.25

2.0

1.8

7.47

7.20

g/l

8.40

1811

4083

Abnormalities of breathing

2462

6961

2.10

220.09

2.3

2.1

7.37

7.34

g/l

0.37

2234

6281

Pain in joint

1729

4683

2.42

219.88

2.0

2.2

7.43

7.34

g/l

1.03

1560

4192

Other diseases of blood and blood-forming organs, wide

945

3169

3.19

217.49

3.1

2.3

7.06

7.45

g/l

8.57

877

2846

Dyspnoea

2759

10629

1.97

216.50

2.3

2.2

7.50

7.35

g/l

4.22

2489

9541

Autoimmune diseases

3071

8208

1.94

214.40

2.0

2.4

7.37

7.32

g/l

0.80

2806

7331

Codeine or tramadol medication

3268

9662

1.89

214.32

2.1

2.2

7.51

7.30

g/l

8.70

2961

8671

Erysipelas

1829

7410

2.26

211.94

2.1

2.0

7.64

7.28

g/l

13.91

1662

6573

Used for control exclusion in common control thyroid runs

2888

7543

1.97

210.95

2.0

2.4

7.35

7.32

g/l

0.43

2635

6745

Cardiovascular diseases (excluding rheumatic etc)

1335

2893

2.71

208.68

2.2

2.0

7.31

6.98

g/l

8.06

1252

2654

Polymyalgia rheumatica

716

2099

3.76

208.15

1.7

2.3

8.21

7.48

g/l

18.03

625

1841

Caries of dentine

867

2739

3.25

207.88

3.7

2.1

7.39

7.37

g/l

0.15

794

2495

Acute tubulo-interstitial nephritis

1885

7592

2.21

206.54

2.2

2.1

7.68

7.31

g/l

15.13

1671

6728

Persons encountering health services in other circumstances, wide

3354

9492

1.86

205.19

2.1

2.3

7.36

7.38

g/l

0.27

3088

8439

Transplanted organ and tissue status

497

1146

4.79

201.46

5.3

2.1

7.07

7.34

g/l

2.77

478

1039

Oxycodone

1353

5056

2.52

200.62

4.5

2.0

7.79

7.30

g/l

16.26

1206

4493

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

401

482

6.26

197.63

2.3

2.2

7.77

7.05

g/l

8.65

376

431

Pain, not elsewhere classified

887

3007

3.07

197.48

2.6

2.1

7.43

7.28

g/l

1.67

815

2698

Asthma

2087

5157

2.17

196.93

2.0

1.8

7.47

7.22

g/l

7.87

1911

4638

Other heart diseases, wide

2394

7386

2.02

196.81

2.3

2.2

7.39

7.29

g/l

1.73

2201

6670

GASTRO-related operations

1983

4562

2.22

196.64

2.3

1.8

7.37

7.27

g/l

1.54

1804

4125

Any gastric operation

1983

4562

2.22

196.64

2.3

1.8

7.37

7.27

g/l

1.54

1804

4125

Cerebrovascular diseases (FINNGEN)

893

2044

3.20

196.02

2.3

2.2

7.46

7.05

g/l

8.07

812

1856

Other specified/unspecified arthritis

944

3339

2.96

195.34

2.1

2.4

7.80

7.26

g/l

15.19

862

2988

Other specific joint derangements/joint disorders

1945

5918

2.17

194.62

2.0

2.3

7.36

7.24

g/l

2.24

1756

5354

Other diseases of intestines

2811

8508

1.92

194.54

2.3

2.1

7.34

7.33

g/l

0.08

2545

7680

Asthma (mode)

2056

5199

2.16

194.26

2.0

1.8

7.45

7.22

g/l

6.53

1888

4678

Asthma (only as main-diagnosis), excluding more controls

1767

4534

2.28

192.08

2.0

1.8

7.46

7.20

g/l

7.83

1621

4083

Diabetic nephropathy, excluding more controls

662

1545

3.83

190.44

1.7

2.0

8.20

7.62

g/l

11.67

611

1367

Type 2 diabetes, wide definition

2501

8392

1.96

187.79

2.0

2.4

7.90

7.18

g/l

69.00

2262

7507

Certain infectious and parasitic diseases

1979

4671

2.17

184.20

2.3

1.8

7.49

7.22

g/l

7.86

1824

4155

Low back pain

2118

7648

2.03

182.69

2.5

2.1

7.44

7.36

g/l

1.27

1924

6856

Spondylopathies

2383

7367

1.98

182.35

2.5

2.1

7.40

7.38

g/l

0.22

2174

6583

Pain in throat and chest

2259

6899

2.01

180.93

2.2

2.1

7.34

g/l

0.04

2061

6220

Enlarged lymph nodes

590

1652

3.78

180.49

2.0

2.2

7.36

7.30

g/l

0.34

557

1489

Headache

1636

6042

2.21

179.58

2.0

7.32

7.29

g/l

0.33

1488

5423

Ulcer of lower limb, not elsewhere classified

704

2239

3.42

178.83

2.3

2.2

7.93

7.45

g/l

9.04

639

1980

L04AA Selective immunosuppressants

816

2806

3.07

178.62

1.8

2.3

7.42

7.38

g/l

0.28

774

2550

Complications of surgical and medical care, not elsewhere classified

2857

10927

1.83

177.92

2.2

7.50

7.34

g/l

4.74

2567

9814

Other disorders of skin and subcutaneous tissue

2188

10149

1.97

177.91

2.2

7.55

7.39

g/l

3.96

1970

9059

Other disorders of fluid, electrolyte and acid-base balance

1136

4390

2.58

177.62

2.5

2.2

7.62

7.39

g/l

3.92

1016

3869

Viral Sepsis

805

2772

3.08

176.14

3.2

2.0

7.45

7.41

g/l

0.24

721

2463

Gout, idiopatic and unspecified

1064

4248

2.66

175.84

2.0

2.3

7.71

7.38

g/l

7.70

971

3782

Implicit viral Sepsis

802

2771

3.06

174.42

3.2

2.0

7.45

7.41

g/l

0.22

718

2462

Non-Hodgkin lymphoma, all, including Hilmo

626

1879

3.62

174.39

2.8

1.4

7.18

7.48

g/l

3.59

593

1647

Disorders resulting from impaired renal tubular function

271

420

7.82

173.54

2.2

2.6

7.56

7.31

g/l

1.25

260

384

Care involving use of rehabilitation procedures

1858

8520

2.06

172.82

2.3

2.1

7.45

7.33

g/l

2.42

1769

7583

Hypertensive heart and/or renal disease

985

2750

2.80

171.70

1.9

2.4

7.60

7.21

g/l

8.27

900

2403

Small fibre neuropathy

244

345

8.89

171.07

2.4

2.3

7.09

7.40

g/l

1.61

219

310

Continuous positive airway pressure

682

1774

3.40

170.99

2.2

2.3

7.66

7.12

g/l

10.20

607

1609

Rheumatoid arthritis

1091

3957

2.57

169.03

1.8

2.4

7.75

7.30

g/l

12.17

1003

3510

Symptoms and signs involving cognition, perception, emotional state and behaviour

2732

10444

1.82

167.58

2.0

2.3

7.32

7.38

g/l

1.05

2436

9441

Cardiovascular diseases

1138

2352

2.65

167.44

2.1

1.8

7.28

6.98

g/l

5.70

1062

2168

Symptoms and signs involving the skin and subcutaneous tissue

2076

10690

1.95

167.14

2.3

2.2

7.15

7.41

g/l

10.43

1879

9578

Asthma (only as main-diagnosis)

1841

5157

2.11

166.94

2.0

1.8

7.47

7.22

g/l

7.40

1685

4638

Exposure to unspecified factor

2760

11227

1.80

166.49

2.1

2.2

7.37

g/l

0.05

2459

10131

Coagulation defects, purpura and other haemorrhagic conditions

759

2616

3.08

165.96

2.4

2.2

6.98

7.47

g/l

11.34

697

2352

L04AD Calcineurin inhibitors

463

1173

4.28

164.97

2.5

2.4

7.27

7.30

g/l

0.13

446

1079

Heart failure and bmi 25plus

1213

3446

2.48

162.41

2.1

2.5

7.75

7.54

g/l

3.28

1088

3004

Neurological diseases, wide definition

578

716

4.13

162.33

2.1

2.0

7.25

7.02

g/l

1.83

538

651

Syncope and collapse

1332

5108

2.30

161.43

2.2

2.1

7.36

g/l

0.01

1160

4541

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2093

10032

1.92

157.89

2.4

2.3

7.52

7.40

g/l

2.48

1897

8938

COPD/asthma/ILD related infections

2736

7653

1.82

157.84

3.0

1.8

7.47

7.27

g/l

6.73

2498

6859

COPD/asthma related infections

2736

7653

1.82

157.84

3.0

1.8

7.47

7.27

g/l

6.73

2498

6859

Disorders of thyroid, IBD co-morbidities

415

630

4.77

157.34

2.0

2.1

7.48

7.01

g/l

4.34

375

569

Diseases of the skin and subcutaneous tissue

2656

7386

1.84

156.91

2.2

7.37

7.34

g/l

0.40

2413

6615

Diseases of arteries, arterioles and capillaries

2183

8687

1.91

156.38

2.0

2.4

7.72

7.38

g/l

13.56

1971

7719

Fall on same level

2983

9425

1.76

156.01

2.2

7.40

7.32

g/l

1.73

2610

8660

Dorsalgia

2602

7754

1.83

154.66

2.3

2.1

7.38

7.36

g/l

0.29

2363

6950

Gout, unspecified

879

3409

2.75

154.51

2.1

2.2

7.68

7.38

g/l

5.61

810

3036

Other necrotizing vasculopathies (FG)

326

667

5.48

153.53

1.4

2.9

8.45

7.15

g/l

21.39

298

595

Preparatory care for dialysis

297

568

6.18

153.08

2.1

2.8

7.62

7.29

g/l

2.13

279

519

Gout, strict definition

803

2996

2.87

152.80

2.1

2.4

7.79

7.37

g/l

8.61

734

2672

Other pulmonary diagnosis

2030

5207

1.99

152.06

2.6

1.8

7.43

7.22

g/l

5.76

1859

4684

Glomerulonephritis

462

1247

4.04

151.17

2.8

2.3

7.85

7.37

g/l

6.13

438

1137

Atrial fibrillation and flutter

840

1954

2.88

150.51

2.6

2.1

7.36

7.06

g/l

4.45

782

1772

Disturbances of skin sensation

849

3266

2.70

149.20

2.0

2.2

6.92

7.38

g/l

13.70

778

2972

Non-ischemic cardiomyopathy

1164

4107

2.39

148.69

2.2

2.3

7.47

7.42

g/l

0.41

1041

3595

Excluding asthma or asthma-COPD overlap

2012

5207

1.97

146.98

2.5

1.8

7.45

7.22

g/l

6.27

1848

4684

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2582

9619

1.78

146.41

2.7

2.1

7.38

7.35

g/l

0.34

2347

8691

Benign neoplasm of colon, rectum, anus and anal canal

2054

9740

1.89

145.41

2.3

7.44

7.43

g/l

0.07

1817

8701

Malignant immunoproliferative diseases

148

142

17.19

145.16

9.3

2.1

7.00

7.41

g/l

1.65

143

129

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

770

1278

3.08

144.03

2.2

1.9

7.34

7.23

g/l

0.71

713

1167

Symptoms and signs concerning food and fluid intake

424

1107

4.09

143.92

2.0

2.2

7.26

7.44

g/l

1.14

388

980

COPD differential diagnosis

1997

5199

1.96

143.43

2.5

1.8

7.43

7.22

g/l

5.47

1837

4678

Disorders of calcium metabolism

338

754

5.00

143.42

3.8

2.3

7.51

7.33

g/l

0.93

297

683

ILD differential diagnosis

1997

5199

1.96

143.42

2.5

1.8

7.43

7.22

g/l

5.47

1837

4678

Symptoms and signs involving the nervous and musculoskeletal systems

1740

9136

1.96

141.84

2.0

2.3

7.20

7.43

g/l

7.45

1586

8165

Speech therapy

959

4021

2.50

141.60

2.2

2.3

7.57

7.43

g/l

1.80

919

3576

Disorders of mineral metabolism

392

990

4.32

140.77

3.5

2.3

7.50

7.32

g/l

1.11

346

894

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

979

2479

2.55

139.87

2.3

2.1

7.27

6.99

g/l

5.05

909

2265

Symptoms and signs involving the urinary system

2258

9710

1.81

139.21

2.1

2.3

7.40

7.41

g/l

0.13

2004

8707

Seropositive rheumatoid arthritis

812

3160

2.67

138.46

1.8

2.5

7.71

7.25

g/l

10.44

749

2787

Endocrine, nutritional and metabolic diseases

1808

4656

2.00

138.12

2.1

2.3

7.43

7.06

g/l

14.35

1663

4230

Lower back pain or/and sciatica

2840

11087

1.70

137.84

2.4

2.2

7.44

7.35

g/l

2.03

2575

9955

Other necrotizing vasculopathies

381

965

4.40

137.41

1.6

2.6

8.41

7.34

g/l

17.06

350

870

Parasetamol

1770

4542

2.01

136.84

2.4

1.9

7.45

7.10

g/l

11.88

1618

4140

Hyperlipidaemia, other/unspecified

1282

5625

2.17

136.12

2.2

7.63

7.37

g/l

5.68

1149

4983

Other special examinations and investigations of persons without complaint or reported diagnosis

1649

4130

2.06

136.10

2.2

2.1

7.30

7.41

g/l

1.57

1504

3744

Other dorsopathies, not elsewhere classified

2576

7760

1.77

135.89

2.2

2.1

7.31

7.36

g/l

0.58

2334

6956

Constipation

2524

10200

1.75

135.53

2.7

2.1

7.34

7.40

g/l

0.91

2222

9197

Pain (limb, back, neck, head abdominally)

1892

4933

1.96

135.38

2.2

7.38

7.34

g/l

0.41

1727

4393

Asthma (diagnoses ohter than nonallergic)

2359

11324

1.76

134.86

2.0

2.2

7.51

7.35

g/l

4.43

2136

10154

Other CVD (FINNGEN)

440

910

3.99

134.48

2.8

2.2

7.48

7.16

g/l

2.76

385

806

Follow-up examination after treatment for conditions other than malignant neoplasms

1167

3464

2.28

132.58

2.3

2.1

7.41

g/l

0.03

1063

3149

Bleeding

2410

9973

1.76

132.00

2.2

2.3

7.48

7.40

g/l

1.40

2164

8926

Purpura and other haemorrhagic conditions

544

1795

3.24

129.04

2.5

2.3

6.87

7.44

g/l

11.06

502

1620

Diabetic nephropathy

665

2427

2.91

128.67

1.7

2.0

8.20

7.71

g/l

9.58

613

2175

Osteoporosis with pathological fracture (FG)

347

860

4.45

128.34

1.9

2.5

7.68

7.37

g/l

2.28

276

741

Extracorporeal dialysis

323

763

4.75

127.96

2.5

2.4

7.53

7.30

g/l

1.28

300

700

Cardiac arrhythmias

1364

4285

2.11

127.70

2.4

2.2

7.29

7.08

g/l

4.06

1259

3906

Soft tissue disorders

2558

7702

1.74

127.13

2.2

2.3

7.33

7.35

g/l

0.19

2334

6896

Symptoms and signs involving the circulatory and respiratory systems

2420

6970

1.77

126.68

2.2

2.1

7.32

7.34

g/l

0.17

2212

6290

Nephrotic syndrome

201

316

7.45

126.14

2.7

2.5

8.18

7.21

g/l

7.66

196

288

Any reimbursement code in KELA

1123

2444

2.34

126.13

2.4

1.5

7.38

6.89

g/l

15.19

1053

2176

Other and unspecified dermatitis

1484

7687

1.98

126.09

2.1

2.2

7.39

g/l

0.04

1349

6873

Asthma, hospital admission 2, infections

1639

8591

1.91

125.23

2.2

7.58

7.37

g/l

5.13

1492

7658

Asthma-related infections

1639

8591

1.91

125.23

2.2

7.58

7.37

g/l

5.13

1492

7658

Heart failure and coronary heart disease

1522

5559

2.01

124.39

1.9

2.4

7.62

7.44

g/l

3.41

1382

4875

Atrial fibrillation and flutter with reimbursement

715

1662

2.83

123.59

2.5

2.2

7.50

7.07

g/l

7.25

658

1499

Valvular heart disease excluding rheumatic fever

1399

5075

2.05

122.30

2.4

2.3

7.25

7.40

g/l

2.40

1253

4517

Dermatitis and eczema

2892

11076

1.64

122.16

2.1

2.2

7.33

7.38

g/l

0.64

2633

9933

Intestinal infectious diseases

2479

11286

1.70

122.11

2.8

2.1

7.48

7.34

g/l

3.37

2256

10126

Complications of medical and surgical care

2072

11021

1.77

121.12

2.3

2.2

7.51

7.37

g/l

3.39

1869

9872

Dermatitis

1716

9397

1.86

121.06

2.1

2.3

7.40

7.38

g/l

0.13

1559

8408

Non-rheumatic valve diseases

1393

5065

2.04

120.75

2.4

2.3

7.25

7.40

g/l

2.45

1247

4507

Diseases of the musculoskeletal system and connective tissue

1139

2553

2.27

120.03

2.2

2.1

7.37

7.16

g/l

3.18

1052

2296

Bacterial pneumonia, not elsewhere classified

1215

5220

2.11

119.90

3.6

1.9

7.63

7.31

g/l

8.07

1146

4633

Bacterial pneumoniae

1257

5477

2.08

119.70

3.6

1.9

7.63

7.30

g/l

8.66

1178

4874

Persons encountering health services for examination and investigation

1601

4130

1.98

118.42

2.1

7.33

7.41

g/l

1.01

1455

3744

Abnormalities of gait and mobility

536

1853

3.12

117.94

1.8

2.3

7.37

7.47

g/l

0.66

489

1665

Rheumatoid arthritis, including avohilmo

1204

5981

2.08

116.15

1.8

2.3

7.73

7.41

g/l

7.77

1106

5304

Intestinal infectious diseases

3002

10788

1.61

115.83

2.7

2.1

7.40

7.36

g/l

0.63

2725

9676

Haemorrhage from respiratory passages

1096

4709

2.17

115.71

2.1

2.2

7.36

7.45

g/l

0.87

991

4176

Spinal stenosis

1576

6420

1.92

115.06

2.2

7.44

g/l

0.06

1400

5695

Diarrhoea and gastroenteritis of presumed infectious origin

1847

9442

1.80

114.64

2.7

2.0

7.49

7.34

g/l

3.03

1681

8449

Neurological diseases

2027

5723

1.81

114.63

2.1

2.3

7.28

7.43

g/l

3.30

1830

5186

Depression medications

462

634

3.72

114.39

1.8

1.2

7.20

6.89

g/l

2.76

446

591

Other disorders of urethra and urinary system

1886

7702

1.80

113.92

2.1

2.2

7.53

7.35

g/l

4.56

1705

6904

Complications of procedures, not elsewhere classified

2179

10708

1.72

113.63

2.1

2.2

7.48

7.34

g/l

3.09

1966

9610

Chronic lymphocytic leukaemia

208

379

6.59

113.47

2.0

1.4

6.70

7.51

g/l

8.71

196

329

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

208

379

6.59

113.47

2.0

1.4

6.70

7.51

g/l

8.71

196

329

Chronic lymphocytic leukaemia, helper endpoint

208

379

6.59

113.47

2.0

1.4

6.70

7.51

g/l

8.71

196

329

Neoplasms

1588

4407

1.94

113.01

2.7

1.2

7.19

7.35

g/l

2.61

1478

3975

Amyloidosis

175

271

7.90

112.55

7.5

2.3

7.38

7.32

g/l

0.14

167

246

Benign neoplasm: Colon

1723

9261

1.83

112.46

2.3

7.44

7.45

g/l

0.01

1514

8284

Non-follicular lymphoma

446

1434

3.39

111.75

2.5

7.23

7.40

g/l

1.17

423

1291

Asthma, hospital admissions 3, pneumonia

1159

5744

2.08

111.71

2.3

2.2

7.72

7.43

g/l

6.20

1063

5056

Asthma-related pneumonia or sepsis

1159

5744

2.08

111.71

2.3

2.2

7.72

7.43

g/l

6.20

1063

5056

Chronic gastritis

955

4420

2.25

111.54

2.1

2.3

7.41

7.48

g/l

0.59

838

3935

Asthma-related pneumonia

1156

5734

2.08

111.18

2.2

7.72

7.43

g/l

6.21

1060

5046

Adjustment and management of implanted device

712

2923

2.57

110.63

2.5

2.1

7.36

7.43

g/l

0.54

654

2537

Hypothyroidism (congenital or acquired)

410

617

3.82

109.99

2.4

1.2

7.18

6.91

g/l

1.90

385

574

Amyloidosis, other/unspecified

158

226

8.85

109.96

8.0

2.4

7.36

7.30

g/l

0.14

152

204

ILD medications: azathioprine

411

1256

3.41

109.42

1.8

1.5

7.40

7.16

g/l

1.88

380

1136

Genitourinary diseases

1340

3334

2.05

109.42

2.1

7.31

7.23

g/l

0.69

1242

3021

Hypertensive Heart Disease

791

2624

2.46

108.11

2.0

2.4

7.68

7.22

g/l

9.36

712

2289

Antihypertensive medication - note that there are other indications

1082

2646

2.20

107.55

2.0

2.1

7.30

6.97

g/l

7.24

1004

2409

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1758

8010

1.81

107.41

2.1

2.4

7.96

7.24

g/l

52.62

1577

7114

Secondary hypertension

276

642

4.51

107.32

2.2

7.35

7.14

g/l

1.06

261

578

Hypothyroidism and >3 levothyroxin purchases

405

616

3.78

107.31

2.4

1.2

7.22

6.90

g/l

2.39

380

573

Hypothyroidism, levothyroxine purchases

405

616

3.78

107.31

2.4

1.2

7.22

6.90

g/l

2.39

380

573

Hypertensive Renal Disease

214

417

5.79

106.86

1.7

2.6

7.43

7.24

g/l

0.82

205

369

Lymphoid leukaemia

298

760

4.39

106.77

2.6

6.82

7.38

g/l

6.17

282

683

STROKE

1494

5440

1.91

106.63

2.4

7.43

7.22

g/l

4.17

1342

4874

Spondylosis

1542

6898

1.87

105.92

2.0

2.2

7.41

7.40

g/l

0.08

1395

6160

Cardiomyopathy

612

2385

2.69

105.65

2.6

2.2

7.30

7.41

g/l

0.70

562

2112

Dizziness and giddiness

2049

9667

1.71

105.31

2.0

2.3

7.36

7.40

g/l

0.42

1837

8703

Other disorders of kidney and ureter

526

1922

2.92

104.12

2.2

2.3

7.53

7.41

g/l

0.80

502

1733

Disorders of other endocrine glands

1197

6047

2.00

104.06

2.3

2.2

7.37

7.42

g/l

0.45

1074

5402

Myelodysplastic syndrome, including Hilmo

202

387

6.13

103.90

2.2

1.4

6.46

7.54

g/l

13.81

186

334

Certain disorders involving the immune mechanism

636

2555

2.61

103.10

2.7

2.2

7.23

7.38

g/l

1.45

597

2311

Malignant neoplasm, wide definition for exclusion

2164

7619

1.69

101.13

3.6

1.4

7.33

7.36

g/l

0.27

2008

6826

Arthropathies

2066

6141

1.73

101.10

2.1

2.2

7.38

7.25

g/l

2.39

1893

5535

Insulin medication

1681

8095

1.78

100.66

2.0

2.4

7.99

7.19

g/l

55.37

1526

7230

Diaphragmatic hernia

1163

6008

2.00

100.62

2.3

2.2

7.49

7.48

g/l

0.08

1027

5343

Other disorders of white blood cells

268

661

4.49

100.05

2.1

2.5

7.08

7.40

g/l

1.98

243

602

Malignant neoplasm

2122

7532

1.69

99.72

3.8

1.4

7.33

7.37

g/l

0.34

1963

6742

2929

9764

1.57

99.30

3.0

2.0

7.41

7.35

g/l

0.86

2666

8725

Myalgia

651

2681

2.51

99.12

2.0

2.2

7.25

7.36

g/l

0.86

586

2410

Other diseases of urinary system

2544

8971

1.62

99.05

2.2

7.48

7.32

g/l

4.27

2302

8101

Diabetes mellitus

2530

9290

1.62

98.77

1.9

2.4

7.80

7.15

g/l

57.14

2289

8341

Disorders of parathyroid gland

743

3225

2.38

98.65

2.2

7.41

7.58

g/l

1.77

656

2838

Diabetes, varying definitions

2522

9287

1.62

98.59

1.9

2.4

7.80

7.15

g/l

55.86

2282

8337

Gastrointestinal diseases

1251

3153

2.02

98.31

2.4

1.8

7.32

7.36

g/l

0.38

1147

2870

Other antidepressants

2661

8619

1.60

98.23

2.1

2.3

7.34

7.36

g/l

0.28

2361

7815

Diseases of liver

1039

5203

2.06

98.06

1.8

2.4

7.36

7.38

g/l

0.10

915

4712

Hypothyroidism, drug reimbursement

280

462

4.39

97.02

2.3

1.3

7.37

6.93

g/l

3.15

262

424

Disorders of lens

1879

6900

1.74

96.64

2.5

2.3

7.55

7.35

g/l

4.89

1684

6297

Dorsopathies

2456

7765

1.63

96.51

2.3

2.1

7.30

7.36

g/l

0.86

2230

6960

Chronic lower respiratory diseases

2963

10287

1.55

96.48

2.0

2.3

7.54

7.30

g/l

10.00

2699

9242

Bacterial pneumonia (organism specified)

1347

6664

1.88

96.38

3.8

2.0

7.63

7.38

g/l

5.97

1263

5880

Nerve, nerve root and plexus disorders

2748

10886

1.57

95.79

2.2

7.40

7.36

g/l

0.47

2492

9764

Other medical care

1315

6429

1.89

94.94

3.3

2.1

7.65

7.42

g/l

4.30

1209

5651

Other/unspecified dorsalgia

1010

5014

2.05

94.51

2.7

2.1

7.48

7.40

g/l

0.76

905

4464

1130

5832

1.97

94.48

2.3

2.2

7.46

7.33

g/l

1.90

1030

5220

Type 2 diabetes

2472

9147

1.60

93.38

1.9

2.4

7.84

7.16

g/l

60.29

2235

8205

Gastro-oesophageal reflux disease

1782

9141

1.71

93.36

2.0

2.3

7.35

7.37

g/l

0.27

1564

8254

Other intervertebral disc disorders

2070

7568

1.67

93.22

2.2

2.1

7.33

7.36

g/l

0.31

1875

6771

Disorders of choroid and retina

2254

10067

1.62

91.97

2.3

7.53

7.39

g/l

3.00

1997

9033

Use of hypnotics and sedatives

2697

10036

1.56

91.85

2.5

2.2

7.32

7.37

g/l

0.76

2419

9065

Fracture of lumbar spine and pelvis

771

3548

2.26

91.27

2.2

7.45

7.53

g/l

0.62

630

3120

Other functional intestinal disorders

1219

6088

1.90

90.99

2.5

2.2

7.33

7.41

g/l

0.87

1084

5422

Venous thromboembolism

1607

9098

1.75

90.97

2.5

2.2

7.55

7.43

g/l

1.95

1453

8071

Other and unspecified diseases of blood and blood-forming organs

168

307

6.39

90.82

5.0

2.5

6.92

7.39

g/l

2.43

160

284

Thrombocytopenia, unspecified

314

924

3.69

90.57

2.0

2.5

6.57

7.42

g/l

13.92

285

840

Infections of the skin and subcutaneous tissue

1460

8256

1.79

90.43

2.4

2.2

7.48

7.32

g/l

2.85

1337

7474

406

1385

3.06

90.02

2.2

2.3

7.32

g/l

0.02

369

1253

Acquired haemolytic anaemia

164

297

6.52

89.75

3.4

2.1

6.03

7.45

g/l

15.76

155

267

Hypercalcemia

239

591

4.57

89.69

4.2

2.5

7.49

7.42

g/l

0.25

216

527

Sicca syndrome [Sjögren]

340

1056

3.46

89.68

1.8

2.5

7.20

7.44

g/l

1.74

308

947

Abnormal findings on diagnostic imaging of lung

1485

8204

1.78

89.47

2.3

7.63

7.42

g/l

4.22

1333

7291

Other joint disorders

1944

6138

1.69

89.32

2.0

2.2

7.35

7.25

g/l

1.54

1766

5532

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2372

9077

1.60

89.16

1.9

2.4

7.92

7.16

g/l

70.11

2146

8145

Kidney transplant status

222

518

4.69

88.73

1.7

2.4

7.34

7.16

g/l

0.73

215

480

Haemolytic anaemias

188

386

5.50

88.58

3.2

2.1

6.06

7.46

g/l

18.45

178

346

Sulfasalazine

739

3374

2.25

88.48

1.7

2.4

7.64

7.24

g/l

7.79

681

3025

Azathioprine

411

1424

3.00

88.45

1.8

2.5

7.40

7.18

g/l

1.75

380

1293

Injuries to the abdomen, lower back, lumbar spine and pelvis

1141

6047

1.92

87.74

2.3

2.2

7.43

7.42

g/l

0.05

966

5399

Streptococcal septicaemia

335

1046

3.42

87.31

4.2

2.1

7.53

7.20

g/l

2.83

304

925

Intracranial trauma

1245

4722

1.88

86.95

2.1

2.3

7.31

7.43

g/l

1.39

1094

4297

Cerebrovascular diseases

2116

9336

1.62

86.77

2.3

7.52

7.41

g/l

1.86

1856

8396

Need for other prophylactic measures

254

671

4.13

85.96

2.3

2.5

7.60

7.37

g/l

1.33

247

611

Weight loss

391

1357

3.08

85.22

2.1

2.4

7.26

7.40

g/l

0.83

358

1222

Other bacterial intestinal infections

712

3268

2.26

84.78

3.6

2.0

7.44

7.42

g/l

0.11

639

2905

Viral pneumonia

431

1574

2.87

84.67

3.6

1.8

7.56

7.28

g/l

2.27

401

1406

SLE (Finngen)

165

314

5.83

84.23

1.7

2.3

7.22

7.37

g/l

0.47

154

290

Other disorders involving the immune mechanism, not elsewhere classified

164

312

5.93

84.17

2.1

2.5

7.40

7.19

g/l

0.80

156

288

Gonarthrosis [arthrosis of knee](FG)

1833

6436

1.68

83.82

2.0

2.4

7.54

7.20

g/l

13.02

1658

5782

Explicit bacterial Sepsis

381

1313

3.07

83.56

4.3

2.1

7.55

7.38

g/l

1.06

347

1178

All influenza

713

3288

2.24

83.52

4.4

1.8

7.45

7.27

g/l

1.98

643

2934

Injuries to the head

2713

11084

1.52

83.46

2.2

7.35

7.37

g/l

0.14

2397

10028

Diseases of the eye and adnexa

1717

5052

1.72

83.45

2.1

2.0

7.23

7.30

g/l

0.81

1589

4624

Other arrhythmias

1518

6674

1.75

83.45

2.1

2.2

7.25

7.33

g/l

0.98

1361

6007

Diseases of the respiratory system

1546

4423

1.78

83.21

2.6

1.8

7.50

7.26

g/l

5.12

1413

3959

Symptoms and signs involving the digestive system and abdomen

2479

8033

1.57

82.65

2.2

7.31

7.38

g/l

1.12

2261

7184

Benign neoplasms

2303

8115

1.58

82.43

2.2

2.1

7.26

7.36

g/l

1.71

2088

7349

Abnormal weight loss

371

1276

3.12

82.38

1.9

2.4

7.25

7.41

g/l

0.88

340

1150

Paroxysmal tachycardia

502

1641

2.63

81.92

1.8

2.2

7.23

7.07

g/l

1.16

454

1479

Diabetes, insulin treatment (Kela reimbursement)

2537

10081

1.54

81.80

1.9

2.3

7.91

7.19

g/l

69.66

2301

9029

Hypo-osmolality and hyponatraemia

581

2476

2.44

81.73

2.7

2.1

7.48

7.45

g/l

0.10

522

2152

Any event in cancer register

2174

8122

1.60

81.69

3.5

1.5

7.31

7.37

g/l

0.81

2002

7299

Factors influencing health status and contact with health services

716

1555

2.35

81.62

2.3

1.9

7.35

7.40

g/l

0.23

652

1398

Presence of cardiac and vascular implants and grafts

1414

6061

1.78

81.56

1.8

2.2

7.40

7.46

g/l

0.58

1237

5405

Cough

1049

5279

1.92

81.54

2.4

2.2

7.41

g/l

0.02

944

4720

Other external causes of accidental injury

1944

5956

1.66

81.50

2.1

2.3

7.38

7.35

g/l

0.26

1731

5480

Falls/tendency to fall

2517

8204

1.55

81.43

2.2

2.3

7.35

7.32

g/l

0.35

2233

7553

Hard cardiovascular diseases

2117

7979

1.61

81.36

2.3

7.44

7.33

g/l

2.04

1935

7174

Viral hepatitis, IBD co-morbidity

130

200

6.77

81.07

1.9

1.6

7.38

6.90

g/l

1.76

119

188

Disorders of eyelid, lacrimal system and orbit

2210

10847

1.57

80.67

2.3

2.2

7.34

7.40

g/l

0.91

1961

9742

Insulin, combination of fast acting with intermediate-acting or long-acting

1681

9383

1.67

80.42

2.0

2.3

7.99

7.31

g/l

41.59

1526

8397

Peripheral artery disease

1400

6462

1.77

80.37

2.0

2.3

7.98

7.40

g/l

25.45

1263

5699

Insulin, intermediate and long-acting

1518

8814

1.71

79.96

1.9

2.3

7.98

7.31

g/l

38.23

1375

7900

Other and unspecified disorders of white blood cells

205

491

4.66

79.86

2.0

2.6

6.98

7.41

g/l

2.52

189

446

Other bacterial intestinal infections

591

2578

2.39

79.82

3.7

2.0

7.49

7.46

g/l

0.18

533

2289

Seronegative rheumatoid arthritis

370

1289

3.01

79.35

2.0

2.8

7.68

7.22

g/l

4.54

340

1159

Chronic apical periodontitis

2758

10558

1.51

79.22

2.4

2.1

7.36

7.37

g/l

0.10

2453

9535

Senile cataract

1730

6436

1.68

79.00

2.5

2.3

7.56

7.37

g/l

4.11

1540

5858

Viral infections characterized by skin and mucous membrane lesions

2095

11550

1.57

78.53

2.7

2.1

7.30

7.38

g/l

1.34

1894

10395

COPD (mode)

877

3461

2.05

78.40

1.8

1.9

8.03

7.29

g/l

24.37

775

3065

Coxarthrosis [arthrosis of hip](FG)

1414

5771

1.76

78.38

2.1

2.5

7.52

7.22

g/l

8.59

1264

5159

DVT of lower extremities and pulmonary embolism

1260

7181

1.79

78.36

2.6

2.2

7.51

7.44

g/l

0.71

1134

6371

Bronchitis

2640

11153

1.51

78.12

3.2

2.0

7.39

7.37

g/l

0.36

2402

9993

Accidents

1927

5956

1.64

78.09

2.1

2.3

7.37

7.35

g/l

0.19

1716

5480

Pruritus

377

1343

2.96

77.83

1.9

2.3

7.26

7.50

g/l

2.13

345

1213

Unspecified haematuria

1249

5877

1.81

77.48

2.1

2.4

7.37

7.41

g/l

0.39

1121

5262

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1640

9951

1.66

77.40

2.2

7.50

7.38

g/l

2.02

1480

8890

Giant cell arteritis

221

577

4.30

76.98

1.5

2.7

8.79

7.43

g/l

14.74

198

513

Other diseases of pleura

1389

7175

1.74

76.35

2.4

2.2

7.68

7.40

g/l

6.32

1252

6367

Periodontitis

2447

10905

1.52

75.87

2.3

2.2

7.47

7.35

g/l

2.54

2170

9846

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2444

10411

1.52

75.74

2.3

2.2

7.36

7.37

g/l

0.13

2211

9368

Pulmonary heart disease, diseases of pulmonary circulation

1003

5426

1.91

75.49

2.4

2.2

7.50

7.45

g/l

0.34

911

4807

Chronic periodontitis, including avohilmo

2439

10902

1.52

75.36

2.3

2.2

7.47

7.35

g/l

2.49

2161

9844

Injuries to the hip and thigh

1386

7426

1.73

75.15

2.0

2.2

7.48

7.45

g/l

0.28

1136

6659

Diabetes medication

2495

9883

1.52

74.49

1.9

2.3

7.89

7.16

g/l

68.36

2247

8861

Diarrhoea and gastroenteritis of presumed infectious origin

2443

10765

1.51

74.17

2.5

2.1

7.40

7.36

g/l

0.62

2214

9656

Asthma, including avohilmo

2843

10944

1.48

73.84

1.9

2.3

7.46

7.34

g/l

3.28

2586

9818

Statin medication

1473

4869

1.72

73.66

2.0

2.4

7.43

7.06

g/l

12.39

1357

4368

Isolated proteinuria

148

290

5.75

73.57

3.1

2.6

7.73

7.24

g/l

2.05

140

262

Other diseases of blood and blood-forming organs

280

874

3.45

73.49

4.1

2.5

6.94

7.34

g/l

3.50

258

798

Obesity related asthma

919

4870

1.94

73.39

1.8

2.3

7.53

7.31

g/l

3.90

827

4409

Hyperparathyroidism

623

2847

2.26

73.28

2.3

2.2

7.41

7.58

g/l

1.58

553

2501

Sciatica+with lumbago

1242

6602

1.76

73.08

2.1

7.43

7.37

g/l

0.53

1133

5922

Implicit fungal Sepsis

271

832

3.50

72.99

2.7

2.3

7.58

7.41

g/l

0.78

240

751

Other nutritional deficiencies

1535

8844

1.66

72.94

1.9

2.3

7.76

7.27

g/l

22.59

1385

8031

Dialysis

173

388

4.90

72.87

2.2

2.0

7.46

7.24

g/l

0.75

166

358

Vasculitis limited to skin, not elsewhere classified

152

309

5.62

72.81

2.2

2.5

7.37

7.42

g/l

0.13

146

280

Abdominal and pelvic pain

2417

8033

1.53

72.80

2.3

2.2

7.36

7.38

g/l

0.26

2199

7184

General examination and investigation of persons without complaint and reported diagnosis

1373

4121

1.76

72.78

2.3

2.1

7.29

7.41

g/l

1.64

1220

3737

Other cataract

1261

5504

1.78

72.77

2.5

2.3

7.46

7.37

g/l

0.94

1121

4997

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

146

286

5.73

72.50

2.0

2.5

7.36

7.19

g/l

0.54

139

263

Seropositive rheumatoid arthritis, wide

812

4159

2.02

72.26

1.8

2.3

7.71

7.46

g/l

3.67

749

3697

Other acute lower respiratory infections

1365

7773

1.70

71.47

3.2

2.1

7.53

7.38

g/l

2.48

1260

6928

Other specified/unspecified systemic involvement of connective tissue

228

635

3.87

71.34

1.7

2.7

7.37

7.35

g/l

0.06

216

576

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

791

4036

2.03

71.21

1.8

2.3

7.70

7.46

g/l

3.24

729

3590

Hyperkalaemia

246

725

3.67

70.81

2.4

2.2

7.77

7.35

g/l

2.55

219

635

Systemic lupus erythematosus

165

366

4.98

70.60

1.7

2.1

7.22

7.41

g/l

0.68

154

339

Other/unspecified seropositive rheumatoid arthritis

801

4119

2.01

70.48

1.8

2.3

7.71

7.46

g/l

3.54

738

3663

Diseases of the digestive system

1297

7664

1.72

70.41

2.2

7.47

7.43

g/l

0.41

1171

6823

Non-Hodgkin lymphoma, all

214

580

4.07

70.34

3.6

1.4

7.04

7.54

g/l

3.63

207

500

Arthrosis

1702

5775

1.64

70.16

2.0

2.3

7.44

7.27

g/l

3.54

1549

5187

Bacterial intestinal infections, IBD co-morbidities

590

2718

2.26

69.98

3.8

2.1

7.49

7.48

g/l

0.07

533

2416

Mixed connective tissue disease

249

747

3.59

69.59

1.7

2.5

7.30

7.41

g/l

0.46

232

680

Other arthrosis

1321

5384

1.73

69.36

2.0

2.4

7.42

7.28

g/l

2.25

1200

4835

Hernia

2288

10285

1.51

68.75

2.3

2.2

7.34

7.40

g/l

0.88

2043

9235

Asthma, hospital admissions , main diagnosis only

1957

11328

1.54

68.20

2.0

2.2

7.49

7.35

g/l

3.07

1780

10161

Other diseases of intestine

460

1942

2.47

67.15

2.4

2.2

7.45

7.40

g/l

0.22

427

1744

Episodal and paroxysmal disorders

2561

8884

1.48

66.99

1.9

2.3

7.31

7.38

g/l

1.26

2298

8006

Nausea and vomiting

732

3629

2.03

66.69

2.7

2.2

7.58

7.47

g/l

0.94

663

3185

Disorders of gallbladder, biliary tract and pancreas

2469

10653

1.48

66.45

2.2

7.47

7.36

g/l

2.59

2219

9568

Atherosclerosis, excluding cerebral and coronary sclerosis

1294

6128

1.72

66.40

2.0

2.3

7.98

7.40

g/l

23.44

1166

5396

Pulmonary embolism

900

4906

1.89

66.20

2.5

2.2

7.56

7.46

g/l

0.84

816

4353

Fibromyalgia

260

824

3.30

65.65

2.1

2.0

7.50

7.32

g/l

0.91

243

760

Other retinal disorders

1764

8870

1.58

65.60

2.2

2.3

7.63

7.42

g/l

4.79

1546

7911

Other and unspecified vasculitis limited to skin

137

279

5.61

65.53

2.3

2.4

7.35

7.43

g/l

0.18

132

251

Pulmonary heart disease

900

4925

1.88

65.40

2.5

2.2

7.56

7.46

g/l

0.89

816

4370

Abnormalities of heart beat

884

4706

1.88

64.93

2.1

7.26

7.41

g/l

1.87

787

4174

Vocal cord dysfunction

303

931

3.00

64.67

2.5

2.4

7.31

7.03

g/l

1.66

265

869

Dysphagia

726

3716

2.01

64.61

2.2

2.3

7.32

7.47

g/l

1.52

648

3300

Idiopathic gout

363

1406

2.75

64.47

2.1

2.3

7.86

7.37

g/l

5.26

326

1259

Ischemic heart diseases

2073

8266

1.53

64.30

2.3

2.4

7.49

7.34

g/l

3.43

1906

7389

Obesity and other hyperalimentation

1432

8583

1.63

63.97

1.8

2.3

7.81

7.26

g/l

26.10

1296

7793

Cystitis

2028

7969

1.53

63.89

2.2

7.47

7.34

g/l

2.90

1805

7151

Concussion

1020

4694

1.80

63.69

2.0

2.3

7.32

7.43

g/l

1.15

897

4269

Type 2 diabetes, definitions combined

2268

9011

1.50

63.61

2.0

2.4

7.80

7.16

g/l

50.76

2033

8074

SLE, strict definition

159

373

4.71

63.51

1.7

1.9

7.17

7.48

g/l

1.35

148

344

SLE, ICD10

159

373

4.71

63.51

1.7

1.9

7.18

7.48

g/l

1.35

148

344

Obesity

1423

8545

1.63

63.48

1.8

2.3

7.81

7.26

g/l

26.03

1289

7759

Acute bronchitis

1082

6161

1.76

63.46

3.1

2.1

7.55

7.41

g/l

2.13

998

5458

Secondary and unspecified malignant neoplasm of lymph nodes

303

1080

2.98

62.95

1.7

1.4

7.43

7.48

g/l

0.15

285

948

Benzodiazepine use

2416

11487

1.47

62.89

2.1

2.2

7.43

7.36

g/l

1.14

2109

10397

Osteonecrosis

243

767

3.41

62.73

6.9

2.1

7.63

7.37

g/l

1.32

225

712

Temporal arteritis

187

502

4.16

62.68

1.5

2.8

8.79

7.45

g/l

12.90

167

444

Type 2 diabetes, strict (exclude DM1)

2275

9074

1.49

62.62

2.0

2.4

7.80

7.16

g/l

50.67

2040

8132

Immunodeficiencies

190

513

4.01

62.35

4.3

2.3

7.12

7.31

g/l

0.75

179

473

Unspecified privation

353

1367

2.71

62.12

2.0

2.2

7.56

7.41

g/l

0.77

323

1245

Hernia of abdominal wall, postoperative

469

2065

2.34

61.61

2.2

1.9

7.50

7.33

g/l

1.28

432

1882

Diseases of oral cavity, salivary glands and jaws

1589

5119

1.62

61.51

2.2

2.0

7.34

7.47

g/l

2.02

1408

4601

Other gastritis (incl. Duodenitis)

667

3375

2.04

61.49

2.3

7.51

7.43

g/l

0.55

590

3027

Chronic rhinitis, nasopharyngitis and pharyngitis

790

4222

1.91

61.37

2.1

2.2

7.22

7.37

g/l

1.65

707

3823

ILD, hospital admission 2, with pulmonary infections

346

1337

2.73

61.33

2.3

1.8

7.97

7.31

g/l

7.75

322

1173

Fracture of rib(s), sternum and thoracic spine

881

4886

1.85

61.27

2.5

2.2

7.42

7.41

g/l

0.00

768

4376

Mood disorders, excluding more controls

2220

9005

1.49

61.19

2.0

2.3

7.31

7.37

g/l

0.91

1976

8189

Fibrosis and cirrhosis of liver

292

1038

3.00

61.18

1.6

2.6

7.13

7.35

g/l

1.45

265

950

Injuries to the thorax

1225

7438

1.68

61.04

2.3

2.2

7.42

7.40

g/l

0.19

1072

6681

Immunodeficiency with predominantly antibody defects

129

265

5.44

60.73

4.9

2.0

7.05

7.37

g/l

1.19

122

248

Shoulder lesions

1821

7217

1.55

60.48

2.2

2.3

7.44

7.36

g/l

1.09

1643

6457

Emergency coronary revascularization (for ACS)

2192

9072

1.49

60.41

2.0

2.4

7.49

7.37

g/l

2.47

2010

8076

Irritable bowel syndrome

646

3245

2.04

60.25

2.2

7.12

7.36

g/l

3.21

575

2935

Visual disturbances and blindness

1327

8250

1.64

60.06

2.3

2.2

7.31

7.43

g/l

1.71

1178

7370

Coxarthrosis

1291

5172

1.68

60.06

2.1

2.4

7.53

7.31

g/l

4.18

1155

4620

IgA nephropathy (IgA glomerulonephritis)

121

239

5.70

59.67

1.7

2.5

7.28

7.18

g/l

0.26

114

218

Polyuria

683

3526

2.00

59.60

1.9

2.4

7.29

7.42

g/l

1.13

606

3153

Conduction disorders

822

3606

1.90

59.49

2.2

7.45

7.44

g/l

0.04

730

3183

Polyarthrosis

587

2653

2.12

59.42

2.2

2.4

7.71

7.39

g/l

3.74

511

2343

Other symptoms and signs involving cognitive functions and awareness

1271

7124

1.66

59.33

2.0

2.3

7.31

7.46

g/l

2.23

1079

6361

Percutaneous Coronary Intervention

1975

8112

1.51

58.97

2.1

2.4

7.49

7.35

g/l

2.94

1825

7247

Enterocolitis due to Clostridium difficile

379

1559

2.56

58.94

4.2

2.2

7.53

7.49

g/l

0.15

349

1390

Visual disturbances

1229

7549

1.66

58.59

2.3

2.2

7.29

7.43

g/l

1.92

1106

6760

Type 2 diabetes, definitions combined, including avohilmo

2240

8953

1.47

58.45

1.9

2.4

7.79

7.15

g/l

50.22

2013

8027

Undetermined asthma, excluding more controls

329

1262

2.69

58.34

2.0

1.5

7.45

7.29

g/l

0.92

297

1125

Abnormal findings on examination of urine, without diagnosis

185

515

3.90

58.23

3.3

2.6

7.75

7.33

g/l

2.12

173

469

Endocarditis

154

376

4.47

58.20

2.1

7.45

7.41

g/l

0.09

144

336

Insulin, fast-acting

929

5320

1.78

57.50

1.8

2.2

7.99

7.28

g/l

26.69

854

4782

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1484

9574

1.58

57.11

2.1

2.3

7.50

7.40

g/l

1.55

1337

8567

Non-allergic asthma (mode), excluding more controls

444

1950

2.31

57.10

1.9

1.7

7.52

7.29

g/l

2.17

403

1731

Retention of urine

1002

4788

1.76

57.05

1.9

2.4

7.48

7.42

g/l

0.48

890

4277

Diabetic retinopathy, excluding more controls

689

1946

2.05

56.97

1.8

2.0

7.97

7.63

g/l

4.43

627

1729

Systemic lupus erythematosus, unspecified

138

316

4.83

56.91

1.8

1.9

7.14

7.49

g/l

1.54

129

292

Zoster [herpes zoster]

1320

8181

1.62

56.80

3.0

2.2

7.39

7.44

g/l

0.44

1175

7260

Giant cell arteritis with polymyalgia rheumatica

187

538

3.87

56.71

1.5

2.6

8.79

7.51

g/l

11.93

167

479

Other diseases of hard tissues of teeth

1542

5062

1.60

56.71

2.3

2.0

7.31

7.46

g/l

2.69

1360

4555

Persons encountering health services for specific procedures, not carried out

249

840

3.10

56.67

2.2

2.0

7.38

7.23

g/l

0.69

232

770

Biological medication for rheuma

403

1726

2.40

56.51

1.5

2.3

7.61

7.25

g/l

3.74

382

1598

Postmenopausal osteoporosis with pathological fracture

271

971

3.02

56.44

2.0

2.2

7.65

7.72

g/l

0.26

212

860

Type 1 diabetes

600

3002

2.04

56.41

1.7

2.3

7.84

7.13

g/l

16.15

558

2724

Other diseases of pericardium

176

483

3.93

56.39

1.7

2.2

7.86

7.36

g/l

2.52

157

430

Non-invasive ventilation

510

2130

2.18

56.27

3.0

2.3

7.56

7.12

g/l

6.43

471

1930

Coronary revascularization (ANGIO or CABG)

1961

8113

1.50

56.21

2.1

2.4

7.49

7.35

g/l

2.85

1815

7248

Viral infections characterized by skin and mucous membrane lesions

1016

6002

1.72

56.05

3.4

2.1

7.29

7.37

g/l

0.87

932

5390

External causes of morbidity and mortality

1475

4646

1.61

55.65

2.2

7.37

7.32

g/l

0.48

1326

4269

Soft tissue disorders related to use, overuse and pressure

706

3762

1.92

55.60

2.2

2.4

7.34

7.39

g/l

0.31

638

3373

Other diseases of anus and rectum

790

4353

1.85

55.46

2.2

7.50

7.45

g/l

0.30

678

3884

Depression or dysthymia

1667

5995

1.56

55.34

2.1

2.3

7.33

7.40

g/l

0.79

1465

5501

Obesity, other/unspecified

759

4138

1.87

55.31

1.6

2.2

7.79

7.24

g/l

14.92

695

3778

Other (seronegative) rheumatoid arthritis, wide

565

2803

2.09

55.29

1.9

2.2

7.80

7.48

g/l

3.56

516

2497

Myelodysplastic syndrome

124

8.16

55.28

1.7

1.3

6.16

7.89

g/l

9.94

107

Asthma/COPD (KELA code 203)

2164

10283

1.46

55.27

2.0

2.3

7.51

7.30

g/l

6.60

1945

9239

Other disorders of veins

1036

6154

1.71

55.09

2.1

2.2

7.31

7.43

g/l

1.61

910

5511

Gonarthrosis

1530

5587

1.58

54.99

2.0

2.3

7.52

7.29

g/l

5.57

1393

5010

Prurigo nodularis

128

285

5.06

54.97

1.6

3.0

7.43

7.48

g/l

0.11

117

256

Sleep disorders (combined)

2657

9954

1.42

54.84

1.9

2.3

7.36

7.38

g/l

0.24

2372

8965

Marginal zone B-cell lymphoma, including Hilmo

102

189

6.34

54.59

2.5

1.5

7.02

7.67

g/l

2.76

162

Cutaneous abscess, furuncle and carbuncle

640

3322

1.97

54.51

2.1

2.2

7.46

7.32

g/l

1.13

590

3022

Cardiomyopathy, other and unspecified

267

960

2.94

54.50

2.3

2.1

7.43

7.42

g/l

0.03

245

850

Other (not insulin) diabetes medications

2318

9641

1.44

54.35

1.9

2.4

7.91

7.17

g/l

64.86

2080

8632

Chronic nephritic syndrome

164

442

4.04

54.17

2.4

2.7

7.56

7.26

g/l

1.33

156

404

Lumbar disc prolapse

1448

7150

1.57

54.03

2.3

2.1

7.35

7.36

g/l

0.14

1321

6428

Other disorders of lacrimal gland

895

5186

1.77

53.41

2.7

2.2

7.26

7.46

g/l

2.80

791

4656

Acute myeloid leukaemia and myelodysplastic syndromes

114

238

5.44

52.98

1.6

1.3

6.44

7.70

g/l

9.95

105

209

Diffuse large B-cell lymphoma

195

599

3.54

52.96

1.8

1.4

7.66

7.53

g/l

0.40

181

529

Diffuse large B-cell lymphoma, helper endpoint

195

599

3.54

52.96

1.8

1.4

7.66

7.53

g/l

0.40

181

529

Diffuse large B-cell lymphoma, including Hilmo

195

599

3.54

52.96

1.8

1.4

7.66

7.53

g/l

0.40

181

529

Sleep apnoea

2256

10271

1.44

52.94

1.9

2.3

7.42

7.35

g/l

1.18

2044

9290

GI-bleeding

934

5499

1.74

52.75

2.2

7.52

7.45

g/l

0.68

840

4873

Other diseases of the digestive system

932

5487

1.74

52.68

2.2

7.52

7.44

g/l

0.74

836

4862

Any mental disorder

2590

9275

1.41

52.37

2.0

2.3

7.35

7.37

g/l

0.24

2304

8430

Major coronary heart disease event

2083

8720

1.46

52.14

2.1

2.4

7.51

7.35

g/l

3.68

1914

7787

Fracture of femur

829

4294

1.80

51.54

2.1

2.2

7.57

7.54

g/l

0.15

640

3793

Cardiomyopathy in other diseases

12.46

51.37

8.0

2.2

7.20

7.61

g/l

0.81

Benign neoplasm: Colon, unspecified

765

4301

1.84

51.24

2.2

7.44

7.43

g/l

0.05

653

3842

Covid-19 suspected case

485

2333

2.13

51.04

2.3

2.1

7.33

7.27

g/l

0.30

450

2134

Persons with potential health hazards related to communicable diseases

689

3704

1.87

50.75

2.2

2.0

7.27

7.23

g/l

0.26

658

3419

Seropositive rheumatoid arthritis, strict definition

447

2102

2.21

50.58

1.7

2.3

7.83

7.44

g/l

4.38

412

1896

Exposure to other specified factors

1665

10340

1.50

50.56

2.0

2.2

7.41

7.34

g/l

0.89

1464

9394

Early onset COPD, excluding more controls

498

2433

2.10

50.32

2.0

1.8

7.91

7.18

g/l

14.45

452

2196

Agranulocytosis

344

1456

2.47

50.21

3.3

2.3

7.12

7.45

g/l

2.33

330

1319

Insulin, fast-acting or short human

932

5554

1.71

50.00

1.8

2.2

7.99

7.32

g/l

23.81

857

4987

Gingivitis and periodontal diseases

2437

8984

1.41

49.97

2.4

2.1

7.36

7.38

g/l

0.17

2177

8075

Secondary right heart disease

186

577

3.51

49.81

1.9

2.5

7.05

7.51

g/l

3.35

174

517

Other neurological diseases

1861

10116

1.47

49.62

2.2

2.3

7.31

7.44

g/l

2.69

1638

9053

Anxiety disorders, excluding more controls

1815

8072

1.48

49.45

2.2

2.3

7.17

7.37

g/l

5.53

1637

7362

Other anxiety disorders

870

4387

1.74

49.42

1.8

2.1

7.19

7.29

g/l

0.97

792

4025

Calcific aortic valvular stenosis, operated

925

5363

1.72

49.41

2.3

2.2

7.51

7.50

g/l

0.06

833

4682

Calcific aortic valvular stenosis

925

5363

1.72

49.41

2.3

2.2

7.51

7.50

g/l

0.06

833

4682

Calcific aortic valvular stenosis, diagnosis (helper)

924

5358

1.72

49.32

2.3

2.2

7.51

7.50

g/l

0.05

832

4677

Operations 2 for CAVS

924

5358

1.72

49.32

2.3

2.2

7.51

7.50

g/l

0.05

832

4677

Undetermined asthma

329

1370

2.48

49.20

2.0

1.6

7.45

7.30

g/l

0.85

297

1228

Calcific aortic valvular stenosis, including rheumatic fever

926

5371

1.72

49.19

2.3

2.2

7.51

g/l

0.02

834

4688

AV-block

537

2374

2.04

48.92

2.3

2.2

7.47

7.50

g/l

0.11

475

2062

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

457

2199

2.16

48.86

1.5

2.3

7.09

7.38

g/l

2.86

406

2003

Cardiomyopathies, Primary/intrinsic

364

1598

2.37

48.71

1.8

2.2

7.30

7.40

g/l

0.44

331

1416

Methotrexate

367

1614

2.35

48.63

1.8

2.5

7.62

7.26

g/l

3.38

342

1445

Other respiratory diseases principally affecting the interstitium

577

3026

1.98

48.40

2.4

2.2

7.88

7.43

g/l

7.11

536

2682

Biguanides

2274

9899

1.42

48.39

1.9

2.3

7.95

7.19

g/l

69.08

2051

8871

ILD, hospital admissions 3, with pneumonia sepsis

300

1217

2.60

48.31

2.2

1.9

8.01

7.30

g/l

7.63

280

1080

Primary hyperparathyroidism

368

1635

2.36

48.30

2.6

2.4

7.35

7.56

g/l

1.53

325

1449

Other diseases of liver

483

2378

2.10

48.19

2.0

2.3

7.36

7.39

g/l

0.12

433

2170

Iron deficiency anaemia secondary to blood loss (chronic)

481

2368

2.10

48.15

2.0

2.3

7.38

7.46

g/l

0.43

412

2109

Cirrhosis of liver, NAS

211

719

3.16

48.04

1.6

2.7

6.94

7.36

g/l

3.05

194

653

Amputation

354

1552

2.39

47.85

2.1

2.2

8.12

7.42

g/l

9.49

322

1366

Obesity due to excess calories

1009

6203

1.65

47.84

1.8

2.3

7.81

7.24

g/l

20.65

915

5651

Urticaria and erythema

798

4625

1.76

47.36

2.3

2.1

7.31

7.38

g/l

0.55

726

4184

Cardiomyopathy (excluding other)

372

1669

2.31

47.28

1.8

2.3

7.31

7.39

g/l

0.33

338

1477

Convulsions, not elsewhere classified

471

2273

2.09

47.23

1.6

2.1

7.51

7.26

g/l

2.26

426

2050

Other CVD

626

3399

1.90

47.07

2.5

2.2

7.48

7.50

g/l

0.10

540

2980

Mood disorders

2299

10712

1.40

47.01

2.0

2.3

7.30

7.38

g/l

1.44

2053

9664

Noninfective enteritis and colitis

1062

6632

1.63

47.01

2.3

2.1

7.33

7.37

g/l

0.30

958

5981

Abnormal findings on diagnostic imaging of other body structures

414

1948

2.21

46.85

2.8

2.3

7.35

7.47

g/l

0.71

385

1757

Mood [affective] disorders

2291

10699

1.40

46.69

2.0

2.3

7.29

7.38

g/l

1.64

2045

9655

Injuries to the shoulder and upper arm

1994

11383

1.43

46.59

2.4

2.2

7.40

7.38

g/l

0.21

1755

10262

Other headache syndromes

922

5578

1.68

46.38

1.8

2.4

7.19

7.38

g/l

3.26

835

5042

Disorder of lipoprotein metabolism, unspecified

403

1888

2.22

46.10

1.7

2.2

7.75

7.40

g/l

3.66

363

1662

Anaemia in chronic diseases classified elsewhere

114

267

4.75

45.89

1.9

2.6

7.34

7.40

g/l

0.14

105

238

Symptoms and signs involving speech and voice

858

5128

1.71

45.85

2.4

2.2

7.14

7.44

g/l

6.13

761

4595

Ischaemic heart disease, wide definition

1941

8444

1.44

45.85

2.3

2.4

7.60

7.35

g/l

7.23

1777

7534

Disorders of lacrimal system

1047

6559

1.62

45.71

2.6

2.2

7.27

7.46

g/l

3.08

924

5867

Type 1 diabetes, wide definition, subgroup 1

464

2286

2.07

45.71

1.7

2.3

7.90

7.12

g/l

14.62

427

2094

Later onset COPD, excluding more controls

614

2547

1.92

45.58

1.6

1.9

7.98

7.34

g/l

13.76

541

2215

Non-allergic asthma (mode)

444

2137

2.11

45.46

1.9

1.7

7.52

7.28

g/l

2.36

403

1909

Isolated proteinuria with specified morphological lesion

120

7.29

45.40

4.0

2.5

7.85

7.39

g/l

1.09

109

Mycoses

1914

11787

1.43

45.31

2.2

7.31

7.37

g/l

0.82

1692

10655

Anxiety (asthma-related co-morbidities)

1158

5708

1.59

45.19

1.8

2.2

7.18

7.27

g/l

1.22

1055

5240

COPD

1234

6567

1.57

44.95

1.8

2.4

7.89

7.37

g/l

19.03

1101

5844

Volume depletion

294

1219

2.51

44.87

1.8

2.2

7.64

7.38

g/l

1.63

250

1055

Injury, poisoning and certain other consequences of external causes

1173

3688

1.61

44.82

2.2

2.3

7.38

7.31

g/l

0.67

1058

3378

Arthropathies in other diseases classified elsewhere

135

362

4.01

44.78

2.4

7.69

7.14

g/l

2.69

121

328

Hypotension

554

2945

1.95

44.63

2.6

2.2

7.44

7.52

g/l

0.54

471

2571

Other dialysis

131

349

4.12

44.22

2.3

2.7

7.49

7.26

g/l

0.72

125

318

Stroke, excluding SAH

1628

8188

1.48

44.09

2.3

7.50

7.45

g/l

0.56

1432

7320

Idiopathic thrombocytopenic purpura

126

328

4.19

43.82

2.3

2.4

6.76

7.41

g/l

4.31

116

292

Stroke, including SAH

1680

8456

1.46

43.74

2.3

7.50

7.44

g/l

0.60

1481

7572

Other abnormal findings of blood chemistry

163

503

3.46

43.67

3.1

2.4

7.46

7.34

g/l

0.34

156

457

All anxiety disorders

1173

5976

1.57

43.67

1.8

2.2

7.17

7.31

g/l

2.12

1070

5458

Other coagulation defects

224

825

2.85

43.65

2.4

7.21

7.40

g/l

0.85

203

752

Other and unspecified immunodeficiencies with predominantly antibody defects

121

6.99

43.65

5.2

2.2

7.19

7.32

g/l

0.24

114

Secondary uncertain malignant neoplasm

388

1830

2.20

43.64

1.9

1.4

7.64

7.50

g/l

0.70

359

1594

Subjective visual disturbances

638

3561

1.84

43.52

2.2

7.26

7.44

g/l

1.88

571

3203

Hypokalaemia

341

1528

2.31

43.49

2.6

2.1

7.65

7.42

g/l

1.53

305

1345

Fungal Sepsis

159

488

3.51

43.15

2.9

2.3

7.68

7.33

g/l

1.50

146

445

Ischaemic Stroke, excluding all haemorrhages

1550

7918

1.48

43.00

2.3

7.52

7.47

g/l

0.62

1361

7062

Sleep apnoea, including avohilmo

2299

10400

1.38

42.98

1.9

2.3

7.41

7.35

g/l

0.86

2075

9400

Other and unspecified coagulation defects

163

507

3.41

42.97

2.5

7.19

7.32

g/l

0.41

148

463

Amputation of toe

261

1052

2.63

42.85

2.2

2.4

8.08

7.42

g/l

6.61

238

946

Zoster [herpes zoster]

536

2854

1.94

42.83

4.0

2.2

7.31

7.49

g/l

1.68

481

2525

Chronic periodontitis, complicated

1352

9034

1.51

42.71

2.4

2.3

7.55

7.37

g/l

3.44

1209

8176

Motor neuron disease

180

5.47

42.64

1.3

2.2

6.54

7.45

g/l

6.29

163

Rotator cuff syndrome

1431

6929

1.50

42.61

2.2

2.3

7.46

7.37

g/l

1.18

1290

6201

Pleural effusion

496

2583

1.99

42.59

2.5

2.2

7.75

7.41

g/l

3.78

459

2287

Depression

2068

10096

1.40

42.58

2.0

2.3

7.29

7.37

g/l

1.49

1845

9135

Other symptoms and signs involving the nervous and musculoskeletal systems

963

6029

1.62

42.54

2.0

2.3

7.13

7.40

g/l

5.80

886

5418

Peripheral artery operations in Hilmo

415

2029

2.12

42.50

2.2

8.03

7.37

g/l

10.42

376

1791

Other pulmonary heart/vessel disease

190

656

3.12

42.36

1.9

2.5

7.06

7.52

g/l

3.52

176

589

Chronic ulcer of skin, not elsewhere classified

241

939

2.71

42.31

2.1

2.3

7.75

7.39

g/l

2.21

218

844

Other abnormalities of plasma proteins

172

5.71

42.12

4.4

2.8

7.45

7.33

g/l

0.19

151

Sequelae of external causes of morbidity and mortality

683

3930

1.78

42.09

2.3

7.62

7.43

g/l

2.12

641

3524

Motor neuron disease (with DMD)

182

5.38

42.05

1.3

2.2

6.54

7.44

g/l

6.20

165

Unspecified fall

1206

7876

1.53

41.27

2.2

7.44

7.42

g/l

0.17

1031

7079

Diseases of pulp and periapical tissues and dental caries

1697

6027

1.46

41.26

2.1

2.2

7.44

7.42

g/l

0.20

1499

5401

Abnormal involuntary movements

374

1777

2.18

41.24

2.2

2.3

7.10

7.43

g/l

4.20

335

1603

Fracture of shoulder and upper arm

892

5531

1.64

40.97

2.5

2.2

7.45

g/l

0.02

759

4942

Tumor necrosis factor alpha inhibitors

336

1531

2.25

40.83

1.4

2.3

7.59

7.26

g/l

2.72

317

1422

Implicit fungal Sepsis

147

445

3.56

40.82

3.0

2.3

7.70

7.30

g/l

1.65

134

406

Open wound of head

1293

8392

1.51

40.78

2.1

2.2

7.42

7.40

g/l

0.11

1133

7564

Neurotic, stress-related and somatoform disorders

1860

9287

1.41

40.72

2.1

2.2

7.16

7.37

g/l

6.10

1684

8406

Other infectious diseases

285

1222

2.44

40.54

2.4

2.2

7.79

7.38

g/l

3.27

267

1106

Candidiasis

660

3811

1.77

39.97

2.5

2.2

7.39

7.43

g/l

0.20

578

3420

Cellulitis

552

3027

1.87

39.96

2.8

2.2

7.58

7.37

g/l

2.14

504

2741

Type 1 diabetes, wide definition

479

2507

1.95

39.72

1.7

2.2

7.89

7.14

g/l

14.27

441

2287

Functional dyspepsia

628

3583

1.79

39.68

2.4

2.3

7.32

7.43

g/l

0.90

577

3245

Pericarditis

129

365

3.78

39.56

1.9

2.1

8.08

7.37

g/l

3.48

115

327

ILD, hospital admissions

478

2528

1.96

39.31

2.3

7.88

7.43

g/l

5.78

445

2247

Lichen simplex chronicus and prurigo

209

787

2.80

39.27

1.9

2.7

7.44

7.36

g/l

0.24

190

710

Anxiety disorders

1877

9409

1.40

39.22

2.1

2.2

7.17

7.37

g/l

6.22

1698

8518

Any death

1642

8293

1.44

39.22

3.1

2.2

7.72

7.37

g/l

10.61

1474

7411

Other noninfective gastroenteritis and colitis

594

3345

1.81

39.18

2.6

2.2

7.42

7.45

g/l

0.18

535

2989

Dental caries, including avohilmo

1852

6745

1.42

38.94

2.1

2.2

7.38

7.41

g/l

0.27

1640

6063

Other interstitial pulmonary diseases

482

2566

1.95

38.83

2.3

7.89

7.43

g/l

6.12

449

2280

Other and unspecified types of non-Hodgkin lymphoma, hilmo

167

564

3.19

38.77

2.9

2.6

7.10

7.42

g/l

1.48

156

508

Diseases of spleen

184

5.22

38.76

2.0

2.1

6.87

7.41

g/l

1.68

167

Viral pneumonia (unknown virus, not influenza)

201

745

2.82

38.73

2.7

2.5

7.55

7.34

g/l

0.93

188

680

Coxibs

672

1998

1.80

38.56

2.1

2.2

7.46

7.32

g/l

1.14

606

1805

Other diseases of upper respiratory tract

2557

10018

1.34

38.38

2.2

7.30

7.42

g/l

2.68

2308

8983

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1226

5554

1.52

38.37

2.6

1.4

7.29

7.50

g/l

3.92

1088

4907

Conjunctivitis

1548

9074

1.44

38.35

2.2

7.19

7.38

g/l

4.87

1402

8170

Diabetic neuropathy

366

1773

2.15

38.29

2.0

7.86

7.77

g/l

0.43

333

1591

Interstitial lung disease

482

2580

1.94

38.20

2.3

7.89

7.44

g/l

6.04

449

2292

Interstitial lung disease endpoints

482

2580

1.94

38.20

2.3

7.89

7.44

g/l

6.04

449

2292

Trochanteric bursitis

368

1789

2.12

38.12

2.2

2.3

7.45

7.48

g/l

0.10

327

1591

Acute upper respiratory infections of multiple and unspecified sites

1596

8334

1.43

38.01

3.2

2.0

7.27

7.37

g/l

1.40

1456

7497

Adverse effects, not elsewhere classified

438

2263

1.98

38.01

2.1

2.2

7.28

7.37

g/l

0.53

413

2070

Other reaction to severe stress, and adjustment disorders

664

3891

1.73

37.84

2.4

2.1

7.10

7.29

g/l

2.14

615

3568

Rash and other nonspecific skin eruption

278

1216

2.38

37.71

2.0

2.3

7.20

7.48

g/l

1.95

258

1099

Dental operations

1606

5768

1.45

37.45

2.3

2.0

7.38

7.43

g/l

0.57

1423

5169

Asthma and allergy, excluding more controls

215

821

2.63

37.32

1.9

1.4

7.10

7.12

g/l

0.05

193

754

Disorders of conjunctiva

1749

10112

1.40

37.18

2.2

7.19

7.39

g/l

5.17

1584

9095

Osteomyelitis

209

810

2.72

37.09

1.9

2.2

8.04

7.37

g/l

5.00

188

746

Psoriatic and enteropathic arthropathies

263

1128

2.40

37.01

1.7

2.6

7.66

7.09

g/l

5.50

243

1031

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

255

1084

2.45

36.91

3.4

2.3

7.62

7.37

g/l

1.48

238

989

Diseases of the myoneural junction and muscle

358

1748

2.13

36.91

1.6

2.2

7.34

7.44

g/l

0.53

306

1571

Drug-induced osteoporosis with pathological fracture

227

4.75

36.88

1.7

2.3

7.73

7.66

g/l

0.13

203

Other chronic obstructive pulmonary disease

1159

6408

1.52

36.82

1.8

2.4

7.92

7.37

g/l

19.56

1031

5699

Urticaria

603

3478

1.76

36.56

2.2

2.1

7.26

7.38

g/l

0.90

549

3160

Allergic asthma (mode), excluding more controls

389

1906

2.03

36.47

1.9

1.6

7.36

7.17

g/l

1.29

361

1733

Reactive arthropathies, FINNGEN

176

628

2.91

36.31

2.3

2.7

7.30

7.04

g/l

1.25

156

573

Injuries to the knee and lower leg

2632

11142

1.32

36.12

2.0

2.3

7.42

7.35

g/l

1.23

2340

10058

Gastroduodenal ulcer

706

4261

1.69

36.12

2.0

2.3

7.49

7.47

g/l

0.15

631

3795

Need for immunization against other single viral diseases

191

4.91

36.01

2.9

2.4

7.38

7.25

g/l

0.25

175

Diseases of pulp and periapical tissues, including avohilmo

2390

9301

1.34

36.00

2.2

7.39

7.37

g/l

0.17

2133

8356

Psychiatric diseases

2252

8391

1.36

35.96

2.1

2.3

7.36

7.38

g/l

0.25

2001

7654

ILD, hospital admissions 1, main diag only

431

2273

1.97

35.85

2.3

7.90

7.44

g/l

5.52

400

2021

Deforming dorsopathies

609

3545

1.75

35.81

2.3

2.2

7.32

7.42

g/l

0.76

548

3168

Acute sinusitis

1027

6265

1.54

35.68

3.2

2.0

7.30

7.33

g/l

0.18

938

5678

Cholelithiasis, broad definition with cholecystitis

2028

10097

1.37

35.65

2.3

7.50

7.37

g/l

2.79

1823

9038

Other symptoms and signs involving the urinary system

310

1455

2.21

35.49

2.3

2.4

7.43

7.34

g/l

0.39

299

1305

Coronary atherosclerosis

1608

7247

1.42

35.45

2.2

2.4

7.67

7.38

g/l

8.06

1477

6442

Selective serotonin reuptake inhibitors

2216

8619

1.35

35.36

2.1

2.3

7.37

7.36

g/l

0.00

1996

7815

Papulosquamous disorders

923

5984

1.57

35.30

2.1

2.3

7.49

7.37

g/l

1.42

841

5406

Fitting and adjustment of other devices

924

5395

1.57

35.24

2.3

2.1

7.42

7.45

g/l

0.18

794

4715

Acetic acid derivatives and related substances

663

1989

1.76

35.11

2.1

2.2

7.41

7.31

g/l

0.68

599

1796

Eosinophilic disease (BM)

118

6.06

35.04

2.4

1.4

7.34

7.20

g/l

0.24

108

Chronic sinusitis

934

6069

1.56

35.03

2.4

2.3

7.29

7.37

g/l

0.65

854

5483

Malignant neoplasm of skin

1225

5714

1.49

35.02

2.6

1.4

7.26

7.49

g/l

4.66

1079

5050

Overexertion and strenuous or repetitive movements

259

1136

2.36

34.85

2.4

7.58

7.30

g/l

1.32

230

1048

Caries of dentine, including avohilmo

1924

7182

1.38

34.77

2.2

7.38

7.40

g/l

0.20

1710

6461

Somatoform disorder

377

1913

2.02

34.60

2.2

2.3

7.19

7.42

g/l

1.89

337

1748

Phlebitis and thrombophlebitis (not including DVT)

570

3299

1.77

34.49

2.7

2.2

7.43

7.45

g/l

0.09

518

2965

Disorders of continuity of bone

242

1036

2.42

34.39

4.0

2.1

7.40

7.36

g/l

0.16

219

957

Voice disturbances

650

3901

1.70

34.38

2.6

2.3

7.07

7.44

g/l

7.88

584

3510

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1069

6970

1.51

34.36

1.9

2.1

7.18

7.39

g/l

4.02

963

6285

Major coronary heart disease event excluding revascularizations

1537

7309

1.42

33.90

2.2

2.4

7.72

7.39

g/l

10.24

1378

6487

Spondyloarthritis

417

2205

1.93

33.83

2.2

7.64

7.34

g/l

2.67

389

1982

Nonalcoholic fatty liver disease

257

1141

2.34

33.67

2.0

2.5

7.49

7.29

g/l

1.03

233

1050

Injuries to the elbow and forearm

1523

9613

1.41

33.55

2.0

2.3

7.39

7.38

g/l

0.06

1331

8660

Asthma and allergy

215

865

2.50

33.52

1.9

1.5

7.10

7.13

g/l

0.08

193

789

Open wound of lower leg

385

1993

1.99

33.48

1.9

2.2

7.54

7.46

g/l

0.35

339

1798

Rheumatism, unspecified

335

1653

2.08

33.37

2.1

2.3

7.48

7.47

g/l

0.04

312

1469

Other disorders of skin and subcutaneous tissue, not elsewhere classified

389

2030

1.98

33.14

2.2

2.1

7.68

7.47

g/l

1.44

337

1814

L01XX Other antineoplastic agents

211

873

2.57

32.99

3.5

2.4

6.72

7.45

g/l

10.35

195

789

Superficial injury of head

572

3352

1.74

32.98

2.1

2.2

7.56

7.46

g/l

0.61

507

2986

Allergic conjunctivitis

1106

7343

1.48

32.91

1.9

2.2

7.19

7.38

g/l

3.51

997

6637

L04AC Interleukin inhibitors

154

541

2.97

32.84

1.6

2.2

7.61

7.27

g/l

1.40

147

505

Acute upper respiratory infections

2340

10995

1.32

32.83

3.0

2.0

7.32

7.40

g/l

1.52

2128

9842

Myeloproliferative diseases

263

1197

2.30

32.74

2.8

2.4

6.92

7.44

g/l

5.86

234

1082

Other degenerative diseases of the nervous system

669

3021

1.68

32.65

1.9

2.3

7.39

7.55

g/l

1.54

558

2699

Decubitus ulcer and pressure area

207

852

2.56

32.52

1.8

2.3

8.08

7.50

g/l

4.02

178

755

Spondylopathies (FG)

275

1268

2.22

32.52

1.8

2.5

7.37

7.11

g/l

1.70

260

1157

Special screening examination for infectious and parasitic diseases

365

1345

2.02

32.48

2.4

2.1

6.89

7.14

g/l

1.99

326

1269

Solid cancers, helper endpoint

1738

7490

1.38

32.47

2.2

1.4

7.47

7.37

g/l

1.29

1585

6703

Sequelae of cerebrovascular disease

983

5658

1.53

32.41

2.0

2.3

7.53

7.44

g/l

0.79

826

5043

Artrosis, including avohilmo

1858

7490

1.37

32.36

2.0

2.3

7.38

7.30

g/l

1.23

1668

6793

Peripheral arterial reconstruction

518

2981

1.79

32.35

1.9

2.3

8.10

7.42

g/l

13.25

468

2631

Abnormal serum enzyme levels

783

4875

1.60

32.11

2.1

2.3

7.37

7.30

g/l

0.51

718

4396

Other and unspecified effects of external causes

548

3201

1.74

31.86

2.0

2.2

7.25

7.35

g/l

0.65

510

2925

Benign neoplasm of other and ill-defined parts of digestive system

490

2795

1.80

31.48

2.1

2.2

7.34

7.49

g/l

1.11

443

2504

Pacemaker

933

5963

1.53

31.45

2.1

2.3

7.29

7.51

g/l

3.34

815

5231

Hypoparathyroidism

137

468

3.14

31.23

1.7

2.3

7.49

7.57

g/l

0.18

116

423

All influenza (not pneumonia)

336

1699

2.02

31.17

4.3

1.8

7.31

7.21

g/l

0.44

301

1535

Allergic asthma (mode)

389

2016

1.91

31.07

1.9

1.6

7.36

7.20

g/l

1.01

361

1829

Gastric ulcer

485

2766

1.80

31.05

2.0

2.3

7.47

g/l

0.01

428

2454

Hypothyroidism, strict autoimmune

1470

6939

1.41

31.00

2.0

2.4

7.42

7.34

g/l

1.04

1318

6166

Other disorders of bone

419

2283

1.87

30.99

3.7

1.9

7.36

7.31

g/l

0.25

380

2112

Pain in thoracic spine

337

1710

2.02

30.95

2.8

2.1

7.20

7.40

g/l

1.36

314

1539

Other diseases of arteries and capillaries

260

1205

2.24

30.82

1.9

2.3

7.72

7.38

g/l

1.90

230

1085

Complications of internal orthopaedic prosthetic devices, implants and grafts

617

3767

1.68

30.78

2.0

2.2

7.64

7.48

g/l

1.33

541

3313

Cholelithiasis

1927

9981

1.34

30.78

2.3

7.48

7.37

g/l

2.13

1729

8930

Mycoses

625

3822

1.67

30.76

2.7

2.2

7.53

7.40

g/l

1.08

566

3436

DVT of lower extremities

503

2909

1.77

30.68

2.9

2.2

7.42

7.45

g/l

0.14

445

2605

Migraine with aura

423

2314

1.86

30.67

1.5

2.3

7.01

7.28

g/l

3.13

388

2124

Reactive arthropathies

212

902

2.43

30.58

2.1

2.4

7.32

7.26

g/l

0.20

188

822

Paralytic ileus and intestinal obstruction

624

3818

1.66

30.54

2.7

2.2

7.53

7.44

g/l

0.77

563

3404

Other inflammation of eyelid

353

1834

1.98

30.51

2.7

2.3

7.18

7.45

g/l

2.30

299

1661

Psoriasis

650

4021

1.65

30.51

1.8

2.3

7.62

7.33

g/l

4.10

594

3649

Substance abuse, excluding more controls

1182

7038

1.45

30.40

1.6

2.3

7.52

7.32

g/l

3.38

1029

6452

Disorders of skin appendages

946

6359

1.50

30.20

2.1

2.2

7.33

7.32

g/l

0.05

876

5764

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1127

5331

1.47

30.20

2.6

1.4

7.28

7.50

g/l

3.95

992

4698

Recurrent or chronic depression

763

3402

1.59

30.20

1.9

2.3

7.17

7.33

g/l

1.87

688

3168

Other general symptoms and signs

119

374

3.27

30.13

1.4

2.5

7.28

7.37

g/l

0.17

107

340

Adalimumab

206

872

2.43

30.00

1.4

2.3

7.55

7.27

g/l

1.47

195

812

Other chronic obstructive pulmonary disease, including avohilmo

1373

8185

1.41

29.57

1.8

2.4

7.84

7.38

g/l

16.64

1224

7321

Pyogenic arthritis

188

773

2.53

29.41

2.8

2.4

7.75

7.24

g/l

2.70

172

694

Migraine

862

4609

1.53

29.32

1.9

2.3

7.15

7.33

g/l

2.88

790

4212

Haemorrhage, not elsewhere classified

127

429

3.13

29.32

2.6

7.19

7.57

g/l

1.73

119

381

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

389

2116

1.89

29.23

1.9

1.4

7.49

7.44

g/l

0.19

365

1873

In situ neoplasms

928

6282

1.50

29.10

2.3

7.43

7.48

g/l

0.38

834

5548

Other and unspecified drugs and medicaments

234

1065

2.28

29.02

3.2

2.4

7.60

7.40

g/l

1.10

217

966

Superficial injury of lower leg

537

3204

1.71

29.00

1.8

2.2

7.43

7.41

g/l

0.09

470

2892

Myeloproliferative diseases (CML excluded)

237

1088

2.28

28.97

2.9

2.5

6.93

7.41

g/l

4.74

211

985

Injuries to unspecified part of trunk, limb or body region

270

1300

2.15

28.94

1.7

2.4

7.53

7.37

g/l

0.75

240

1179

Other diseases of lip and oral mucosa

886

5947

1.51

28.88

2.4

2.3

7.28

7.40

g/l

1.42

784

5366

Myocardial infarction

1233

6142

1.43

28.82

2.2

2.4

7.75

7.41

g/l

9.26

1097

5435

Etanercept

161

621

2.69

28.73

1.5

2.3

7.63

7.31

g/l

1.37

155

578

Other infectious diseases

230

1046

2.29

28.66

2.4

2.3

7.86

7.42

g/l

3.12

215

946

Sub-endpoint used in defining T1D endpoints

638

3924

1.62

28.50

1.7

2.1

7.85

7.33

g/l

10.09

589

3525

Personality disorders, excluding more controls

426

2389

1.81

28.47

1.7

2.2

7.14

7.23

g/l

0.53

386

2222

Other peripheral vascular diseases

224

1012

2.30

28.29

1.7

2.3

7.20

7.34

g/l

0.57

205

920

Charcot foot

181

4.47

28.17

2.4

2.8

7.85

7.12

g/l

2.21

163

Basal cell carcinoma, including avohilmo

1112

5348

1.45

28.06

2.5

1.4

7.33

7.50

g/l

2.53

979

4712

Atopic dermatitis

1013

5713

1.47

27.96

1.8

2.2

7.23

7.29

g/l

0.54

910

5201

Special screening examination for other diseases and disorders

235

1083

2.22

27.89

2.7

2.2

7.57

7.41

g/l

0.69

223

983

Hypocalcemia

260

3.81

27.87

4.1

2.6

7.55

7.45

g/l

0.18

242

Other metabolic disorders

281

1392

2.07

27.69

3.3

2.1

7.33

7.32

g/l

0.02

268

1259

Disorders of muscles

242

1135

2.19

27.67

1.6

2.1

7.33

7.34

g/l

0.03

224

1034

Other pleural conditions

313

1621

2.00

27.58

3.0

2.3

7.63

7.38

g/l

1.70

284

1432

Cerebral palsy and other paralytic syndromes

282

1406

2.07

27.46

1.9

2.3

7.31

7.39

g/l

0.34

254

1283

Other and unspecified aplastic anaemias

120

5.44

27.34

1.5

2.5

6.77

7.23

g/l

1.00

106

Meniscus derangement

1156

5498

1.43

27.09

2.1

2.3

7.35

7.27

g/l

0.71

1039

4945

Cervical disc disorders

797

5305

1.52

27.07

2.2

7.29

7.41

g/l

1.06

715

4757

Discitis, unspecified

183

4.39

26.98

3.4

2.0

8.44

7.23

g/l

4.75

165

Injuries to the ankle and foot

1333

8632

1.38

26.98

2.1

2.2

7.34

7.31

g/l

0.26

1208

7867

Hypertrophic cardiomyopathy

141

530

2.82

26.88

2.6

2.7

7.23

7.40

g/l

0.47

131

481

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

725

4738

1.55

26.88

2.3

2.2

7.34

7.43

g/l

0.63

652

4272

Phobic anxiety disorders

206

912

2.29

26.78

2.1

7.21

g/l

0.00

194

850

Progressive vascular leukoencephalopathy

148

574

2.76

26.72

2.1

2.4

7.53

7.67

g/l

0.40

124

506

Nonorganic sleeping disorders, excluding more controls

362

1974

1.87

26.70

1.6

2.3

7.11

7.34

g/l

1.79

330

1819

Diseases of external ear

766

5078

1.53

26.60

2.1

2.2

7.44

7.39

g/l

0.31

633

4579

Sequelae with surgical and medical care as external cause

522

3172

1.68

26.60

2.1

2.3

7.62

7.46

g/l

1.27

486

2830

Other viral diseases

647

4093

1.59

26.55

3.2

2.0

7.31

7.28

g/l

0.18

615

3750

Migraine without aura

307

1588

1.96

26.52

2.1

2.2

7.19

7.23

g/l

0.20

285

1471

Intracranial injury

1261

8659

1.39

26.43

2.1

2.2

7.31

7.40

g/l

1.13

1093

7779

Basal cell carcinoma

1070

5193

1.45

26.40

2.5

1.4

7.32

7.51

g/l

2.89

939

4571

Superficial injury of hip and thigh

376

2089

1.84

26.34

1.9

2.2

7.42

7.49

g/l

0.28

322

1873

Other enthesopathies

605

3811

1.61

26.31

1.9

2.3

7.33

7.34

g/l

0.04

548

3435

Infection of intervertebral disc (pyogenic)

157

4.71

26.30

2.1

2.2

8.23

7.20

g/l

3.42

140

Disorders of sclera, cornea, iris and ciliary body

1170

8414

1.41

26.25

2.1

2.2

7.42

7.37

g/l

0.47

1066

7575

Psoriatic arthropathies

226

1056

2.20

26.10

1.7

2.3

7.78

7.21

g/l

4.82

206

962

Gonarthrosis,primary

2141

10274

1.30

25.97

2.0

2.3

7.52

7.37

g/l

3.78

1910

9215

Protozoal diseases

109

364

3.22

25.94

6.0

2.6

7.54

7.29

g/l

0.73

103

330

Other viral diseases

526

3202

1.66

25.90

3.5

2.1

7.32

7.29

g/l

0.16

502

2934

Noninfectious colitis NAS

323

1724

1.92

25.74

2.6

2.2

7.45

7.46

g/l

0.02

295

1553

Myeloid leukaemia

103

335

3.31

25.67

1.8

2.6

6.85

7.34

g/l

2.08

302

Nonischemic cardiomyopathy

273

1383

2.04

25.52

2.3

2.2

7.22

7.32

g/l

0.40

249

1227

Valvular operations

354

1951

1.86

25.52

1.6

2.2

6.99

7.43

g/l

4.87

320

1712

Postprocedural endocrine and metabolic disorders, not elsewhere classified

261

1300

2.06

25.40

3.2

2.1

7.35

7.31

g/l

0.10

248

1181

Presence of other functional implants

1428

7348

1.36

25.15

2.2

7.56

7.46

g/l

1.29

1246

6571

1245

8218

1.38

25.04

1.6

2.3

7.41

7.31

g/l

1.19

1099

7505

Alcohol use disorder, Swedish definition

1188

7903

1.39

24.97

1.6

2.3

7.38

7.31

g/l

0.62

1045

7216

Other disorders of eye and adnexa

315

1685

1.91

24.92

1.9

2.3

7.28

7.40

g/l

0.61

292

1530

Other and unspecified acquired haemolytic anaemias

115

5.38

24.79

2.9

1.6

5.79

7.33

g/l

7.23

106

Sequelae of other external causes

160

664

2.51

24.70

2.7

2.5

7.50

7.36

g/l

0.46

155

602

Other symptoms and signs involving the circulatory and respiratory systems

166

699

2.46

24.65

2.3

7.19

7.43

g/l

1.02

146

627

Stomatitis and related lesions

426

2500

1.74

24.64

2.7

2.2

7.35

7.41

g/l

0.30

388

2259

Essential (haemorrhagic) thrombocythaemia

126

468

2.85

24.62

2.5

1.4

6.83

7.46

g/l

3.70

110

415

Heart failure and hypertrophic cardiomyopathy

235

3.80

24.44

3.0

2.6

7.48

7.36

g/l

0.19

209

Benign neoplasm: Sigmoid colon

511

3162

1.66

24.37

2.3

7.51

7.44

g/l

0.38

460

2831

Other encephalitis

278

3.44

24.26

2.0

2.5

7.23

7.36

g/l

0.25

256

Other overlap syndromes

179

4.18

24.26

1.8

2.4

7.06

7.42

g/l

1.11

164

Neuromuscular dysfunction of bladder

239

1177

2.10

24.24

2.0

2.5

7.19

7.31

g/l

0.50

220

1063

Viral pneumonia (known virus, not influenza)

305

3.34

24.16

6.3

2.5

7.21

7.39

g/l

0.40

270

Degeneration of macula and posterior pole

1252

7321

1.38

24.14

2.2

2.3

7.57

7.48

g/l

1.10

1075

6462

Disorders of the thyroid gland

2036

10367

1.29

24.10

2.1

2.3

7.39

7.37

g/l

0.20

1834

9314

1289

8388

1.37

24.03

1.6

2.3

7.40

7.31

g/l

0.96

1137

7663

Cardiodefibrillation

940

6620

1.44

23.88

2.1

2.3

7.24

7.47

g/l

3.97

859

5884

Encephalitis

296

3.33

23.86

1.9

2.4

7.24

7.32

g/l

0.16

273

Diabetic retinopathy

862

3685

1.49

23.82

1.8

2.0

7.92

7.78

g/l

1.46

781

3314

Other or unspecified ileus, impaction or obstruction

444

2661

1.70

23.77

2.5

2.2

7.53

7.42

g/l

0.67

400

2376

Cervicalgia

445

2670

1.70

23.68

2.1

2.2

7.27

7.45

g/l

1.36

393

2395

Disorders of synovium and tendon

1031

6448

1.41

23.65

1.9

2.3

7.39

7.35

g/l

0.34

934

5782

COPD, early/later onset

1171

7209

1.39

23.62

1.8

2.3

7.92

7.38

g/l

19.39

1041

6431

Other complications of surgical and medical care, not elsewhere classified

241

1201

2.07

23.60

2.5

2.3

7.56

7.38

g/l

0.81

217

1093

Other enthesopathy of foot (+metatarsalgia)

228

1113

2.10

23.54

2.2

7.28

7.35

g/l

0.26

208

1014

Myocardial infarction, strict

1139

5877

1.40

23.47

2.1

2.4

7.78

7.41

g/l

10.09

1018

5196

Bipolar affective disorders

328

1807

1.84

23.46

1.8

2.2

7.25

7.26

g/l

0.05

300

1674

Missing teeth due to accident, extraction or parodontitis

1394

9880

1.34

23.42

2.2

2.3

7.50

7.42

g/l

0.86

1161

8940

Metatarsalgia

219

1056

2.13

23.40

2.2

2.3

7.29

7.35

g/l

0.18

200

963

Diabetic maculopathy, excluding more controls

267

1383

1.98

23.40

1.4

2.3

8.11

7.19

g/l

13.24

245

1252

Benign neoplasm of other and unspecified endocrine glands

329

1826

1.85

23.32

2.3

7.39

7.44

g/l

0.22

289

1665

Radiculopathy

393

2295

1.75

23.25

2.4

2.2

7.30

7.48

g/l

1.35

356

2043

Systemic atrophies primarily affecting the central nervous system

138

554

2.63

23.09

1.4

2.7

6.80

7.36

g/l

4.53

129

501

Panic disorder

238

1191

2.03

22.76

1.6

2.3

7.31

7.28

g/l

0.11

219

1101

Fracture of foot, except ankle

476

2935

1.65

22.73

2.4

2.2

7.29

7.35

g/l

0.37

430

2693

Cramp and spasm

128

498

2.69

22.67

2.4

7.09

7.28

g/l

0.67

116

460

Idiopathic urticaria

178

4.00

22.65

1.2

1.9

6.94

7.40

g/l

1.43

168

Other/unspecified reactive arthropathies

165

721

2.37

22.65

2.3

2.4

7.32

7.29

g/l

0.07

147

667

Transient ischemic attack

1306

7902

1.35

22.54

2.1

2.3

7.36

7.46

g/l

1.14

1146

7045

Pneumonia derived septicemia

108

387

2.94

22.54

6.0

2.4

7.53

7.34

g/l

0.53

346

Myocardial infarction, without ST-elevation

1058

7000

1.40

22.47

2.1

2.3

7.74

7.43

g/l

6.66

931

6197

COPD related to multimorbidity

1038

6335

1.41

22.46

1.7

2.3

7.94

7.38

g/l

17.82

915

5638

Fracture of forearm

1158

7804

1.37

22.38

2.0

2.3

7.39

7.43

g/l

0.29

1003

6987

Angina pectoris

1362

6806

1.35

22.32

2.3

2.4

7.57

7.39

g/l

3.25

1245

6037

Non-selective monoamine reuptake inhibitors

840

5654

1.45

22.31

2.1

2.3

7.51

7.41

g/l

1.00

752

5074

Oter anti-inflammatory and antirheumatic agents, non-steroids

543

1870

1.63

22.26

2.4

2.3

7.50

7.34

g/l

1.15

485

1680

Paracetamol or NSAID medication

298

777

1.95

22.22

2.4

1.8

7.26

7.16

g/l

0.42

270

713

COPD, hospital admissions

1152

7168

1.38

22.21

1.8

2.3

7.91

7.38

g/l

18.45

1024

6390

Other skin changes

456

2808

1.66

22.15

3.3

2.3

7.31

7.50

g/l

1.55

403

2514

5-aminosalicylic acid

370

2150

1.75

22.09

1.8

2.3

7.23

7.16

g/l

0.31

338

1950

Budesonide

271

1440

1.92

21.87

1.9

2.4

7.20

7.19

g/l

0.01

244

1302

Herpesviral [herpes simplex] infections

463

2863

1.64

21.86

2.7

2.2

7.21

7.37

g/l

1.30

423

2597

Oxicams

540

1923

1.62

21.82

2.2

2.3

7.21

7.33

g/l

0.78

479

1732

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

328

3.06

21.74

1.5

2.0

7.26

7.35

g/l

0.18

306

Unspecified acute lower respiratory infection

335

1907

1.79

21.70

3.2

2.1

7.47

7.34

g/l

0.71

313

1726

Raynaud syndrome

198

948

2.15

21.65

1.5

2.5

6.88

7.35

g/l

3.30

181

869

Respiratory insufficiency

206

999

2.12

21.60

1.7

1.6

7.55

7.29

g/l

1.30

178

874

Carpal tunnel syndrome

1312

8712

1.34

21.60

2.3

7.49

7.37

g/l

1.74

1210

7801

Other extrapyramidal and movement disorders in other diseases

563

3663

1.57

21.59

2.2

7.18

7.46

g/l

3.65

502

3288

Faecal incontinence

243

1260

1.99

21.38

1.5

2.3

7.48

7.59

g/l

0.42

221

1110

Other respiratory disorders and diseases

528

3396

1.59

21.37

2.0

2.2

7.69

7.42

g/l

2.83

465

3010

Other diseases of the respiratory system

528

3396

1.59

21.37

2.0

2.2

7.69

7.42

g/l

2.83

465

3010

Elevated blood glucose level

201

977

2.12

21.16

2.0

2.2

7.75

7.32

g/l

2.40

172

892

Pneumococcal septicemia

103

373

2.91

21.11

5.9

2.5

7.52

7.29

g/l

0.68

335

Open wound of ankle and foot

233

1194

2.00

21.09

2.1

2.3

7.76

7.32

g/l

2.83

209

1099

Thyroiditis, ILD-related definition

234

1200

1.99

21.08

2.3

7.47

7.37

g/l

0.34

213

1085

Other embolism and thrombosis

317

1795

1.81

21.03

2.7

2.2

7.49

7.45

g/l

0.17

292

1604

Fissure and fistula of anal and rectal regions

493

3129

1.60

20.94

2.2

7.37

7.35

g/l

0.11

438

2838

Benign neoplasm: Transverse colon

300

1679

1.85

20.91

2.6

2.4

7.50

7.41

g/l

0.38

261

1512

Amputation of foot

344

3.03

20.89

1.6

2.7

8.08

7.32

g/l

3.01

304

Injury of unspecified body region

198

965

2.12

20.75

1.6

2.5

7.56

7.37

g/l

0.75

173

877

Benign neoplasm: Ascending colon

378

2262

1.72

20.73

2.2

2.3

7.45

7.48

g/l

0.10

332

2019

Generalized anxiety disorder

240

1246

1.95

20.68

1.7

2.3

6.95

7.28

g/l

2.32

217

1151

Recurrent aphthous stomatitis , including avohilmo

316

1795

1.80

20.68

2.7

2.2

7.33

7.48

g/l

0.80

289

1623

Eosinophilia

182

3.89

20.62

2.4

2.2

7.34

7.42

g/l

0.12

168

Amiodarone users

287

1595

1.86

20.51

2.0

2.3

7.27

7.41

g/l

0.68

267

1434

Vascular disorders of the intestines

195

950

2.13

20.51

2.4

2.1

7.63

7.47

g/l

0.65

179

835

Diseases of salivary glands

666

4532

1.49

20.47

2.2

7.30

7.41

g/l

0.87

585

4100

Mixed and other personality disorders

152

669

2.33

20.39

1.6

2.0

7.13

7.22

g/l

0.26

142

628

Extrapyramidal and movement disorders

897

6454

1.41

20.39

2.0

2.3

7.18

7.47

g/l

6.19

789

5754

Other and unspecified myopathies

236

1236

1.97

20.24

1.6

2.3

7.46

7.44

g/l

0.06

195

1108

Hydronephrosis

265

1440

1.89

20.13

1.7

2.1

7.73

7.36

g/l

2.66

248

1293

Inflammatory bowel disease

614

4126

1.51

20.05

2.1

2.3

7.26

7.32

g/l

0.38

558

3765

Chronic pancreatitis

306

1741

1.80

20.04

1.8

2.3

7.39

7.34

g/l

0.20

278

1580

Other specified and unspecified disorders of eye and adnexa

113

443

2.68

19.84

2.2

2.4

7.16

7.34

g/l

0.52

104

402

Retinal detachments and breaks

856

6148

1.41

19.71

2.5

2.3

7.36

7.42

g/l

0.45

768

5496

Ascites

201

1005

2.07

19.71

1.5

2.4

6.74

7.44

g/l

6.70

186

897

Hyperplasia of prostate

865

3479

1.43

19.63

2.5

2.4

7.14

7.38

g/l

3.34

786

3171

Suppurative and necrotic conditions of lower respiratory tract

160

736

2.27

19.62

2.8

2.5

7.95

7.30

g/l

3.40

150

661

Acute pancreatitis

456

2892

1.61

19.60

1.8

2.3

7.50

7.38

g/l

0.75

415

2596

Spondylolisthesis/Spondylolysis

388

2366

1.67

19.55

2.5

2.2

7.36

7.45

g/l

0.52

350

2121

Other viral hepatitis

125

515

2.50

19.52

2.2

1.9

7.41

7.16

g/l

0.76

116

483

Enthesopathies of lower limb, excluding foot

429

2680

1.62

19.51

2.2

7.25

7.36

g/l

0.66

387

2420

Substance abuse

1182

8376

1.34

19.51

1.6

2.3

7.52

7.29

g/l

4.29

1029

7645

Fracture of lower leg, including ankle

1150

8566

1.34

19.42

2.0

2.3

7.51

7.37

g/l

1.94

1010

7713

Bronchiectasis

230

1215

1.96

19.33

2.7

2.5

7.66

7.42

g/l

1.33

213

1075

Migraine with aura and triptan purchases

237

1256

1.91

19.26

1.4

1.9

7.02

7.32

g/l

2.30

223

1146

Vitamin B12 deficiency anaemia

276

1542

1.84

19.26

1.9

2.4

7.37

7.44

g/l

0.27

247

1373

Localized swelling, mass and lump of skin and subcutaneous tissue

661

4548

1.47

19.24

2.2

7.29

7.43

g/l

1.28

595

4082

Disorders of adult personality and behaviour

455

2890

1.59

19.20

1.7

2.1

7.12

7.23

g/l

0.76

413

2683

Psoriasis vulgaris

407

2526

1.64

19.15

1.7

2.2

7.60

7.34

g/l

2.31

369

2312

Other hammer toe(s) (acquired)

395

2239

1.66

19.14

1.9

2.5

7.62

7.42

g/l

1.38

339

1961

Disease of hard tissues of teeth, NOS

1223

4802

1.34

19.03

2.2

2.1

7.32

7.45

g/l

1.57

1100

4330

Hallux valgus (acquired)

663

3259

1.48

18.94

2.1

2.4

7.54

7.33

g/l

2.24

580

2902

Mental and behavioural disorders due to psychoactive substance use

1214

8550

1.33

18.94

1.6

2.3

7.52

7.29

g/l

4.55

1059

7793

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

262

1451

1.86

18.87

1.8

1.4

7.94

7.46

g/l

3.26

237

1271

Persistent mood disorders

394

2434

1.65

18.83

2.0

2.2

7.37

7.42

g/l

0.23

359

2207

Persons encountering health services in other circumstances

738

5171

1.43

18.80

2.3

2.2

7.27

7.36

g/l

0.89

685

4604

Pyothorax

127

540

2.46

18.79

3.1

2.5

7.86

7.30

g/l

2.11

119

487

Carcinoma in situ of skin of scalp and neck

102

395

2.79

18.73

1.7

2.6

7.35

7.49

g/l

0.41

352

Drug-induced polyneuropathy

5.03

18.62

13.7

1.3

6.88

7.58

g/l

1.98

Diagnoses used for exclusion with ILD

604

4120

1.49

18.50

2.1

2.2

7.43

7.40

g/l

0.13

538

3688

Dilated cardiomyopathy

313

1839

1.75

18.43

1.7

2.3

7.32

7.35

g/l

0.10

284

1664

Other disorders of glucose regulation and pancreatic internal secretion

194

980

2.03

18.40

1.9

2.3

7.56

7.39

g/l

0.68

174

888

Memory loss

257

1429

1.86

18.39

2.1

2.4

7.23

7.49

g/l

1.67

218

1293

Ankylosing spondylitis

185

918

2.06

18.39

1.7

2.1

7.37

7.29

g/l

0.28

175

843

Other disorders of eyelid

1064

7607

1.35

18.33

2.0

2.3

7.46

7.48

g/l

0.15

941

6759

Sarcoidosis

307

1794

1.75

18.31

1.9

2.2

7.25

7.39

g/l

0.78

285

1638

Scoliosis

169

812

2.13

18.29

2.3

2.2

7.17

7.43

g/l

1.21

150

729

Guillain-Barre syndrome

168

3.79

18.24

2.5

2.2

7.32

7.29

g/l

0.03

153

Atopic dermatitis, strict definition with reimbursement

428

2615

1.60

18.23

1.8

2.0

7.12

7.26

g/l

1.01

386

2411

Vasomotor and allergic rhinitis

638

4316

1.46

18.22

2.1

7.05

7.32

g/l

4.28

572

3928

Nonorganic sleeping disorders

362

2209

1.66

18.14

1.6

2.2

7.11

7.30

g/l

1.35

330

2036

COPD, hospital admissions 3, with asthma pneumonia sepsis

714

4296

1.44

18.13

1.9

2.4

8.03

7.39

g/l

15.61

634

3790

1055

7272

1.35

18.05

2.7

2.2

7.38

7.52

g/l

1.78

925

6395

Collagenous colitis

224

1199

1.92

17.99

3.0

2.4

7.47

7.42

g/l

0.16

201

1086

Bullous disorders

167

809

2.15

17.99

2.0

2.4

7.11

7.45

g/l

2.20

156

731

Disorders of vitreous body and globe

1175

8623

1.32

17.93

2.3

7.31

7.45

g/l

2.15

1059

7705

KRA_PSY_EATING, excluding more controls

348

2.73

17.92

1.6

1.7

7.14

7.18

g/l

0.08

324

Exclusions for E4_PCOS_BROAD

333

1996

1.70

17.90

2.9

2.2

7.33

7.34

g/l

0.03

308

1830

Folate deficiency anaemia

117

4.49

17.76

2.1

1.7

7.12

7.34

g/l

0.30

106

Congenital malformations, deformations and chromosomal abnormalities

1135

7946

1.33

17.70

1.8

2.2

7.19

7.33

g/l

1.84

1029

7228

Conjunctivitis (acute, non atopic)

516

3424

1.52

17.66

2.7

2.1

7.22

7.41

g/l

1.72

475

3113

Viral hepatitis

145

666

2.23

17.66

2.1

2.0

7.39

7.22

g/l

0.48

132

618

Coxarthrosis, primary

1447

9618

1.29

17.65

2.1

2.3

7.54

7.44

g/l

1.30

1280

8551

Actinic keratosis

990

6856

1.36

17.61

2.7

2.2

7.38

7.53

g/l

1.83

868

6019

COPD, hospital admission 2, with asthma infections

813

5045

1.40

17.60

1.8

2.3

8.01

7.39

g/l

17.71

721

4479

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

243

1344

1.86

17.60

2.8

2.4

7.46

7.38

g/l

0.27

221

1228

COPD-related respiratory insufficiency

326

1962

1.71

17.59

1.9

2.4

8.07

7.37

g/l

8.14

283

1724

Vitreous haemorrhage

251

1405

1.84

17.48

2.0

2.4

7.72

7.45

g/l

1.48

233

1273

Intestinal stricture

727

5188

1.42

17.45

2.6

2.2

7.50

7.43

g/l

0.46

650

4615

Cutaneous lupus erythematosus

276

3.04

17.44

2.1

7.28

7.50

g/l

0.49

251

Heartburn

237

1303

1.86

17.37

2.0

2.3

7.22

7.42

g/l

1.05

206

1163

Candidiasis

296

1737

1.74

17.37

3.1

2.2

7.58

7.43

g/l

0.77

263

1566

Chronic tubulo-interstitial nephritis

104

418

2.59

17.34

2.1

7.32

7.41

g/l

0.20

379

Familial hypercholesterolemia

365

2266

1.64

17.29

2.3

2.2

7.69

7.40

g/l

2.52

320

1979

Herpesviral [herpes simplex] infections

249

1393

1.83

17.26

3.2

2.3

7.36

7.38

g/l

0.07

230

1267

Invasive ventilation

188

964

2.01

17.24

2.6

2.4

7.88

7.36

g/l

2.70

169

872

Benign neoplasm: Stomach

258

1465

1.81

17.20

2.3

2.4

7.38

7.47

g/l

0.31

230

1319

Use of pramipexole

530

3582

1.51

17.13

1.9

2.3

7.30

7.48

g/l

1.54

457

3198

Agoraphobia

173

3.51

17.13

1.7

7.30

7.20

g/l

0.14

165

Crystal arthropathies, rheuma endpoint

221

3.30

17.08

1.7

3.3

8.08

7.11

g/l

3.19

192

Diplopia

304

1808

1.72

17.04

2.0

2.2

7.30

7.45

g/l

0.88

277

1637

Primary biliary cholangitis (PBC)

226

3.24

17.03

1.4

1.9

7.83

7.39

g/l

1.36

207

Disorders of vitreous body

1138

8427

1.32

16.99

2.3

7.29

7.46

g/l

2.54

1026

7535

Skin changes due to chronic exposure to nonionizing radiation

1005

6985

1.35

16.99

2.7

2.2

7.38

7.53

g/l

1.91

882

6133

Cyst of kidney

198

1041

1.97

16.96

2.5

2.6

7.60

7.42

g/l

0.77

190

943

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

417

2662

1.58

16.95

1.9

2.2

7.36

7.27

g/l

0.51

370

2467

Sequelae of injuries of lower limb

203

1072

1.94

16.94

2.1

2.4

7.43

7.30

g/l

0.53

189

987

Fall on and from stairs and steps

553

3774

1.49

16.91

2.2

7.54

7.43

g/l

0.77

482

3394

Restless leg syndrome

307

1836

1.71

16.87

2.0

2.3

7.15

7.47

g/l

2.61

272

1666

Ulcerative colitis

474

3145

1.53

16.60

2.2

7.28

7.33

g/l

0.29

428

2868

Other disorders of ear

1993

10643

1.23

16.60

2.2

7.31

7.41

g/l

1.57

1752

9620

Abnormal findings in nipple discharge synovial fluid wound secretions

145

3.85

16.57

3.4

2.1

7.48

7.50

g/l

0.03

133

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1028

7569

1.33

16.57

2.3

2.2

7.13

7.37

g/l

4.86

925

6857

Substance use, excluding alcohol

357

2223

1.63

16.55

1.5

2.3

7.65

7.26

g/l

4.09

298

2067

Carcinoma in situ of skin of other and unspecified parts of face

253

1449

1.81

16.51

2.1

2.4

7.56

7.58

g/l

0.07

234

1273

Other diseases of pancreas

213

1157

1.90

16.45

2.1

2.4

7.45

7.40

g/l

0.16

190

1044

111

468

2.41

16.41

1.4

1.7

6.81

7.06

g/l

0.91

106

440

Other and unspecified local infections of skin and subcutaneous tissue

216

1177

1.88

16.39

2.9

2.3

7.53

7.36

g/l

0.77

195

1078

Fenamates

321

1304

1.70

16.31

2.0

2.2

7.43

7.31

g/l

0.58

288

1172

Iridocyclitis

474

3162

1.52

16.26

2.4

2.2

7.57

7.40

g/l

1.43

434

2853

Other/unspecified rheumatoid arthritis

310

1879

1.69

16.25

1.8

2.3

7.84

7.53

g/l

2.03

279

1662

Hypermobility syndrome

341

2.68

16.21

2.1

1.8

7.21

7.35

g/l

0.32

330

Inflammatory diseases of the central nervous system

186

970

1.97

16.17

2.7

2.3

7.34

g/l

0.00

161

883

Alcoholic liver disease

245

1396

1.80

16.11

1.3

2.4

7.13

7.32

g/l

0.83

205

1280

Alcohol induced polyneuropathy

112

4.33

16.09

1.3

2.0

7.11

7.30

g/l

0.29

100

Migraine without aura and triptan purchases

227

1258

1.83

16.09

1.5

1.9

7.15

7.30

g/l

0.78

212

1160

Fibroblastic disorders

502

3401

1.50

15.96

2.3

7.35

7.39

g/l

0.21

447

3034

Other local infections of skin and subcutaneous tissue

227

1267

1.83

15.94

2.9

2.3

7.52

7.37

g/l

0.64

202

1160

Other specified/unspecified bacterial intestinal infections

168

852

2.04

15.94

3.2

2.4

7.55

7.36

g/l

0.65

146

778

Personality disorders

426

2785

1.55

15.94

1.7

2.1

7.14

7.24

g/l

0.68

386

2584

Abnormal results of function studies

194

1031

1.93

15.94

2.4

2.5

7.26

7.33

g/l

0.21

175

952

Cervicobrachial syndrome

410

2664

1.56

15.85

2.1

2.2

7.23

7.38

g/l

1.02

386

2388

Other inflammatory liver diseases

160

799

2.07

15.82

1.7

2.7

7.65

7.31

g/l

1.49

140

731

Thyrotoxicosis

514

3505

1.49

15.81

1.8

2.2

7.52

7.45

g/l

0.41

457

3142

Chronic viral hepatitis

399

2.52

15.79

1.9

1.8

7.46

7.09

g/l

1.19

381

Benign neoplasm: Adrenal gland

201

1087

1.91

15.79

2.0

2.6

7.42

7.38

g/l

0.11

176

990

Congenital malformations, deformations and chromosomal abnormalities

998

7219

1.33

15.74

1.9

2.2

7.19

7.31

g/l

1.31

907

6572

Insulin, fast-acting (human)

259

1504

1.75

15.74

1.6

2.1

7.78

7.25

g/l

4.86

238

1385

Nummular dermatitis

197

1058

1.92

15.74

2.3

2.5

7.30

7.37

g/l

0.25

180

958

Acute posthaemorrhagic anaemia

396

2.56

15.72

3.1

2.6

7.48

7.53

g/l

0.09

350

Special screening examination for neoplasms

131

608

2.22

15.65

3.0

2.1

7.44

7.42

g/l

0.03

115

556

Benign neoplasm: Caecum

283

1697

1.72

15.58

2.7

2.3

7.41

7.48

g/l

0.32

254

1532

Haemorrhoids and perianal venous thrombosis

669

4791

1.41

15.50

2.3

7.40

7.44

g/l

0.18

600

4268

Demyelinating diseases of the central nervous system

160

803

2.04

15.48

1.6

2.1

6.99

7.30

g/l

1.59

148

742

Traumatic subdural haemorrhage

315

1858

1.66

15.47

2.2

2.3

7.14

7.60

g/l

5.50

266

1659

Sequelae of injuries, of poisoning and of other consequences of external causes

469

3156

1.51

15.43

2.5

2.3

7.43

7.32

g/l

0.71

419

2890

Other viral diseases, not elsewhere classified

435

2862

1.53

15.41

3.0

2.1

7.37

7.31

g/l

0.26

412

2618

Thyrotoxicosis, other and/or unspecified

397

2580

1.56

15.40

1.9

2.2

7.48

7.42

g/l

0.28

357

2326

Other and unspecified visual disturbances

230

1305

1.81

15.33

2.5

2.2

7.33

7.41

g/l

0.28

212

1184

Acute pancreatitis (for exclusion)

456

3059

1.52

15.32

1.8

2.3

7.50

7.40

g/l

0.61

415

2756

Diseases of male genital organs

1038

3962

1.33

15.32

2.1

2.3

7.17

7.32

g/l

1.88

959

3632

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

314

1934

1.66

15.31

2.4

1.4

7.37

7.56

g/l

1.18

277

1661

Lesion of lateral popliteal nerve

122

557

2.27

15.28

2.3

7.17

7.25

g/l

0.22

110

508

Problems related to lifestyle

186

987

1.92

15.25

1.5

2.3

7.53

7.26

g/l

1.10

170

898

Abnormality of white blood cells, not elsewhere classified

4.75

15.22

1.9

1.7

7.19

7.53

g/l

0.43

Other and unspecified urticaria

358

2279

1.59

15.19

2.3

2.1

7.30

7.39

g/l

0.49

323

2075

Diseases of the ear and mastoid process

2344

9794

1.21

15.17

2.2

7.29

7.37

g/l

1.23

2100

8894

Other viral diseases, not elsewhere classified

328

2043

1.62

15.07

3.2

2.1

7.45

7.32

g/l

0.61

313

1869

Other shoulder lesions

186

993

1.91

15.02

1.6

2.1

7.46

7.31

g/l

0.53

171

911

Disorders of vestibular function (Vertigo)

1040

7890

1.31

14.94

2.0

2.3

7.44

7.45

g/l

0.07

911

7014

Juvenile arthritis (FINNGEN)

247

2.90

14.92

1.8

2.0

7.33

7.06

g/l

0.66

231

Speech disturbances, not elsewhere classified

224

1274

1.81

14.89

1.8

2.4

7.29

7.46

g/l

0.67

190

1153

Thoracic aortic aneurysm

349

2228

1.60

14.86

2.1

2.4

7.13

7.27

g/l

0.80

306

2019

Allergic urticaria

160

816

2.01

14.83

2.0

2.3

7.40

7.34

g/l

0.18

146

751

Other and unspecified injuries of head

162

832

2.00

14.80

1.6

2.3

7.25

7.46

g/l

0.62

138

751

Transport accidents

783

4982

1.36

14.66

1.8

2.2

7.21

7.34

g/l

1.45

707

4611

Oesophageal varices

113

511

2.30

14.59

1.5

2.5

7.04

7.38

g/l

1.18

100

465

Benign neoplasm: Rectum, anus and anal canal

491

3380

1.48

14.58

2.1

2.3

7.43

7.46

g/l

0.10

446

3021

Fracture of skull and facial bones

419

2791

1.52

14.50

2.6

2.2

7.23

7.34

g/l

0.62

371

2559

Other crystal arthropathies

244

2.98

14.44

1.7

2.3

8.08

7.23

g/l

2.60

213

Neuralgia and neuritis, unspecified

116

531

2.25

14.41

2.6

2.3

7.39

7.35

g/l

0.11

104

486

Hypothyroidism, other/unspecified

1810

9763

1.23

14.36

2.1

2.3

7.39

7.37

g/l

0.19

1628

8763

Diseases of inner ear

1194

9108

1.28

14.34

1.9

2.3

7.45

7.42

g/l

0.16

1049

8132

Internal derangement of knee

666

4814

1.39

14.33

1.9

2.3

7.40

7.24

g/l

1.53

588

4349

Delirium, not induced by alcohol and other psychoactive substances

309

1930

1.63

14.32

2.0

2.3

7.62

7.45

g/l

0.91

263

1726

Early onset COPD

498

3447

1.47

14.31

2.0

2.4

7.91

7.29

g/l

11.20

452

3114

Mucosal proctocolitis

232

1346

1.75

14.22

2.2

2.3

7.24

7.26

g/l

0.08

220

1243

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

301

2.67

14.13

1.5

1.7

7.78

7.08

g/l

2.39

289

Aortic aneurysm

561

3906

1.43

14.02

2.1

2.3

7.29

7.32

g/l

0.16

491

3490

Pain and other conditions associated with female genital organs and menstrual cycle

296

1682

1.63

13.97

1.9

2.0

7.23

7.38

g/l

0.85

263

1529

Barrett oesophagus

131

639

2.13

13.96

2.2

2.7

7.48

7.36

g/l

0.31

117

583

Allergic rhinitis

453

3049

1.48

13.96

2.2

2.1

7.02

7.29

g/l

2.84

408

2808

Other bursopathies

284

1751

1.65

13.92

2.2

7.45

7.42

g/l

0.09

260

1574

Microscopic polyangiitis

4.74

13.85

1.4

1.9

8.28

7.62

g/l

1.07

Hypoglycaemia, other or unspecified

150

768

2.00

13.84

1.6

2.3

7.60

7.37

g/l

0.83

137

699

Fall involving bed

101

447

2.37

13.83

2.4

2.5

7.82

7.56

g/l

0.70

394

Alcohol-induced chronic pancreatitis

151

778

2.00

13.75

1.8

2.5

7.37

7.22

g/l

0.42

132

721

Viral haemorrhagic fevers, not elsewhere classified/unspecified

329

2106

1.59

13.74

2.5

2.2

7.32

7.38

g/l

0.32

305

1915

Open wound of forearm

196

1096

1.83

13.73

2.0

2.3

7.57

7.37

g/l

0.86

175

1001

Epilepsy

604

4341

1.40

13.68

1.9

2.4

7.31

7.39

g/l

0.50

524

3919

Congenital malformations of the urinary system

126

609

2.13

13.63

1.9

2.5

7.39

7.31

g/l

0.19

120

560

Unspecified nephritic syndrome

258

2.82

13.51

2.0

2.5

7.77

7.35

g/l

1.11

234

Dermatophytosis

1207

9594

1.27

13.49

2.1

2.2

7.26

7.37

g/l

1.31

1063

8671

Biomechanical lesions, not elsewhere classified

128

627

2.12

13.49

2.3

2.5

7.35

7.42

g/l

0.20

120

571

Traumatic subarachnoid haemorrhage

375

2.46

13.48

2.4

2.1

6.95

7.53

g/l

2.43

342

Intestinal malabsorption

110

508

2.24

13.45

1.9

2.6

7.22

7.26

g/l

0.09

104

462

Tubulo-interstitial nephritis, not specified as acute or chronic

153

797

1.97

13.43

2.5

2.0

7.56

7.38

g/l

0.64

138

720

Misadventures to patients during surgical and medical care

311

1979

1.60

13.40

1.8

2.2

7.62

7.43

g/l

1.01

280

1782

Congenital malformations of the urinary system

118

562

2.16

13.28

1.9

2.4

7.46

7.28

g/l

0.48

113

517

Keratitis

686

5079

1.36

13.20

2.1

2.2

7.37

7.34

g/l

0.16

619

4585

Other lack of coordination

179

3.21

13.17

1.7

2.8

6.99

7.32

g/l

0.80

162

Arthropathic psoriasis

238

1424

1.71

13.16

1.6

2.4

7.82

7.32

g/l

3.91

216

1311

Intestinal adhesions without obstruction

195

1106

1.81

13.11

3.3

2.1

7.48

7.43

g/l

0.16

173

990

Dermatitis due to substances taken internally

120

582

2.12

12.91

3.9

2.6

7.42

7.43

g/l

0.02

112

529

Cardiac arrest

132

560

2.06

12.90

2.2

2.3

7.70

7.08

g/l

3.07

119

495

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

303

1872

1.59

12.88

1.7

2.2

7.18

7.36

g/l

0.94

274

1710

Mental and behavioural disorders due to alcohol

1009

7593

1.29

12.88

1.6

2.3

7.47

7.30

g/l

2.44

891

6940

Other diseases of stomach and duodenum

159

853

1.92

12.86

2.0

2.6

7.70

7.50

g/l

0.80

147

773

Mantle cell lymphoma, including Hilmo

156

3.37

12.84

2.4

1.3

6.97

7.40

g/l

1.08

137

Postviral fatigue syndrome

6.30

12.76

1.1

2.1

6.46

6.94

g/l

0.90

Atopic dermatitis, strict definition

397

2628

1.49

12.71

1.8

2.0

7.11

7.24

g/l

0.91

363

2436

Hypothyreosis and Thyroxine purchase for inclusion criteria

1873

10237

1.21

12.71

2.1

2.2

7.40

7.37

g/l

0.29

1685

9179

Spirochaetal infections, other/unspecified

202

1170

1.77

12.68

2.2

2.5

7.05

7.39

g/l

2.02

162

1060

Artificial opening status

141

732

1.99

12.65

3.0

2.2

7.71

7.49

g/l

0.84

128

665

Acute gastritis

178

994

1.84

12.64

1.8

2.5

7.55

7.48

g/l

0.17

157

901

Other specified/unspecified soft tissue disorders

115

554

2.14

12.63

2.3

2.1

7.55

7.43

g/l

0.33

109

492

Cholecystectomy

1505

10640

1.23

12.62

2.3

2.2

7.47

7.39

g/l

0.93

1355

9497

Pemphigoid

383

2.42

12.61

1.6

2.5

7.13

7.57

g/l

1.94

340

Myocarditis

348

2.44

12.60

2.2

2.1

6.97

6.98

g/l

0.03

313

Poisoning by drugs, medicaments and biological substances

378

2540

1.50

12.56

1.9

2.2

7.51

7.26

g/l

2.13

337

2356

Colectomy operation

398

2713

1.49

12.52

2.6

2.3

7.67

7.45

g/l

1.60

357

2416

Ptosis of eyelid

270

1693

1.63

12.52

2.6

2.4

7.32

7.50

g/l

1.15

250

1524

Drug-induced cataract

257

2.74

12.49

2.4

7.18

7.34

g/l

0.32

236

Ankylosing spondylitis, ICD10

174

968

1.84

12.46

1.7

2.4

7.38

7.28

g/l

0.34

164

896

Otitis externa

426

2941

1.47

12.42

2.1

2.2

7.38

7.40

g/l

0.07

364

2684

Fentanyl

228

1368

1.70

12.41

5.5

1.7

7.84

7.40

g/l

2.93

191

1199

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

280

1714

1.60

12.33

1.8

2.3

7.16

7.36

g/l

0.98

254

1573

Mixed hyperlipidaemia

103

481

2.22

12.32

1.6

2.2

7.98

7.27

g/l

3.44

437

Other disorders of the musculoskeletal system and connective tissue

330

2172

1.55

12.30

2.3

7.52

7.44

g/l

0.38

306

1967

Arthropod-borne viral fevers and viral haemorrhagic fevers

366

2458

1.51

12.30

2.6

2.2

7.38

7.39

g/l

0.04

342

2229

Poisoning by medicine

341

2254

1.53

12.29

2.0

2.2

7.51

7.24

g/l

2.01

305

2092

Primary gonarthrosis, bilateral

1182

8118

1.26

12.27

1.9

2.4

7.63

7.41

g/l

4.87

1046

7223

Other localized connective tissue disorders

214

2.91

12.26

2.7

2.1

7.23

7.49

g/l

0.48

195

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

552

4008

1.39

12.11

1.5

2.5

8.25

7.10

g/l

42.29

508

3667

Glucagon-like peptide-1 (GLP-1) analogues

552

4008

1.39

12.11

1.5

2.5

8.25

7.10

g/l

42.29

508

3667

Mental disorders, not otherwise specified

141

740

1.94

12.09

1.7

2.1

7.24

g/l

0.01

135

689

Total colectomy operation

439

2.26

12.07

2.6

7.49

7.22

g/l

0.79

404

Total colectomy

439

2.26

12.07

2.6

7.49

7.22

g/l

0.79

404

Squamous cell neoplasms and carcinomas of the skin

209

1239

1.73

12.06

2.3

1.4

7.37

7.52

g/l

0.62

183

1057

Benign neoplasm: Rectum

432

3015

1.46

12.05

2.1

2.3

7.45

7.44

g/l

0.04

392

2698

Diabetic retinopathy, strict definition

387

2328

1.50

12.04

1.7

1.9

8.02

7.75

g/l

2.17

346

2089

Psoriatic arthropathies, ICD10

220

1323

1.70

12.00

1.7

2.4

7.78

7.32

g/l

3.26

200

1213

Ocular pain

163

900

1.85

11.98

1.6

2.4

7.38

7.35

g/l

0.09

151

821

Malignant melanoma, including Hilmo

376

2557

1.49

11.95

2.3

1.4

7.33

7.48

g/l

0.84

328

2261

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

102

478

2.17

11.92

1.5

1.8

7.57

7.15

g/l

1.56

455

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

549

3968

1.39

11.91

2.0

2.1

7.25

7.27

g/l

0.13

498

3665

Synovial cyst of popliteal space [Baker]

166

925

1.84

11.89

2.6

2.2

7.55

7.47

g/l

0.25

152

831

Other diseases of oesophagus

220

1328

1.69

11.84

1.9

2.5

7.42

7.45

g/l

0.10

203

1197

Mental and behavioural disorders due to alcohol, excluding acute intoxication

880

6821

1.29

11.84

1.6

2.3

7.46

7.29

g/l

2.15

772

6238

Adhesive capsulitis of shoulder

335

2230

1.52

11.79

1.8

2.2

7.65

7.39

g/l

1.69

302

2008

Personal history of other diseases and conditions

160

877

1.84

11.76

4.1

1.9

7.16

7.38

g/l

0.93

141

806

Malignant neoplasm of kidney, except renal pelvis

208

1241

1.72

11.75

1.8

1.4

7.89

7.47

g/l

2.15

187

1085

Vitamin deficiency, wide

112

550

2.10

11.74

2.4

7.28

7.29

g/l

0.01

499

Vitamin deficiency

112

550

2.10

11.74

2.4

7.28

7.29

g/l

0.01

499

Anterior Iridocyclitis

404

2794

1.47

11.73

2.4

2.2

7.55

7.40

g/l

1.11

371

2532

Personal history of malignant neoplasm

152

829

1.88

11.70

2.8

1.8

7.86

7.56

g/l

0.96

138

753

Lesion of ulnar nerve

284

1829

1.58

11.67

2.0

2.1

7.47

7.32

g/l

0.75

263

1677

Hernia of abdominal wall

955

7540

1.28

11.57

2.3

7.51

7.37

g/l

1.82

879

6780

Paraplegia, diplegia of upper limbs

238

2.73

11.56

1.8

2.5

7.93

7.18

g/l

2.49

217

Macular pucker

385

2654

1.48

11.55

1.9

2.5

7.53

7.47

g/l

0.26

327

2363

Benign neoplasm: Rectosigmoid junction

115

576

2.08

11.55

2.0

2.7

7.36

7.40

g/l

0.09

106

519

Temporomandibular joint disorders, including avohilmo

673

4996

1.34

11.53

2.1

7.08

7.32

g/l

3.71

610

4552

Superficial injury of abdomen, lower back and pelvis

282

1817

1.57

11.52

2.0

2.2

7.25

7.41

g/l

0.80

256

1652

Olecranon bursitis

139

741

1.93

11.50

2.3

2.1

7.31

g/l

0.02

127

677

Asthma and opportunity respiratory infection

129

675

1.98

11.42

2.4

2.7

7.80

7.40

g/l

1.77

121

598

Viral and other specified intestinal infections

385

2551

1.47

11.39

2.1

2.0

7.47

7.27

g/l

1.61

362

2327

Sulfonylureas

863

5352

1.30

11.39

1.8

2.4

8.16

7.28

g/l

37.12

762

4692

Carcinoma in situ of other and unspecified digestive organs

452

2.22

11.38

2.0

2.8

7.32

7.38

g/l

0.13

405

Mental and behavioural disorders due to sedatives or hypnotics

124

637

1.99

11.38

1.4

2.1

7.45

7.20

g/l

0.94

108

590

Adrenocortical insufficiency

386

2.31

11.36

2.7

2.6

7.46

7.38

g/l

0.15

360

Other and unspecified glaucoma

188

1105

1.75

11.31

2.0

2.5

7.63

7.51

g/l

0.41

163

970

Exposure to other and unspecified inanimate mechanical forces

141

758

1.90

11.31

2.3

2.4

7.31

7.29

g/l

0.05

135

691

Background retinopathy and retinal vascular changes

247

2.68

11.30

1.7

2.7

7.51

7.40

g/l

0.19

225

Malignant neoplasm of urinary organs

224

1377

1.66

11.29

1.7

1.4

7.95

7.47

g/l

2.86

203

1206

Unstable angina pectoris

876

5399

1.29

11.27

2.2

2.4

7.72

7.43

g/l

5.65

793

4744

Exfoliative dermatitis

112

3.64

11.27

1.5

2.5

7.40

7.32

g/l

0.10

Retinal vascular occlusion

299

1968

1.55

11.26

2.4

2.3

7.49

7.51

g/l

0.07

270

1732

Ventral hernia

513

3736

1.39

11.14

2.5

2.2

7.52

7.44

g/l

0.51

466

3338

Other specified/unspecified hearing loss

205

1237

1.70

11.13

2.6

2.3

7.24

7.46

g/l

1.12

192

1113

Social phobias

102

491

2.10

11.10

1.8

7.10

7.25

g/l

0.37

464

Other congenital malformations

202

1212

1.69

11.03

1.7

2.3

7.12

7.35

g/l

1.21

188

1118

Other and unspecified mood [affective] disorders

102

493

2.10

11.03

1.6

2.0

7.19

7.27

g/l

0.18

458

Exclusions for E4_PCOS_CONSORTIUM

1241

6305

1.24

11.00

2.1

7.49

7.39

g/l

1.02

1100

5669

Other disorders of adrenal gland

463

2.16

10.97

2.6

2.5

7.41

7.37

g/l

0.08

430

Inflammatory diseases of female pelvic organs

1012

5922

1.26

10.92

1.7

2.2

7.44

g/l

0.05

893

5303

Retinal vascular disorders

301

1998

1.54

10.90

2.4

2.3

7.50

7.51

g/l

0.06

272

1760

Symptoms and signs involving emotional state

244

2.62

10.90

1.7

1.9

7.61

7.44

g/l

0.34

222

Fall on same level involving ice and snow

1130

9157

1.24

10.88

2.0

2.3

7.33

7.41

g/l

0.85

991

8229

Gingival hyperplasia

368

2.31

10.86

3.1

2.7

7.56

7.32

g/l

0.55

334

Emotionally unstable personality disorder

159

896

1.80

10.85

1.6

1.8

7.17

7.19

g/l

0.08

144

843

Colonic or urogenital fistula

532

3913

1.37

10.84

2.3

7.47

7.37

g/l

0.63

472

3548

Other sleep disorders

223

1383

1.64

10.79

1.6

2.4

7.41

7.40

g/l

0.03

189

1265

Acute and subacute iridocyclitis

373

2586

1.46

10.74

2.5

2.2

7.52

7.39

g/l

0.77

341

2350

Other psoriatic arthropathies

209

1278

1.67

10.74

1.8

2.4

7.79

7.31

g/l

3.40

190

1171

Coeliac disease

230

1439

1.62

10.73

2.3

2.2

7.22

7.36

g/l

0.62

210

1305

Carbimazole or st.post thyroidectomy, condition for graves disease

384

2677

1.45

10.72

2.4

2.2

7.35

7.42

g/l

0.33

346

2422

Superficial injury of thorax

298

1980

1.53

10.65

1.5

2.3

7.33

7.42

g/l

0.37

257

1794

Other/unspecified enthesopathies of lower limb, excluding foot

132

709

1.90

10.63

1.8

2.2

7.14

7.32

g/l

0.58

121

649

Injuries to the neck

395

2772

1.44

10.61

2.5

2.1

7.17

7.32

g/l

1.08

350

2537

Anogenital herpesviral [herpes simplex] infection

142

780

1.84

10.57

2.1

2.0

6.87

7.25

g/l

2.42

130

731

Emphysema

182

1080

1.73

10.57

2.7

2.5

7.74

7.29

g/l

2.93

168

964

Ovarian cyst

598

2557

1.36

10.57

1.9

2.1

7.34

7.54

g/l

2.15

544

2293

Impacted cerumen

232

1468

1.61

10.43

2.4

2.5

7.38

7.46

g/l

0.27

159

1324

Artificial joint operation, meniscal resection

1972

10917

1.18

10.38

2.2

2.3

7.54

7.37

g/l

4.39

1763

9810

Follicular lymphoma, hilmo

116

606

1.99

10.37

1.4

2.8

7.51

7.41

g/l

0.23

108

548

Striking against or struck by other objects

559

4165

1.35

10.36

1.9

2.2

7.24

7.28

g/l

0.21

487

3820

Lung cancer and mesothelioma

398

2399

1.44

10.36

2.1

1.9

8.12

7.28

g/l

14.95

357

2115

Speech and linguistic disorders, excluding more controls

429

2.11

10.34

2.3

7.20

7.43

g/l

0.62

386

Cervicocranial syndrome

200

1221

1.67

10.31

2.0

2.2

7.40

7.44

g/l

0.11

185

1093

Dementia in Alzheimer disease

221

2920

0.63

10.31

1.5

2.2

7.44

7.59

g/l

0.56

155

2564

Malignant melanoma

307

2072

1.51

10.24

2.3

1.4

7.37

7.49

g/l

0.54

264

1822

Hallux rigidus

276

1821

1.54

10.23

2.1

2.4

7.41

7.34

g/l

0.29

235

1625

Acute generalized exanthematous pustulosis

102

511

2.06

10.20

4.0

2.5

7.34

7.39

g/l

0.14

463

Other disorders of nervous system

154

882

1.79

10.17

2.5

2.4

7.24

7.38

g/l

0.53

136

807

Propionic acid derivatives

546

2010

1.38

10.16

2.4

2.2

7.36

7.32

g/l

0.25

492

1817

Caries of enamel

1614

9793

1.19

10.12

2.5

2.2

7.25

7.34

g/l

1.16

1445

8919

Anti-inflammatory and antirheumatic products, non-steroids

545

2010

1.37

10.03

2.6

2.2

7.39

7.32

g/l

0.40

494

1817

Secondary thrombocytopenia

142

3.16

10.02

4.3

1.6

7.61

7.48

g/l

0.16

130

Polycystic ovarian syndrome, consortium definition

1192

5760

1.23

10.00

1.9

2.1

7.54

7.44

g/l

1.28

1025

5178

Cholecystitis

320

2189

1.49

9.98

2.2

7.58

7.44

g/l

0.73

285

1931

Artificial joint re-operation

179

1077

1.71

9.96

2.1

2.5

7.94

7.46

g/l

3.01

164

962

Cardiomyopathy, Hypertrophic obstructive

192

2.78

9.92

1.6

2.5

7.17

7.34

g/l

0.26

173

Acute nephritic syndrome

221

2.65

9.92

2.3

2.6

7.62

7.22

g/l

1.00

199

Other demyelinating diseases of the central nervous system

305

2.36

9.90

1.6

1.8

7.00

7.26

g/l

0.59

288

Alcohol-induced acute pancreatitis

396

2.19

9.90

2.1

2.6

7.52

7.12

g/l

1.03

366

Trigger finger

263

1729

1.54

9.90

1.6

2.3

7.62

7.39

g/l

1.31

243

1577

Specific personality disorders

340

2352

1.46

9.86

1.7

2.1

7.17

7.23

g/l

0.26

306

2182

Other and unspecified erythematous conditions

365

2.25

9.82

2.5

2.3

7.14

7.41

g/l

0.80

331

Left bundle-branch block

159

928

1.75

9.80

1.7

2.2

7.23

7.51

g/l

1.15

133

817

Eating disorder

460

2.06

9.80

1.6

7.14

7.30

g/l

0.42

435

Parkinson's disease, excluding more controls

295

1877

1.50

9.73

1.9

2.3

7.31

7.60

g/l

2.19

251

1680

Crohn disease

220

1396

1.60

9.69

1.6

2.3

7.35

7.29

g/l

0.17

206

1280

Pollen allergy

224

1407

1.59

9.65

2.4

2.0

6.90

7.23

g/l

2.38

197

1320

Infections with a predominantly sexual mode of transmission

411

2951

1.40

9.59

2.1

2.0

7.24

7.22

g/l

0.08

370

2731

Carcinoma in situ of colon

263

2.49

9.54

2.4

2.9

7.60

7.47

g/l

0.21

234

Xerosis cutis

197

2.75

9.53

1.6

2.4

6.88

7.37

g/l

1.44

179

Attention to artificial openings

497

2.03

9.52

2.6

2.0

7.63

7.32

g/l

1.04

452

Other and unspecified nerve root and plexus disorders, also in other diseases

370

2622

1.43

9.50

2.5

2.2

7.30

7.33

g/l

0.16

325

2393

Dissociative [conversion] disorders

279

2.38

9.50

1.2

1.9

7.44

7.32

g/l

0.24

257

Benign neoplasm of mouth and pharynx

234

1517

1.57

9.49

3.1

2.4

7.55

7.41

g/l

0.48

204

1379

Other and unspecified injuries of lower leg

136

766

1.81

9.45

2.3

2.4

7.23

7.39

g/l

0.51

123

703

Alcohol use disorder, ICD-based

796

6308

1.27

9.44

1.6

2.3

7.50

7.28

g/l

3.13

705

5764

Ulcerative colitis, NAS

246

1612

1.55

9.42

2.0

2.3

7.22

7.30

g/l

0.33

227

1478

Disorders of oesophagus in diseases classified elsewhere

258

2.48

9.39

3.4

2.9

7.66

7.50

g/l

0.27

228

Deviated nasal septum

638

4919

1.31

9.36

2.6

2.3

7.13

7.36

g/l

3.30

585

4492

Other infective otitis externa

126

697

1.85

9.36

2.2

2.4

7.33

7.32

g/l

0.03

112

638

Parkinson's disease, strict definition, excluding more controls

278

1782

1.51

9.36

1.8

2.3

7.28

7.59

g/l

2.35

238

1599

Pain associated with micturition

233

1513

1.57

9.35

2.4

2.3

7.14

7.45

g/l

2.47

202

1362

Acute peritonitis

144

830

1.78

9.34

2.2

2.5

7.37

g/l

0.00

139

754

Other disorders of bladder

265

1772

1.52

9.32

2.1

2.4

7.39

7.32

g/l

0.25

233

1586

Supplementary factors related to causes of morbidity and mortality classified elsewhere

578

4405

1.32

9.32

1.9

2.2

7.40

7.37

g/l

0.16

494

3977

Chronic laryngitis and laryngotracheitis

285

1934

1.50

9.28

1.7

2.2

7.51

7.44

g/l

0.27

244

1741

750

5148

1.28

9.28

2.2

7.64

7.54

g/l

0.79

636

4497

Infections with a predominantly sexual mode of transmission

503

3492

1.35

9.27

2.0

7.18

7.23

g/l

0.25

456

3231

Idiopathic pulmonary fibrosis

197

1237

1.63

9.27

2.1

2.4

8.06

7.40

g/l

5.26

180

1099

Algoneurodystrophy

283

2.36

9.26

1.3

1.9

7.09

7.37

g/l

0.77

268

Coronary artery bypass grafting

625

3579

1.32

9.19

1.6

2.4

7.71

7.42

g/l

3.78

567

3135

Dermatographic urticaria

118

643

1.87

9.16

1.9

2.3

7.07

7.38

g/l

1.51

112

598

Calculus of kidney and ureter

636

4926

1.30

9.16

2.0

2.3

7.39

7.37

g/l

0.12

578

4443

Other or ill-defined heart diseases

103

537

1.96

9.15

2.1

7.40

7.33

g/l

0.14

484

Bacterial, viral and other infectious agents

155

915

1.72

9.14

2.9

2.2

7.25

7.26

g/l

0.04

144

850

Otalgia

150

879

1.74

9.12

2.0

2.3

7.10

7.43

g/l

1.60

126

802

Other erythematous conditions

403

2.13

9.10

2.5

2.3

7.19

7.43

g/l

0.66

366

Crushed, pushed or stepped on by crowd or human stampede

110

587

1.90

9.08

2.5

2.1

7.06

7.29

g/l

0.73

101

542

Eating disorders

127

707

1.81

9.07

2.2

1.8

7.19

7.29

g/l

0.30

118

658

Melanocytic naevi

518

3906

1.34

9.02

2.4

2.3

7.12

7.39

g/l

3.01

491

3536

Right bundle-branch block

418

2.10

8.99

2.8

2.2

7.53

7.41

g/l

0.27

372

Viral and other specified intestinal infections

273

1799

1.49

8.97

2.0

1.9

7.55

7.26

g/l

2.14

253

1639

Cluster headache, strict

287

2.32

8.95

1.7

2.7

7.32

g/l

0.00

265

Anogenital herpesviral [herpes simplex] infection

444

2.04

8.94

2.2

1.8

6.93

7.25

g/l

1.28

414

Cryoglobulinemia

13.97

8.93

4.3

1.3

7.62

8.76

g/l

1.53

Benign paroxysmal vertigo

610

4719

1.31

8.89

2.0

2.3

7.45

7.48

g/l

0.17

534

4218

Hepatic failure, not elsewhere classified

448

2.05

8.87

1.9

2.7

7.02

7.32

g/l

0.65

404

Cerebral cysts

107

572

1.91

8.85

1.6

2.3

6.81

7.30

g/l

1.93

525

Pulmonary oedema

235

2.50

8.79

2.8

2.4

8.06

7.46

g/l

1.30

203

Abscess of anal and rectal regions

147

865

1.73

8.79

1.3

2.1

7.46

7.26

g/l

0.66

134

803

Diseases of peritoneum

220

1433

1.56

8.78

2.0

2.3

7.44

7.41

g/l

0.11

201

1290

Bullous pemphigoid

306

2.30

8.71

1.4

2.6

7.21

7.56

g/l

1.13

269

Mental and behavioural disorders due to opioids

234

2.44

8.71

1.7

1.8

7.26

7.12

g/l

0.23

223

Hypothyroidism, strict autoimmune, 3 medication purchases required

1643

9468

1.18

8.70

2.0

2.2

7.44

7.38

g/l

0.67

1473

8478

Other congenital malformations

127

718

1.79

8.70

1.7

2.3

7.05

7.33

g/l

1.21

121

665

Organic, including symptomatic, mental disorders

1216

7214

1.21

8.65

2.1

2.3

7.56

7.48

g/l

0.90

1011

6427

Hemiplegia

110

599

1.88

8.63

1.7

2.3

7.04

7.37

g/l

1.42

541

MS-disease / Multiple Sclerosis

116

641

1.84

8.62

1.6

2.0

6.85

7.29

g/l

2.47

111

593

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

453

2.03

8.61

2.6

2.5

7.15

7.40

g/l

0.78

413

Excessive, frequent and irregular menstruation

617

2595

1.31

8.60

1.8

2.1

7.53

7.54

g/l

0.03

542

2322

Disorders of optic nerve and visual pathways

171

1054

1.65

8.60

2.1

2.5

7.47

7.30

g/l

0.59

154

969

Acute pharyngitis

202

1282

1.58

8.57

2.6

1.9

7.16

7.20

g/l

0.13

191

1189

Anosmia

122

3.02

8.57

3.4

1.5

6.88

7.18

g/l

0.43

108

Other and unspecified psoriasis

145

859

1.73

8.55

1.9

2.5

7.52

7.32

g/l

0.70

133

784

Alcohol abuse, main dg, excluding more controls

253

1706

1.50

8.50

1.2

2.5

7.44

7.26

g/l

0.85

222

1579

Arterial embolism and thrombosis

137

801

1.75

8.47

1.4

2.4

7.97

7.40

g/l

2.75

122

716

Superficial injury of ankle and foot

176

1095

1.63

8.47

1.7

2.3

7.33

7.31

g/l

0.05

155

1014

Duodenal ulcer

246

1655

1.51

8.44

1.8

2.4

7.63

7.43

g/l

1.02

227

1478

Other disorders of patella

246

1651

1.50

8.42

2.0

2.3

7.27

7.14

g/l

0.53

224

1526

Follicular cysts of skin and subcutaneous tissue

349

2505

1.41

8.41

2.4

2.2

7.47

7.36

g/l

0.56

324

2276

Melanocytic naevi of trunk

219

1438

1.55

8.40

2.1

2.3

7.06

7.37

g/l

1.86

206

1322

Mouth breathing

743

5923

1.26

8.37

2.5

2.3

7.26

7.31

g/l

0.33

683

5418

Pediculosis, acariasis and other infestations

243

1631

1.51

8.33

1.6

2.3

7.31

7.26

g/l

0.17

229

1510

Other symptoms and signs involving the digestive system and abdomen

306

2149

1.44

8.33

1.9

2.3

7.31

7.50

g/l

1.20

260

1912

Panniculitis affecting regions of neck and back

369

2.11

8.32

1.8

2.0

7.42

7.26

g/l

0.38

337

Thiazolidinediones

265

1819

1.48

8.27

1.7

2.4

8.30

7.23

g/l

17.43

237

1624

Respiratory disorders in diseases classified elsewhere

164

2.77

8.27

1.5

2.0

7.74

7.43

g/l

0.59

150

COPD, hospital admissions 1, only main diagnosis

800

5513

1.25

8.27

1.8

2.3

7.92

7.40

g/l

13.73

704

4900

Carcinoma in situ of skin

212

1394

1.56

8.22

2.0

2.5

7.52

g/l

0.01

194

1241

Allergic contact dermatitis

222

1468

1.53

8.21

1.4

2.3

7.58

7.40

g/l

0.82

202

1337

Suggestive for eosinophilic asthma

193

1241

1.58

8.19

2.2

2.3

7.26

7.33

g/l

0.25

182

1128

Generalized skin eruption due to drugs and medicaments

447

2.00

8.19

4.2

2.6

7.31

7.39

g/l

0.22

406

Type of accident

535

4112

1.31

8.18

1.9

2.2

7.43

7.39

g/l

0.23

453

3719

therapeutic use

414

2.06

8.18

1.5

2.4

7.39

7.40

g/l

0.02

374

Other specified and unspecified retinal disorders

442

2.01

8.13

2.4

2.6

7.31

7.40

g/l

0.20

401

Portal vein thrombosis

171

2.70

8.12

2.0

2.5

6.87

7.35

g/l

0.91

160

Fracture of neck

141

843

1.71

8.10

3.1

2.2

7.17

7.38

g/l

0.89

123

762

Other spirochaetal diseases

582

4532

1.30

8.09

2.6

2.3

7.06

7.40

g/l

4.90

506

4106

Menorrhagia

588

2514

1.31

8.06

1.8

2.1

7.47

7.55

g/l

0.49

502

2244

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

417

3099

1.36

8.03

1.9

2.1

7.36

7.24

g/l

0.73

370

2872

Arthropathy in hypersensitivity reactions classified elsewhere

23.01

8.02

1.7

1.3

7.11

7.77

g/l

—

Exophthalmic conditions

116

3.11

8.02

5.3

1.8

7.73

7.46

g/l

0.27

107

Umbilical hernia

517

3970

1.31

7.99

2.0

2.3

7.48

7.37

g/l

0.82

480

3625

D07AA Corticosteroids, weak (group I)

233

1563

1.50

7.98

1.8

2.2

7.40

7.32

g/l

0.28

204

1437

Cluster headache, wide

328

2.15

7.98

1.7

2.7

7.30

7.32

g/l

0.03

301

Acute bronchiolitis

240

2.28

7.95

5.9

1.8

7.32

7.39

g/l

0.12

219

Congenital malformations and deformations of the musculoskeletal system

148

891

1.67

7.95

1.5

2.1

7.36

7.37

g/l

0.02

139

826

Somnolence, stupor and coma

487

1.94

7.92

1.4

2.8

7.41

7.47

g/l

0.10

439

Alzheimer disease, excluding more controls

393

1898

1.38

7.90

2.0

2.4

7.65

7.62

g/l

0.10

315

1689

Dislocation, sprain and strain of joint and ligaments of hip

475

1.96

7.88

1.8

2.5

7.50

7.51

g/l

0.01

433

Pneumonia due to Streptococcus pneumoniae

425

2.00

7.87

4.7

1.8

7.54

7.28

g/l

0.66

376

Crohn's disease NAS

112

631

1.81

7.87

1.9

2.3

7.29

7.25

g/l

0.09

102

582

Additional codes for the location of defect, injury or illness

118

677

1.78

7.84

1.4

2.5

7.40

7.39

g/l

0.02

109

619

Superficial injury of wrist and hand

315

2248

1.41

7.83

1.8

2.2

7.28

7.32

g/l

0.14

284

2064

Other/unspecified disorders of vestibular function

533

1.89

7.83

1.8

2.6

7.43

g/l

0.01

485

Superficial injury of forearm

159

986

1.64

7.82

2.2

2.3

7.30

7.39

g/l

0.25

140

910

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.33

7.81

1.7

2.1

6.98

7.47

g/l

0.76

Other/unspecified enthesopathies, not elsewhere classified

169

1066

1.61

7.79

1.7

2.1

7.34

7.40

g/l

0.19

154

965

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

236

1598

1.49

7.78

1.9

2.2

7.54

7.22

g/l

2.22

208

1493

Bacterial, viral and other infectious agents

141

850

1.68

7.77

3.0

2.2

7.23

7.22

g/l

0.03

130

792

Other spirochaetal diseases

574

4489

1.29

7.74

2.6

2.3

7.06

7.40

g/l

4.94

499

4066

Chondrocostal junction syndrome [Tietze]

422

2.00

7.71

2.0

2.1

7.35

7.51

g/l

0.36

383

Superficial injury of shoulder and upper arm

207

1370

1.53

7.69

2.1

2.2

7.27

7.41

g/l

0.57

180

1259

Disorders of orbit

521

1.89

7.69

3.5

2.4

7.72

7.38

g/l

0.93

479

Other specified and unspecified personality disorders

136

815

1.69

7.65

1.9

2.1

7.24

7.23

g/l

0.02

122

757

Gonarthrosis, primary, with knee surgery

1286

8690

1.19

7.61

2.1

2.4

7.72

7.41

g/l

8.50

1144

7742

Other follicular disorders

122

712

1.74

7.59

2.3

7.61

7.31

g/l

1.11

114

658

IBD patients in KELA-register

365

2685

1.37

7.57

2.2

2.1

7.16

7.28

g/l

0.71

338

2475

Rosacea

213

1424

1.52

7.56

1.9

2.3

7.18

7.37

g/l

0.92

199

1299

Vascular diseases of the intestine

539

1.87

7.56

2.9

2.3

7.90

7.44

g/l

1.81

481

Blepharochalasis

626

4966

1.27

7.56

1.9

2.3

7.40

7.51

g/l

0.86

549

4421

Clear cell adenocarcinoma of kidney

103

576

1.84

7.53

1.6

1.4

8.06

7.49

g/l

1.82

512

Inguinal hernia

1171

6579

1.20

7.53

2.6

2.2

7.07

7.39

g/l

8.57

1062

5924

Erosion of teeth , including avohilmo

372

2747

1.37

7.53

2.3

2.1

7.22

7.27

g/l

0.24

337

2531

Bronchitis, not specified as acute or chronic

167

1060

1.60

7.51

1.8

2.3

7.02

7.30

g/l

1.28

146

945

Benign neoplasm: Small intestine

104

585

1.84

7.51

2.3

2.6

7.28

7.46

g/l

0.55

528

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

190

1244

1.56

7.50

2.2

2.4

7.39

7.41

g/l

0.04

161

1121

Diabetic maculopathy

265

1746

1.45

7.47

1.4

2.0

8.13

7.74

g/l

2.97

243

1561

Spirochaetal infections, other/unspecified

571

4484

1.28

7.47

2.6

2.3

7.06

7.40

g/l

4.87

496

4062

Impingement syndrome of shoulder

438

3321

1.33

7.46

2.5

2.4

7.33

7.31

g/l

0.05

379

3005

Enteropathic arthropathies

184

2.52

7.43

1.4

2.3

7.04

7.01

g/l

0.04

170

Abnormal spermatozoa

124

2036

0.60

7.40

1.9

2.5

7.38

7.26

g/l

0.36

112

1834

Lyme disease

567

4455

1.28

7.39

2.6

2.3

7.06

7.40

g/l

5.10

492

4035

Carcinoma in situ of skin of trunk

502

1.90

7.38

3.1

2.4

7.39

7.51

g/l

0.28

444

Type 1 diabetes, definitions combined

114

655

1.75

7.37

1.9

7.10

7.00

g/l

0.29

101

619

Mantle cell lymphoma

3.26

7.37

1.8

1.3

6.83

7.50

g/l

1.49

Other disorders of optic [2nd] nerve and visual pathways

123

727

1.73

7.37

2.2

2.6

7.47

7.32

g/l

0.36

108

666

Malignant melanoma of skin, including Hilmo

291

2079

1.42

7.31

2.2

1.4

7.21

7.48

g/l

2.16

254

1836

Other orthopaedic follow-up care

111

639

1.77

7.31

1.7

2.0

7.42

7.31

g/l

0.29

100

578

Other hearing loss

650

5088

1.26

7.29

2.3

2.2

7.33

7.52

g/l

2.10

561

4507

Primary coxarthrosis, bilateral

649

5196

1.26

7.28

2.2

2.3

7.47

7.48

g/l

0.07

575

4582

Diseases of tongue

124

737

1.72

7.27

2.5

2.0

7.14

7.52

g/l

1.79

111

651

Urolithiasis

672

5400

1.26

7.25

2.0

2.3

7.40

7.38

g/l

0.15

607

4863

Speech and linguistic disorders

506

1.84

7.25

2.2

2.0

7.20

7.37

g/l

0.44

458

Other and unspecified disorders of vitreous body

868

7070

1.22

7.18

2.3

7.17

7.46

g/l

5.53

777

6335

Polycythaemia vera

427

1.96

7.16

2.7

1.4

6.76

7.59

g/l

4.95

369

Carrier of infectious disease

238

2.30

7.14

1.2

2.1

7.25

7.33

g/l

0.15

221

Benign neoplasm: Descending colon

163

1045

1.60

7.14

2.1

2.5

7.73

7.38

g/l

1.35

140

954

Golimumab

283

2.17

7.13

1.2

1.8

7.52

7.28

g/l

0.46

274

Scabies

188

1239

1.53

7.11

1.6

2.2

7.24

7.27

g/l

0.11

178

1153

Type 1 diabetes, strict (exclude DM2)

113

655

1.74

7.10

1.9

7.12

6.99

g/l

0.40

100

619

Behavioural syndromes associated with physiological disturbances and physical factors

1690

10423

1.15

7.10

2.0

2.2

7.22

7.38

g/l

3.76

1509

9406

Varicose veins

1279

8239

1.18

7.07

2.3

2.2

7.47

7.42

g/l

0.48

1136

7348

Hypopituitarism

112

652

1.75

7.06

2.6

2.3

7.01

7.24

g/l

0.62

103

610

Seborrhoeic keratosis

473

3658

1.31

7.05

2.5

2.2

7.29

7.46

g/l

1.34

425

3245

Other benign neoplasms of skin

746

6081

1.24

7.05

3.0

2.3

7.31

7.45

g/l

1.46

651

5437

Hyperkinetic disorders, excluding more controls

408

1.91

6.95

1.4

1.6

6.87

7.05

g/l

0.44

386

Chondropathies

257

1813

1.43

6.92

1.9

2.1

7.56

7.34

g/l

1.08

227

1669

Other noninfective disorders of lymphatic vessels and lymph nodes

404

1.96

6.89

1.5

2.4

7.44

7.37

g/l

0.13

370

Other abnormal uterine and vaginal bleeding

417

2262

1.33

6.87

2.1

2.2

7.65

7.62

g/l

0.14

330

2003

Disorders of ocular muscles, binocular movement, accommodation and refraction

765

6209

1.23

6.86

2.1

2.2

7.23

7.33

g/l

0.98

702

5618

Thyrotoxicosis with toxic multinodular goitre

139

867

1.64

6.85

1.7

2.3

7.58

7.52

g/l

0.14

118

774

Chronic hepatitis, not elsewhere classified

370

2.00

6.85

1.6

2.6

7.67

7.30

g/l

0.80

344

Atypical facial pain

104

600

1.77

6.84

1.8

2.4

7.25

7.36

g/l

0.26

541

Wet age-related macular degeneration

430

3202

1.32

6.80

2.3

2.1

7.70

7.56

g/l

0.86

368

2762

Dermatophytosis

263

1872

1.42

6.80

2.3

7.50

7.38

g/l

0.50

239

1689

Visual impairment including blindness (binocular or monocular)

146

922

1.61

6.80

2.1

7.44

7.47

g/l

0.09

116

822

Melanoma in situ

109

641

1.75

6.78

2.4

2.7

7.51

7.41

g/l

0.19

576

Coxarthrosis, primary, with hip surgery

1058

8371

1.19

6.77

2.1

2.3

7.49

7.45

g/l

0.34

936

7423

Childhood asthma (age<16), excluding more controls

397

1.83

6.76

1.4

7.02

6.90

g/l

0.27

378

Nail disorders

147

930

1.61

6.75

1.7

2.3

7.25

7.34

g/l

0.28

134

855

Open wound of abdomen, lower back and pelvis

270

2.16

6.73

1.7

2.1

7.65

7.19

g/l

1.23

252

Injury of eye and orbit

230

1599

1.45

6.71

1.9

2.1

7.17

7.27

g/l

0.36

203

1485

Other and unspecified rosacea

164

1067

1.56

6.69

1.9

2.4

7.22

7.37

g/l

0.62

154

978

Benign neoplasm: Duodenum

354

2.03

6.68

2.6

2.7

7.47

7.43

g/l

0.06

320

Disorders of breast

804

6019

1.22

6.66

1.9

2.2

7.32

7.48

g/l

1.79

711

5371

Disorders of synovium and tendon in diseases classified elsewhere

201

2.37

6.64

1.6

2.2

7.42

7.29

g/l

0.21

186

Other superficial mycoses

152

973

1.58

6.61

1.6

2.3

7.15

7.32

g/l

0.63

134

897

Suicide or other Intentional self-harm

371

2798

1.34

6.59

2.0

2.2

7.44

7.28

g/l

1.04

330

2586

Monoamine oxidase A inhibitors

217

1500

1.47

6.58

1.9

2.5

7.19

7.41

g/l

1.39

196

1361

Benign neoplasm of major salivary glands

203

1388

1.49

6.56

1.8

2.4

7.49

7.44

g/l

0.15

184

1254

Congenital malformations and deformations of the musculoskeletal system

111

655

1.70

6.53

1.5

1.9

7.36

7.31

g/l

0.10

106

610

Fracture at wrist and hand level

579

4621

1.26

6.51

2.3

2.2

7.29

7.31

g/l

0.13

511

4200

Event of undetermined intent

106

623

1.73

6.51

1.9

2.3

7.57

7.29

g/l

0.76

575

Psoriasis (vulgaris), strict definition

342

2.01

6.51

1.4

2.6

7.45

7.15

g/l

0.71

317

Other symptoms and signs involving general sensations and perceptions

441

1.88

6.48

2.3

2.4

7.12

7.54

g/l

1.61

402

Palmar fascial fibromatosis [Dupuytren]

320

2372

1.37

6.47

2.3

2.2

7.39

7.37

g/l

0.07

281

2111

Bell's palsy

216

1497

1.46

6.47

2.3

2.1

7.19

7.39

g/l

1.00

190

1352

Thrombotic microangiopathy

3.69

6.46

4.0

1.5

7.16

7.39

g/l

0.21

Benign neoplasm: Other and unspecified parts of mouth

421

1.91

6.46

3.1

2.6

7.85

7.40

g/l

1.01

383

Unspecified/other endometriosis

120

729

1.66

6.46

1.9

7.33

7.37

g/l

0.11

107

662

Malignant neoplasm of bladder, including Hilmo

252

1786

1.42

6.45

2.3

1.4

7.41

7.46

g/l

0.18

217

1569

Plantar fascial fibromatosis

168

1108

1.54

6.43

2.4

2.1

7.24

7.37

g/l

0.46

154

1014

Testicular dysfunction

323

2.03

6.40

1.4

2.5

7.30

7.03

g/l

0.46

296

Ganglion

321

2381

1.36

6.39

2.0

2.2

7.15

7.32

g/l

1.06

289

2153

Postmenopausal bleeding

541

2273

1.28

6.38

2.0

2.2

7.58

7.63

g/l

0.25

471

2016

Childhood asthma (age<16)

405

1.80

6.38

1.4

1.3

7.02

6.92

g/l

0.22

385

Psychotic depression

103

604

1.73

6.37

2.0

2.7

7.10

7.36

g/l

1.12

553

Periapical abscess

800

6640

1.21

6.33

2.0

2.3

7.44

7.30

g/l

1.45

734

6049

Inflammatory bowel disease, strict (require KELA)

365

2766

1.33

6.30

2.2

7.16

7.29

g/l

0.75

338

2551

Visual field defects

175

1172

1.52

6.29

2.4

2.2

7.40

7.41

g/l

0.02

157

1060

Other/unspecified synovitis and tenosynovitis

196

1341

1.48

6.27

1.9

2.2

7.48

7.35

g/l

0.47

180

1213

Bursitis of shoulder

252

2.17

6.25

2.4

1.9

7.49

7.40

g/l

0.11

230

Benign neoplasm: salivary glands, exclude unknown (D119)

182

1231

1.50

6.24

1.8

2.4

7.50

7.39

g/l

0.30

165

1124

Nontoxic goitre/thyroid nodule

581

4679

1.25

6.23

2.1

2.3

7.42

7.53

g/l

0.90

515

4150

Type1 diabetes, definitions combined, early onset

303

2.03

6.23

1.4

1.5

7.23

7.09

g/l

0.32

290

Thyroiditis

130

816

1.62

6.23

2.2

2.3

7.49

7.43

g/l

0.14

114

745

Other and unspecified vascular occlusions

214

1495

1.46

6.22

2.5

2.4

7.54

7.48

g/l

0.20

194

1324

Other Crohn's disease

106

632

1.70

6.18

1.4

2.1

7.30

7.25

g/l

0.13

583

Postprocedural disorders of nervous system

564

1.74

6.18

2.2

2.0

6.91

7.34

g/l

2.01

529

Unspecified lump in breast

280

2048

1.38

6.17

1.9

2.3

7.39

7.56

g/l

1.01

254

1832

Other specified/unspecified spondylopathies

301

2.06

6.17

2.8

2.0

7.75

7.34

g/l

1.23

267

Malignant neoplasm of other connective and soft tissue, including Hilmo

515

1.79

6.16

4.0

1.4

7.58

7.48

g/l

0.17

456

Other disorders of penis

175

1176

1.51

6.15

1.6

2.3

7.08

7.27

g/l

0.74

157

1063

Viral warts

325

2432

1.35

6.14

2.1

2.2

7.03

7.35

g/l

3.16

294

2226

Assault

168

1118

1.52

6.14

1.6

2.1

7.35

7.17

g/l

0.62

150

1055

Retinal detachment with retinal break

274

2003

1.39

6.11

2.7

2.3

7.38

7.40

g/l

0.04

242

1804

Pneumothorax

143

923

1.58

6.11

2.4

2.3

7.49

7.29

g/l

0.71

130

840

Acidosis

242

2.18

6.09

1.9

2.4

7.65

7.30

g/l

0.61

221

Disorders of psychological development

116

656

1.65

6.08

2.0

1.9

7.27

g/l

0.01

106

604

Injuries to the wrist and hand

1886

11577

1.13

6.04

2.0

2.2

7.32

7.36

g/l

0.41

1702

10448

Follow-up examination after treatment for malignant neoplasms

185

1262

1.48

6.04

2.3

2.1

7.80

7.49

g/l

1.58

164

1125

Other and/or unspecified nontoxic goitre

167

1118

1.52

6.03

2.2

2.4

7.40

7.52

g/l

0.46

153

1005

Benign neoplasm: Parotid gland

162

1078

1.53

6.03

1.9

2.4

7.48

7.40

g/l

0.20

148

984

Pustular psoriasis

563

1.74

6.03

1.9

2.3

7.99

7.38

g/l

3.65

517

Entropion and trichiasis of eyelid

202

1406

1.46

6.02

2.2

2.5

7.66

7.51

g/l

0.57

179

1247

Astigmatism

577

1.72

5.98

2.3

2.4

7.32

7.35

g/l

0.06

522

Complications of cardiac and vascular prosthetic devices, implants and grafts

278

2.09

5.97

1.9

2.7

7.87

7.34

g/l

1.12

247

Combinations of oral blood glucose lowering drugs

576

4661

1.25

5.95

1.7

2.5

8.09

7.19

g/l

26.05

534

4206

Other obstructive and reflux uropathy

388

1.89

5.95

1.9

2.1

7.61

7.30

g/l

1.16

357

Cardiac murmurs and other cardiac sounds

137

869

1.58

5.93

2.8

2.1

7.66

7.52

g/l

0.40

127

781

Other and unspecified tonsillitis

408

2652

1.30

5.92

1.7

1.9

7.31

7.18

g/l

0.77

387

2478

Unspecified urinary incontinence

180

1229

1.49

5.90

1.4

2.3

7.77

7.56

g/l

0.73

132

1090

Scleritis and episcleritis

108

657

1.67

5.89

1.6

2.1

7.25

7.30

g/l

0.09

101

615

Sleep disorders

1596

10134

1.14

5.89

1.9

2.2

7.21

7.38

g/l

3.64

1424

9152

Other and unspecified parapsoriasis

3.60

5.80

1.5

1.9

6.76

7.50

g/l

1.20

Other chondrocalcinosis

183

2.37

5.78

1.6

2.1

7.84

7.42

g/l

0.79

164

Disorders of optic nerve, not elsewhere classified

268

2.09

5.78

2.3

2.8

7.40

7.41

g/l

0.01

243

Other aneurysm

121

763

1.62

5.76

2.0

2.5

7.65

7.34

g/l

1.08

115

688

Open wound of hip and thigh

308

1.99

5.76

1.3

2.5

6.82

7.15

g/l

0.82

288

Viral warts

156

1039

1.52

5.75

2.0

2.4

7.16

7.32

g/l

0.58

144

951

Amenorrhoea

457

1.79

5.74

1.9

7.06

7.34

g/l

0.75

425

Ulcer of oesophagus

147

970

1.54

5.72

2.2

2.6

7.45

7.43

g/l

0.03

129

879

Iridocyclitis in diseases classified elsewhere

202

2.25

5.72

1.8

2.3

7.44

7.42

g/l

0.03

188

Hyperaldosteronism

338

1.95

5.71

2.3

2.5

7.57

7.47

g/l

0.18

310

Necrosis of pulp, including avohilmo

944

8004

1.18

5.71

2.2

7.31

7.29

g/l

0.13

871

7304

Status epilepticus

387

1.88

5.71

1.6

2.8

7.39

7.45

g/l

0.10

351

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

247

1795

1.39

5.68

2.4

2.2

7.20

7.29

g/l

0.38

229

1654

Conductive and sensorineural hearing loss

1664

9917

1.14

5.67

2.3

2.2

7.37

7.44

g/l

0.88

1446

8936

Disorders of purine and pyrimidine metabolism

3.38

5.65

1.5

7.85

7.31

g/l

0.47

Other epidermal thickening

514

1.75

5.63

2.0

2.6

7.09

7.35

g/l

0.92

467

Other congenital malformations of skin

124

789

1.59

5.63

1.8

2.3

7.11

7.34

g/l

0.77

114

724

Other secondary coxarthrosis

419

1.84

5.61

1.6

2.4

7.56

7.34

g/l

0.50

383

Benign neoplasm: Parathyroid gland

142

2.52

5.55

2.6

1.9

7.78

7.44

g/l

0.44

132

Postzoster neuralgia

186

2.30

5.52

3.9

2.0

7.41

g/l

0.00

163

Seborrhoeic dermatitis

176

1213

1.47

5.51

2.2

2.4

7.33

7.38

g/l

0.14

154

1107

Drug-induced neutropenia

145

963

1.53

5.50

2.8

2.6

7.57

7.38

g/l

0.60

139

877

Insomnia

1532

9832

1.14

5.49

1.9

2.3

7.20

7.38

g/l

3.85

1365

8885

Other obstetric conditions, not elsewhere classified

273

1274

1.37

5.48

1.5

1.7

6.87

7.05

g/l

1.23

253

1208

Ulcerative colitis (strict definition, require KELA)

254

1866

1.37

5.47

2.5

2.2

7.20

7.29

g/l

0.43

235

1723

Autoimmune hyperthyroidism

578

1.69

5.46

2.2

2.5

7.56

7.32

g/l

0.66

529

Alzheimer’s disease (Late onset), excluding more controls

330

1641

1.33

5.45

2.2

2.3

7.67

7.64

g/l

0.09

265

1454

Crohn's disease of small intestine

107

663

1.64

5.44

1.7

2.3

7.30

7.29

g/l

0.02

610

Adenomyosis (Endometriosis of uterus)

240

1751

1.39

5.43

2.2

7.32

7.61

g/l

1.98

219

1562

Extreme obesity with alveolar hypoventilation

490

1.75

5.43

1.8

2.6

8.10

7.22

g/l

5.61

446

Endometriosis

537

2535

1.25

5.37

1.8

2.1

7.37

7.54

g/l

1.62

478

2269

Other noninflammatory disorders of vulva and perineum

147

982

1.51

5.37

1.5

2.1

7.42

7.50

g/l

0.23

132

886

Unspecified misadventure during surgical and medical care

113

714

1.61

5.36

1.9

2.5

7.40

7.34

g/l

0.14

100

650

severe traumatic brain injury, does not include concussion

462

3695

1.26

5.35

2.2

7.28

7.43

g/l

1.16

392

3282

Pure hyperglyceridaemia

242

2.09

5.30

1.8

2.3

7.64

7.27

g/l

0.84

221

Inflammatory disease of uterus

190

1337

1.43

5.29

1.7

2.1

7.26

7.44

g/l

0.94

168

1223

Use of donepezil

301

3766

0.76

5.29

1.7

2.2

7.70

7.57

g/l

0.56

235

3264

Other and specified injuries of hip and thigh

263

2.04

5.28

1.4

2.2

7.44

7.55

g/l

0.16

238

Lactose intolerance

283

1.99

5.28

1.4

1.7

7.22

7.35

g/l

0.24

261

Viral infections of the central nervous system

122

787

1.57

5.26

2.2

2.3

7.33

7.38

g/l

0.10

108

720

Benign neoplasm: Pancreas

385

1.85

5.26

2.4

2.7

7.42

7.44

g/l

0.03

347

Degenerative macular diseases

265

1978

1.36

5.25

2.2

2.3

7.49

7.51

g/l

0.07

233

1740

Other retinal artery occlusion

313

1.95

5.25

2.0

2.8

7.46

7.48

g/l

0.03

283

Monocytic leukaemia

3.94

5.25

3.1

1.4

6.69

7.83

g/l

1.30

Lichen ruber planus, wide definition including periferal and oral lichen planus

415

3287

1.27

5.24

2.3

7.35

7.46

g/l

0.69

375

2956

Procreative management

444

2945

1.26

5.20

1.8

2.1

7.00

7.30

g/l

3.59

420

2715

Other and unspecified bullous disorders

128

2.55

5.19

3.0

2.0

7.07

7.43

g/l

0.65

117

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.54

5.19

1.4

1.3

8.10

7.41

g/l

0.55

Lichen planus

251

1861

1.37

5.19

2.7

2.3

7.32

7.48

g/l

0.99

227

1674

Other keratitis

182

1277

1.44

5.19

2.1

2.2

7.39

7.33

g/l

0.15

165

1169

Postprocedural disorders of digestive system, not elsewhere classified

393

1.83

5.18

1.8

2.7

7.65

7.35

g/l

0.72

357

Use of anticholinesterases

594

5665

0.82

5.17

1.8

2.2

7.57

7.54

g/l

0.11

472

4954

N06DA Anticholinesterases

594

5665

0.82

5.17

1.8

2.2

7.57

7.54

g/l

0.11

472

4954

Viral infections of the central nervous system

129

847

1.54

5.15

2.2

2.3

7.35

7.37

g/l

0.04

114

774

Lichen planus, including avohilmo

355

2766

1.30

5.14

2.4

2.3

7.35

7.46

g/l

0.64

322

2482

Benign neoplasm: Spinal meninges

135

2.50

5.13

1.3

1.9

7.22

7.64

g/l

0.42

120

Irregular menses

635

4148

1.21

5.12

2.1

7.37

7.33

g/l

0.20

580

3794

Tobacco use

551

1.68

5.11

1.6

2.4

7.75

7.27

g/l

1.96

511

Deficiency of other B group vitamins

253

2.04

5.09

3.6

2.0

7.16

7.33

g/l

0.28

229

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

260

1219

1.36

5.05

1.4

1.7

6.88

7.03

g/l

0.90

242

1157

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.79

5.03

1.5

1.4

7.89

7.48

g/l

0.59

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

117

2.55

5.03

4.9

1.7

7.17

7.16

g/l

0.02

108

Tinnitus

439

3518

1.26

5.02

2.2

2.3

7.20

7.43

g/l

2.25

396

3195

Alcohol abuse, main dg

253

1886

1.35

5.02

1.2

2.2

7.44

7.27

g/l

0.82

222

1746

Use of antiglaucoma preparations and miotics

181

1283

1.43

4.96

2.2

2.4

7.78

7.49

g/l

1.29

154

1116

Other condition

235

1737

1.37

4.94

2.2

7.44

7.35

g/l

0.36

218

1588

Other and unspecified trigeminal disorders

143

2.38

4.94

1.8

2.0

6.83

7.27

g/l

0.93

128

Obsessive-compulsive disorder

375

1.80

4.93

2.0

7.03

7.26

g/l

0.54

356

Orchitis and epididymitis

169

1183

1.45

4.92

1.9

2.2

7.34

7.29

g/l

0.15

152

1064

Other disorders of pigmentation

535

1.68

4.91

2.7

2.3

7.05

7.45

g/l

1.46

487

Otitis externa, unspecified

176

1241

1.43

4.91

1.9

2.3

7.32

g/l

0.01

157

1135

Presence of other devices

509

4142

1.23

4.89

2.6

2.2

7.37

7.51

g/l

1.19

460

3659

Acute laryngitis and tracheitis

127

826

1.52

4.86

1.6

1.8

7.19

7.30

g/l

0.30

118

765

Benign neoplasm: Pituitary gland, craniopharyngeal duct

576

1.64

4.82

2.8

2.5

7.19

7.31

g/l

0.26

526

Rare circulating lymphoid malignancy

3.22

4.81

3.5

1.3

7.62

7.42

g/l

0.22

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

273

2072

1.33

4.80

2.4

2.2

7.17

7.30

g/l

0.71

254

1909

Maternal care for other conditions predominantly related to pregnancy

215

1541

1.38

4.79

1.9

7.06

7.12

g/l

0.19

200

1450

Abnormal blood-pressure reading, without diagnosis

477

1.71

4.79

2.1

2.4

7.33

7.44

g/l

0.20

433

Cluster headache, strict, including avohilmo

439

1.74

4.79

1.6

2.2

7.24

7.20

g/l

0.08

409

Vulvovaginal ulceration/inflammation in other diseases

469

1.71

4.77

1.8

2.0

7.30

7.45

g/l

0.33

440

Other disorders of iris and ciliary body

323

1.88

4.77

2.1

2.6

7.80

7.31

g/l

1.41

290

Specific development disorders of speech and language

379

1.77

4.77

1.8

2.2

7.22

7.42

g/l

0.39

339

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

496

4052

1.23

4.75

2.5

2.2

7.34

7.33

g/l

0.02

452

3690

Urethral stricture

122

808

1.54

4.75

2.0

2.5

7.51

7.29

g/l

0.77

108

723

Later onset COPD

679

4548

1.20

4.75

1.6

2.4

7.92

7.42

g/l

10.13

593

3989

Ulcerative colitis (strict definition, all Crohn cases excluded)

216

1586

1.37

4.74

2.7

2.3

7.12

7.29

g/l

0.82

198

1466

Congenital malformations of the circulatory system

209

1481

1.38

4.72

1.7

2.3

6.92

7.35

g/l

2.69

185

1359

Thyrotoxicosis with diffuse goitre

222

1640

1.37

4.70

2.1

2.3

7.55

7.41

g/l

0.52

205

1499

Disorders of refraction and accommodation

385

3050

1.26

4.69

2.0

2.1

7.23

7.36

g/l

0.82

355

2780

Cluster headache, wide,, including avohilmo

472

1.70

4.69

1.7

2.2

7.23

7.20

g/l

0.07

437

Other otitis externa (chronic)

119

786

1.54

4.68

2.4

7.73

7.32

g/l

1.27

718

Familial hypercholesterolemia, with ischemic heart disease

213

1569

1.38

4.67

1.8

2.4

7.80

7.44

g/l

2.06

187

1370

Disorders of speech understanding and production

311

1.86

4.65

1.8

2.3

7.40

7.46

g/l

0.09

277

Other disorders of cornea

177

1265

1.42

4.63

1.9

2.2

7.24

7.41

g/l

0.63

160

1149

Sequelae of injuries of neck and trunk

312

1.87

4.61

3.0

2.6

7.43

7.22

g/l

0.38

289

Malignant neoplasm, without specification of site, including Hilmo

614

1.61

4.61

2.9

1.4

7.95

7.55

g/l

1.33

527

Type 1 diabetes, strict definition

412

1.73

4.60

1.3

1.5

7.08

6.91

g/l

0.44

394

Nontoxic multinodular goitre

381

3040

1.26

4.59

1.9

2.3

7.44

7.56

g/l

0.68

328

2701

Alcohol dependence

492

4038

1.23

4.54

1.6

2.4

7.48

7.25

g/l

2.14

428

3702

Spontaneous abortion

461

3813

0.81

4.54

1.9

2.3

7.33

7.37

g/l

0.21

422

3447

Cholangitis (primary sclerosing, PSC)

118

784

1.53

4.53

1.9

2.4

7.57

7.36

g/l

0.67

106

709

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

329

2549

1.28

4.51

2.1

2.0

7.06

7.25

g/l

1.32

300

2347

Premature rupture of membranes

109

1181

0.66

4.50

1.9

1.8

6.86

7.20

g/l

1.54

101

1109

Colitis, primary sclerosing, strict definition

2.78

4.49

2.1

2.2

7.17

g/l

0.00

Other salmonella infections

411

1.74

4.48

2.8

2.1

7.30

g/l

0.00

370

Other and unspecified iridocyclitis

510

1.66

4.47

3.0

2.3

7.67

7.27

g/l

1.38

467

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

423

3423

1.24

4.45

1.6

2.2

7.27

7.30

g/l

0.13

384

3149

Ulcerative proctitis

619

1.59

4.45

1.4

2.2

7.19

7.28

g/l

0.19

566

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

626

1.58

4.44

2.0

2.3

7.18

7.10

g/l

0.17

581

499

3867

1.22

4.43

2.1

2.2

7.64

7.57

g/l

0.41

421

3340

malignant neoplasm of male genital organs

562

2838

1.21

4.40

2.0

1.4

7.39

7.36

g/l

0.13

500

2552

Arterial embolism and thrombosis of lower extremity artery

490

1.67

4.39

1.4

2.7

7.86

7.38

g/l

1.55

442

Lactose intolerance, other/unspecified

253

1.94

4.36

1.4

1.7

7.28

7.34

g/l

0.08

234

Other and unspecified follicular disorders

400

1.73

4.32

3.0

2.4

7.45

7.26

g/l

0.37

374

Recurrent dislocation and subluxation of joint

521

1.63

4.32

2.0

2.2

7.13

7.09

g/l

0.06

489

Congenital malformations of cardiac septa

580

1.59

4.31

1.6

2.3

6.85

7.31

g/l

1.67

534

Other ulcerative colitis

569

1.60

4.31

1.3

2.4

7.46

7.25

g/l

0.58

521

Other deformities of toe(s)

401

1.73

4.30

2.3

2.2

7.62

7.32

g/l

0.54

355

Malignant neoplasm, without specification of site

394

1.74

4.29

2.8

1.4

8.05

7.60

g/l

1.14

333

Diffuse brain injury

297

1.85

4.29

2.5

1.9

7.61

7.42

g/l

0.26

274

Excessive earwax

1095

9408

1.14

4.26

2.5

2.2

7.30

7.43

g/l

1.84

945

8432

Malignant neoplasm of prostate, including Hilmo

572

2832

1.21

4.25

2.0

1.4

7.39

7.37

g/l

0.09

514

2545

Disorder of external ear, unspecified

380

1.75

4.25

2.8

2.7

7.34

g/l

0.01

350

Asthma mixed form (mode), excluding more controls

455

1.67

4.22

1.9

1.5

7.40

7.35

g/l

0.10

403

Corneal scars and opacities

307

1.84

4.22

1.7

2.7

7.60

7.43

g/l

0.22

275

Glucosamine medication

1059

7426

1.14

4.19

2.3

7.46

7.51

g/l

0.43

948

6537

Meralgia paraesthetica

367

1.75

4.17

1.5

2.2

7.27

7.31

g/l

0.05

333

Brachial plexus disorders

126

864

1.47

4.14

2.4

2.2

7.03

7.22

g/l

0.69

121

807

Benign neoplasm of urinary organs

632

1.56

4.13

2.0

2.6

7.37

7.40

g/l

0.07

573

Malignant neoplasm of mesothelium and soft tissue

499

1.64

4.11

3.0

1.4

7.93

7.50

g/l

0.94

441

Hydrocele

224

1696

1.33

4.10

2.4

2.5

7.00

7.35

g/l

3.21

207

1522

Other, unspecified and serous retinal detachments

392

1.72

4.10

1.9

2.7

7.74

7.41

g/l

0.85

353

Drug-induced hypoglycaemia without coma

169

2.13

4.10

1.3

2.5

7.53

7.22

g/l

0.39

153

Other and unspecified mononeuropathies of upper limb

295

1.83

4.09

1.4

2.1

6.91

7.26

g/l

0.72

274

Subacute thyroiditis

407

1.70

4.09

2.7

2.2

7.45

7.44

g/l

0.01

373

Aortic valve malfunction, age under 60 years

149

1058

1.42

4.09

1.8

2.3

7.05

7.26

g/l

0.76

139

984

Bicipital tendinitis

554

1.60

4.08

2.1

2.4

7.02

7.31

g/l

0.88

513

Achilles tendinitis

166

1202

1.40

4.06

2.5

2.2

7.33

7.35

g/l

0.08

149

1110

Congenital iodine-deficiency syndrome/hypothyroidism

379

1.73

4.03

3.0

2.1

7.59

7.54

g/l

0.06

340

Other specified/unspecified disorders of bone/cartilage

297

1.83

4.02

2.7

2.0

6.78

7.27

g/l

1.56

277

Other and unspecified nonorganic psychotic disorders

252

1943

1.30

4.01

1.5

2.3

7.40

7.23

g/l

0.94

224

1803

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

144

1021

1.43

4.01

1.9

2.4

7.62

7.41

g/l

0.71

129

927

Redundant prepuce, phimosis and paraphimosis

319

2511

1.27

3.98

1.9

2.4

7.51

7.25

g/l

1.63

298

2295

Other and unspecified mononeuropathies, also in other diseases

335

1.77

3.98

1.8

2.3

7.33

g/l

0.00

298

Arthropathy in ulcerative colitis

125

2.31

3.98

1.5

1.8

6.75

7.18

g/l

0.73

118

Oesophageal obstruction

457

1.65

3.97

2.7

2.8

7.41

7.44

g/l

0.05

414

Hordeolum and other deep inflammation of eyelid

629

1.55

3.97

2.4

2.5

7.14

7.29

g/l

0.38

589

Left ventricular outflow tract obstruction (LVOTO), broad definition

155

1114

1.41

3.97

1.7

2.3

7.12

7.25

g/l

0.38

145

1034

Alzheimer’s disease (Early onset)

664

0.50

3.97

1.2

2.0

7.74

7.59

g/l

0.15

584

Lichen simplex chronicus

373

1.72

3.96

2.7

7.70

7.32

g/l

0.77

340

Central retinal artery occlusion

307

1.81

3.95

3.4

2.3

7.60

7.45

g/l

0.29

274

Tongue abnormality

119

818

1.48

3.94

2.5

7.12

7.42

g/l

1.19

106

738

Salpingitis and oophoritis

279

2188

1.29

3.93

1.7

2.4

7.65

7.46

g/l

1.07

253

1984

Vascular dementia

209

1522

1.34

3.92

2.3

2.2

7.72

7.55

g/l

0.61

170

1334

Complications of genitourinary prosthetic devices, implants and grafts

285

1.83

3.92

1.8

7.28

7.39

g/l

0.18

254

Status post-ami

570

3663

1.19

3.91

1.6

2.4

7.78

7.43

g/l

4.55

508

3202

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

639

1.54

3.91

1.8

2.2

7.20

7.36

g/l

0.48

590

UC patients in KELA-register (code 208), prior to 1994

538

1.59

3.88

2.5

7.01

7.33

g/l

1.42

494

Benign neoplasm: Kidney

437

1.66

3.88

2.1

2.7

7.23

7.36

g/l

0.28

395

All dysplastic lesions of the cervix uteri, vagina or vulva

331

2611

1.25

3.87

2.2

1.9

7.28

7.26

g/l

0.08

304

2403

Leisure time condition

310

2469

1.27

3.86

1.6

2.2

7.41

7.44

g/l

0.11

248

2231

Carcinoma in situ of skin of ear and external auricular canal

223

1.96

3.85

1.7

2.6

7.00

7.30

g/l

0.57

192

Sensorineural hearing loss

1580

9684

1.11

3.85

2.3

7.36

7.45

g/l

1.12

1373

8719

Ulcerative enterocolitis

294

1.80

3.83

1.8

2.3

7.36

7.27

g/l

0.12

268

Chronic iridocyclitis

563

1.57

3.83

2.1

2.4

7.72

7.30

g/l

1.45

514

Acute suppurative otitis media

275

2011

1.28

3.82

2.8

2.0

7.29

7.19

g/l

0.44

256

1867

Malignant neoplasm of colon, including Hilmo

358

2900

1.24

3.81

2.4

1.4

7.63

7.52

g/l

0.52

313

2539

Dislocation, sprain and strain of joints and ligaments at neck level

202

1523

1.34

3.81

2.3

7.18

7.26

g/l

0.27

185

1411

Other neurotic disorders

572

1.56

3.81

1.5

2.5

7.22

7.37

g/l

0.36

515

Post-traumatic wound infection, not elsewhere classified

273

1.83

3.81

1.7

2.6

7.59

7.24

g/l

0.80

250

Other salmonella infections

470

1.62

3.79

2.7

2.2

7.34

7.33

g/l

0.03

427

Early complications of trauma

486

1.61

3.78

2.4

7.53

7.26

g/l

0.77

447

!Aliquae complicationes praecoces traumatis

486

1.61

3.78

2.4

7.53

7.26

g/l

0.77

447

Other blood glucose lowering drugs, excl. Insulins

330

2656

1.25

3.78

1.8

2.3

8.21

7.29

g/l

16.71

300

2344

Postprocedural musculoskeletal disorders, not elsewhere classified

143

1026

1.42

3.77

2.5

7.60

7.43

g/l

0.56

133

935

Senility

2.50

3.75

2.0

1.6

6.66

7.96

g/l

1.33

Benign neoplasm: Skin of ear and external auricular canal

536

1.58

3.73

2.5

7.26

7.41

g/l

0.33

488

Other renal tubulo-interstitial diseases

210

1.94

3.72

1.8

2.0

7.45

7.29

g/l

0.22

195

Focal brain injury

104

703

1.50

3.72

2.0

2.4

7.46

7.42

g/l

0.07

641

Injury of muscle and tendon at lower leg level

259

2030

1.29

3.71

2.5

2.4

7.18

7.29

g/l

0.50

239

1872

Secondary parkinsonism, excluding more controls

239

1.88

3.70

2.6

2.1

7.21

7.57

g/l

0.85

214

Vascular dementia (subcortical)

514

1.59

3.70

2.8

2.2

7.62

g/l

0.01

449

Triptan medication for migraine, min. 3 purchases

735

4847

1.16

3.67

2.2

2.1

7.00

7.29

g/l

5.76

677

4453

Other noninflammatory disorders of uterus, except cervix

403

2226

1.23

3.67

2.4

2.2

7.62

7.63

g/l

0.04

357

1971

Malignant neoplasm of prostate

551

2780

1.19

3.65

2.1

1.4

7.41

7.38

g/l

0.13

490

2496

Infective dermatitis

194

1467

1.34

3.64

1.8

2.4

7.60

7.41

g/l

0.85

176

1333

Spontaneous rupture of synovium and tendon

144

1040

1.40

3.63

1.8

2.2

7.59

7.42

g/l

0.59

123

941

Dissection of aorta

430

1.64

3.61

1.6

2.7

7.10

7.33

g/l

0.49

389

Viral encephalitis, not elsewhere classified/unspecified

220

1.91

3.61

3.4

2.4

7.49

7.31

g/l

0.25

199

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

209

1597

1.32

3.61

1.9

2.1

7.29

7.44

g/l

0.71

194

1452

Hepatocellular carcinoma, including Hilmo

369

1.69

3.59

2.8

1.4

7.42

7.48

g/l

0.11

321

Retinal breaks without detachment

301

2413

1.26

3.59

2.3

2.4

7.17

7.39

g/l

1.29

267

2184

Complications of other internal prosthetic devices, implants and grafts

525

1.57

3.59

2.0

2.3

7.20

7.48

g/l

0.62

474

Other disorders of central nervous system

118

2.27

3.58

1.2

1.8

6.84

7.46

g/l

1.43

110

Atlantoaxial subluxation

2.73

3.56

1.3

1.7

7.63

7.22

g/l

0.43

Hereditary angioödema type 1

8.31

3.54

8.3

1.0

6.30

8.07

g/l

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

149

963

1.38

3.52

1.4

1.6

7.08

7.07

g/l

0.04

139

907

Gluteal tendinitis

409

1.64

3.52

2.0

2.3

7.79

7.34

g/l

1.21

375

Flat foot [pes planus] (acquired)

144

1046

1.39

3.51

1.8

2.6

7.48

7.29

g/l

0.63

127

943

Malignant melanoma of skin

200

1529

1.32

3.50

2.3

1.4

7.21

7.46

g/l

1.35

173

1345

Other specified disorders of kidney and ureter

387

1.66

3.50

2.3

2.7

7.15

7.32

g/l

0.38

353

Nasal polyp

346

2825

1.23

3.49

2.9

2.3

7.26

7.35

g/l

0.50

320

2558

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

137

989

1.40

3.46

2.4

7.38

7.48

g/l

0.31

126

890

Focal epilepsy, strict definition

342

2791

1.23

3.45

2.1

2.3

7.26

7.42

g/l

0.94

294

2520

Colitis, primary sclerosing

107

2.30

3.44

2.0

1.9

7.12

7.31

g/l

0.23

101

Campylobacter enteritis

275

1.78

3.43

2.2

2.4

7.34

7.37

g/l

0.05

249

Injury of muscle and tendon at hip and thigh level

159

1179

1.36

3.43

2.1

2.3

7.20

7.33

g/l

0.47

148

1096

Disorders of tooth development and eruption

211

1312

1.31

3.42

1.8

2.0

7.46

7.34

g/l

0.44

192

1192

Atrophic disorders of skin

241

1893

1.28

3.42

2.0

2.1

7.52

7.50

g/l

0.06

222

1692

Tracheo-bronchomalasia

5.19

3.41

1.6

3.7

7.51

6.84

g/l

—

Burns and corrosions

201

1543

1.31

3.40

1.9

2.2

7.62

7.29

g/l

1.79

182

1427

Benign neoplasm: Skin of eyelid, including canthus

297

2396

1.25

3.38

3.1

2.3

7.36

7.49

g/l

0.73

262

2151

Epiphora

277

1.78

3.38

2.5

2.3

7.27

7.47

g/l

0.37

251

Ingrowing nail

524

1.55

3.37

1.8

2.4

7.22

7.26

g/l

0.10

483

Focal epilepsy

362

2981

1.22

3.34

2.1

2.2

7.29

7.42

g/l

0.72

312

2697

Single delivery by forceps and vacuum extractor

670

0.64

3.34

1.3

1.6

6.81

7.21

g/l

1.86

626

Complications of labour and delivery

728

4648

0.87

3.33

2.4

2.2

7.30

7.43

g/l

1.37

674

4179

Type 1 diabetes, strict definition, subgroup 1

374

1.64

3.33

1.3

1.5

7.23

6.89

g/l

1.00

357

Benign neoplasm of meninges

198

1525

1.31

3.32

1.9

2.4

7.29

7.53

g/l

1.03

171

1358

Corns and callosities

118

840

1.42

3.29

2.1

2.3

7.50

7.41

g/l

0.24

102

767

Peroneal tendinitis

129

2.14

3.28

2.1

1.9

6.71

7.20

g/l

1.08

123

Disorders of parathyroid gland, other and/or unspecified

2.43

3.27

1.4

1.8

7.45

7.64

g/l

0.17

Melanoma in situ of trunk

207

1.90

3.26

2.4

2.9

6.95

7.32

g/l

0.73

186

Pneumonitis due to solids and liquids

162

1216

1.35

3.26

1.6

2.2

7.60

7.40

g/l

0.70

130

1081

Autonomic disorders

243

1.81

3.24

2.0

2.3

6.89

7.40

g/l

1.11

220

Allergic contact dermatitis due to drugs in contact with skin

251

1.79

3.23

1.5

2.1

8.01

7.41

g/l

1.33

232

Other diseases of spinal cord

326

1.69

3.22

2.5

2.7

7.70

7.29

g/l

0.90

301

Malnutrition

244

1.81

3.21

1.7

2.1

7.09

7.48

g/l

0.65

216

Paralytic strabismus

131

955

1.39

3.19

1.9

2.4

7.62

7.38

g/l

0.85

117

869

Malignant neoplasm of small intestine, including Hilmo

374

1.64

3.18

2.2

1.4

7.40

7.52

g/l

0.25

332

Assault by bodily force

589

1.49

3.14

1.5

2.1

7.26

7.17

g/l

0.21

557

Single spontaneous delivery

535

3309

0.85

3.12

2.5

2.0

7.53

7.59

g/l

0.32

491

2907

Delivery

538

3313

0.85

3.11

2.5

2.0

7.56

7.59

g/l

0.15

494

2911

Asthma mixed form (mode)

494

1.53

3.10

1.9

1.6

7.40

7.37

g/l

0.04

437

Malignant neoplasm of bladder

132

968

1.38

3.09

2.0

1.4

7.45

7.44

g/l

0.01

113

840

Ectropion of eyelid

635

1.48

3.09

1.4

2.4

7.81

7.53

g/l

0.69

553

Atopic conjunctivitis

384

1.61

3.08

1.4

1.8

7.15

7.48

g/l

0.88

353

Haemangioma and lymphangioma, any site

149

1115

1.35

3.07

2.9

2.4

7.46

7.35

g/l

0.31

137

1018

Ventricular septal defect, a heart condition

132

2.07

3.07

1.5

1.6

6.63

7.41

g/l

1.68

124

Myocardial infarction, with ST-elevation

360

2998

1.21

3.04

1.8

2.2

7.77

7.40

g/l

3.92

324

2657

Other and unspecified primary disorders of muscles

2.50

3.04

1.4

2.5

7.62

7.21

g/l

0.60

Injury of nerves and spinal cord at neck level

256

1.76

3.04

2.6

2.8

7.04

7.27

g/l

0.46

231

Delivery, wide proxy

446

2799

0.84

3.03

2.3

2.0

7.57

7.65

g/l

0.49

406

2425

Disturbance of activity and attention

509

1.51

3.03

1.4

1.5

6.83

7.10

g/l

0.77

483

Injury of other and unspecified intrathoracic organs

113

812

1.41

3.02

1.7

2.3

7.36

7.33

g/l

0.07

103

738

Lung diseases due to external agents

277

2250

1.24

3.01

2.4

2.3

7.61

7.39

g/l

1.30

233

2004

Hyperfunction of pituitary gland

418

1.57

3.01

2.8

1.9

7.09

7.34

g/l

0.67

394

Melanocytic naevi of upper limb, including shoulder

242

1.77

2.99

1.9

2.5

6.73

7.32

g/l

1.64

225

Prepatellar bursitis

483

1.53

2.99

2.4

2.3

7.07

7.23

g/l

0.35

438

Burns and corrosions of external body surface, specified by site

156

1180

1.33

2.99

2.0

2.3

7.60

7.31

g/l

1.17

139

1093

Haemangioma, any site

141

1052

1.35

2.98

2.6

2.4

7.51

7.34

g/l

0.49

129

962

Trigeminal neuralgia

100

705

1.44

2.98

2.6

2.3

7.51

7.37

g/l

0.35

640

Pre-eclampsia or eclampsia

269

2178

1.24

2.97

2.3

2.1

7.41

7.32

g/l

0.41

249

1997

Contusion of toe(s) without damage to nail

191

1.86

2.96

1.2

2.4

7.04

7.22

g/l

0.28

183

Strabismus

399

3357

1.19

2.91

2.1

2.2

7.25

7.38

g/l

0.79

362

3048

Sixth [abducent] nerve palsy

423

1.57

2.90

2.4

2.7

7.61

7.40

g/l

0.43

377

Laparoscopic right hemicolectomy

120

879

1.39

2.90

2.3

2.5

7.48

7.43

g/l

0.12

794

Contusion of other and unspecified parts of foot

398

1.57

2.90

2.2

2.1

7.22

7.27

g/l

0.11

371

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

223

2783

0.80

2.88

1.8

1.4

7.86

7.48

g/l

2.44

201

2458

Schizophrenia

141

1864

0.75

2.87

2.4

2.2

7.55

7.26

g/l

1.45

119

1724

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

9.84

2.87

1.0

6.28

9.27

g/l

—

Postpartum haemorrhage

157

1726

0.76

2.86

1.9

2.0

6.89

7.19

g/l

2.22

142

1607

Other arterial embolism and thrombosis

369

1.60

2.86

1.3

2.5

8.01

7.41

g/l

1.23

329

Crohn's disease of large intestine

496

1.51

2.86

1.6

2.3

7.17

7.24

g/l

0.12

457

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

7.23

8.21

g/l

—

Atrial septal defect

312

1.65

2.84

2.0

7.04

7.40

g/l

0.77

289

Other disorders of the genitourinary system

239

1925

1.25

2.84

2.1

2.3

7.56

7.54

g/l

0.07

216

1707

Any dementia, excluding more controls

806

4925

1.13

2.82

2.1

2.3

7.61

7.51

g/l

0.77

662

4356

Blindness, monocular

104

2.19

2.81

4.6

1.9

7.29

7.53

g/l

0.22

Contact with sharp object, undetermined intent

195

1.83

2.79

1.9

7.55

7.19

g/l

0.56

182

Sequelae of injuries of head

549

1.47

2.77

2.8

2.5

7.46

7.20

g/l

0.57

502

Noninflammatory disorders of female genital tract

598

2605

1.16

2.76

2.2

2.1

7.50

7.54

g/l

0.19

536

2332

1274

0.71

2.75

1.3

2.3

7.23

7.34

g/l

0.24

1150

Benign neoplasm of breast

200

1587

1.27

2.71

2.2

2.1

7.29

7.57

g/l

1.82

174

1412

Hyperkinetic disorders

546

1.46

2.71

1.4

1.5

6.87

7.07

g/l

0.53

518

Contact with heat and hot substances

527

1.48

2.70

1.8

2.3

7.71

7.33

g/l

0.89

484

Other diseases of gallbladder

594

1.45

2.70

2.4

2.5

7.29

7.43

g/l

0.32

531

Explicit viral Sepsis

8.89

2.70

1.2

1.0

7.34

8.17

g/l

—

Endocrine disorders, other/unspecified

201

0.34

2.69

1.6

2.1

7.43

7.44

g/l

—

188

Benign neoplasm: Prostate

2.25

2.69

2.4

3.4

7.17

7.12

g/l

0.04

Septal defects

548

1.46

2.69

1.7

2.3

6.85

7.31

g/l

1.58

506

Crohn disease (strict definition, require KELA)

577

1.45

2.68

1.7

2.1

6.96

7.25

g/l

0.89

535

Other and unspecified mononeuropathies of lower limb

313

1.63

2.65

1.7

2.1

7.35

7.30

g/l

0.07

280

Malignant neoplasm of colon

272

2238

1.22

2.65

2.4

1.4

7.61

7.55

g/l

0.26

241

1947

Lateral epicondylitis

186

1467

1.28

2.64

1.8

2.1

7.37

7.29

g/l

0.22

170

1350

Excessive attrition of teeth

869

7799

1.12

2.64

2.3

2.2

7.16

7.32

g/l

2.20

782

7117

Medical abortion

1009

4930

1.11

2.63

1.8

2.3

7.52

7.45

g/l

0.67

890

4381

Reduction defects of unspecified limb

6.07

2.63

1.0

1.2

6.62

8.01

g/l

—

Corneal ulcer

283

2339

1.22

2.63

2.1

2.2

7.51

7.35

g/l

0.85

255

2132

Convergent concomitant strabismus

481

1.49

2.62

2.2

2.0

7.26

7.32

g/l

0.09

442

Alport

6.00

2.62

1.3

3.5

7.50

7.54

g/l

—

Pre-eclampsia or poor fetal growth

331

2765

1.20

2.61

2.3

2.0

7.26

7.27

g/l

0.03

307

2545

Malignant neoplasm of thymus, including Hilmo

2.75

2.60

3.8

1.2

7.52

7.53

g/l

0.01

Other and unspecified disorders of adult personality and behaviour

3.16

2.60

1.4

1.3

7.40

7.29

g/l

0.08

Other disorders of bone density and structure

230

1.72

2.59

1.6

2.1

7.14

7.37

g/l

0.31

215

Focal epilepsy, mode (most common among epilepsy diagnosis)

311

2598

1.20

2.58

2.1

2.3

7.19

7.42

g/l

1.66

266

2345

Palindromic rheumatism

101

2.14

2.58

1.3

1.6

7.76

7.11

g/l

0.95

Other changes in lacrimal passages

4.88

2.57

3.1

1.8

7.27

8.04

g/l

—

Mental and behavioural disorders due to cannabinoids

135

1.94

2.56

1.8

1.5

7.68

7.04

g/l

0.85

128

Melanoma in situ of other and unspecified parts of face

195

1.81

2.56

2.3

2.8

7.16

7.54

g/l

0.68

173

Meningitis

534

1.46

2.55

2.8

2.3

7.32

g/l

0.01

493

Open wound of shoulder and upper arm

194

1.79

2.54

1.4

2.0

7.51

7.27

g/l

0.33

177

Abdominal aortic aneurysm (AAA)

208

1659

1.25

2.54

1.8

2.3

7.60

7.32

g/l

1.58

181

1456

Burns and corrosions of multiple and unspecified body regions

209

1.75

2.54

1.8

2.5

7.97

7.24

g/l

1.43

195

Malignant neoplasm of digestive organs

707

4957

1.13

2.53

2.1

1.4

7.58

7.50

g/l

0.62

627

4362

Crohn disease (strict definition, require KELA, min 2 HDR)

568

1.44

2.52

1.7

2.0

6.97

7.25

g/l

0.85

527

Secondary polycythaemia

256

1.67

2.50

2.7

2.6

7.47

7.35

g/l

0.21

232

Myopia

147

1135

1.30

2.48

1.9

2.2

7.13

7.29

g/l

0.65

140

1050

Sudden idiopathic hearing loss

184

1465

1.27

2.47

2.0

2.2

7.29

7.44

g/l

0.58

155

1331

Graves ophthalmopathy, strict

242

1.69

2.45

1.2

1.8

7.73

7.53

g/l

0.32

224

Malignant neoplasm of pancreas

931

0.68

2.44

1.9

1.4

7.45

7.52

g/l

0.11

808

All dysplastic lesions of the cervix uteri

263

2156

1.21

2.44

2.2

2.0

7.23

7.22

g/l

0.04

244

1996

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

138

1.91

2.43

2.9

2.1

6.98

7.38

g/l

0.59

129

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

616

1.41

2.42

1.8

1.4

7.71

7.54

g/l

0.34

536

Congenital malformations of heart and great arteries

167

1275

1.28

2.42

2.0

2.3

6.88

7.35

g/l

2.69

144

1180

Appendectomy

1042

9067

1.10

2.42

2.2

7.33

7.32

g/l

0.08

944

8249

Acute lymphadenitis

532

1.44

2.41

2.5

2.4

7.48

7.30

g/l

0.37

489

Contact with and exposure to communicable diseases

316

2650

1.19

2.40

2.2

2.0

7.02

7.16

g/l

0.98

306

2469

Pre-eclampsia

238

1954

1.22

2.39

2.5

2.1

7.43

7.32

g/l

0.50

220

1797

Polyp of the female genital tract

490

2444

1.16

2.38

1.8

2.1

7.52

7.57

g/l

0.23

439

2178

Impotence

703

1.38

2.38

1.8

2.3

7.19

7.26

g/l

0.15

631

Malignant neoplasm of small intestine

268

1.64

2.37

2.7

1.4

7.31

7.56

g/l

0.51

237

Suppurative and unspecified otitis media

436

3343

1.16

2.35

2.6

2.0

7.29

7.27

g/l

0.10

406

3065

Hereditary sideroblastic anaemia

2.90

2.33

2.9

1.6

7.61

7.39

g/l

0.12

Alkalosis

3.71

2.33

1.9

2.4

7.06

7.55

g/l

—

Mental and behavioural disorders due to tobacco

136

1052

1.30

2.32

1.7

2.5

7.84

7.27

g/l

3.40

110

971

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

629

1.39

2.31

1.7

2.2

7.04

7.26

g/l

0.62

578

Open wound of wrist and hand

698

6102

1.12

2.30

2.2

7.36

7.29

g/l

0.48

636

5582

Migraine, single triptan purchase ok & required. ICD-code if available is included

1151

7133

1.09

2.29

2.1

2.2

7.08

7.34

g/l

6.22

1063

6501

Triptan medication for migraine, single purchase ok

1151

7133

1.09

2.29

2.1

2.2

7.08

7.34

g/l

6.22

1063

6501

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

115

871

1.33

2.29

2.1

1.4

7.53

g/l

0.01

100

756

Burn and corrosion of wrist and hand

325

1.56

2.29

1.6

2.1

7.42

7.16

g/l

0.58

299

Benign neoplasm: Liver/bile ducts

263

1.62

2.27

2.4

1.9

7.26

7.44

g/l

0.34

246

Other and unspecified injuries of wrist and hand

350

1.53

2.27

1.1

1.9

7.22

7.27

g/l

0.09

322

HSIL lesion of the cervix uteri, vagina or vulva

208

1695

1.23

2.26

2.1

1.9

7.32

7.27

g/l

0.17

188

1565

Other puerperal infections

439

1.47

2.26

1.2

1.6

6.97

7.28

g/l

0.88

420

Other factor of the environment

128

1.92

2.25

3.8

1.6

7.45

7.41

g/l

0.04

119

Disorders of eyelid in diseases classified elsewhere

360

1.52

2.23

1.1

2.4

7.39

7.44

g/l

0.08

327

Acute alcohol intoxication, ICD10

306

2594

1.19

2.21

1.3

2.3

7.44

7.27

g/l

0.90

272

2394

Malignant neoplasm of thyroid gland, including Hilmo

114

867

1.33

2.21

2.7

1.4

7.33

7.44

g/l

0.28

102

765

Nonspecific lymphadenitis

593

1.40

2.20

1.7

2.1

7.47

7.30

g/l

0.37

554

Benign neoplasm: Cerebral meninges

173

1390

1.26

2.19

2.0

2.4

7.23

7.55

g/l

1.63

152

1243

Respiratory tuberculosis, confirmed

227

1.66

2.19

1.7

2.5

8.04

7.45

g/l

1.00

199

Ménière disease

169

1355

1.26

2.18

1.7

2.5

7.47

7.46

g/l

0.01

152

1224

Right hemicolectomy

113

862

1.33

2.17

2.9

2.4

7.68

7.45

g/l

0.65

107

777

Maternal care for known or suspected fetal abnormality and damage

135

902

1.29

2.17

1.7

6.83

7.11

g/l

1.42

130

854

Other predominantly sexually transmitted diseases, not elsewhere classified

203

1660

1.23

2.15

2.0

7.04

7.21

g/l

0.84

183

1548

Schizophrenia or delusion, excluding more controls

405

3482

1.16

2.14

1.9

2.3

7.46

7.32

g/l

1.00

351

3188

Retinal haemorrhage

340

1.53

2.14

4.6

2.7

7.53

7.52

g/l

0.01

305

Benign neoplasm of middle ear and respiratory system

138

1084

1.29

2.13

2.4

7.29

7.38

g/l

0.23

128

984

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

4.45

2.12

2.8

1.0

6.52

8.42

g/l

—

Use of other anti-dementia drugs

492

4616

0.88

2.11

1.8

2.2

7.61

7.56

g/l

0.26

376

4023

Use of memantine

492

4616

0.88

2.11

1.8

2.2

7.61

7.56

g/l

0.26

376

4023

Smoking dependency

136

1067

1.29

2.11

1.7

2.5

7.84

7.28

g/l

3.24

110

985

Malignant neoplasm of ureter, including Hilmo

103

2.01

2.11

2.2

1.4

7.84

7.39

g/l

0.66

Polypectomy (DHB20)

112

858

1.32

2.09

2.6

2.4

7.33

7.35

g/l

0.05

105

786

Other or unspecified paralytic strabismus

2.24

2.09

1.1

2.5

7.34

7.23

g/l

0.09

Disorders of lacrimal system and orbit in diseases classified elsewhere

270

1.58

2.06

1.2

1.8

7.65

7.42

g/l

0.39

251

Other disorders of conjunctiva

259

2182

1.20

2.06

2.7

2.3

7.23

7.50

g/l

1.83

235

1960

Hypertrophic disorders of skin

524

1.41

2.06

2.5

2.2

7.25

7.41

g/l

0.30

488

Other facial nerve disorders

286

1.56

2.06

2.3

2.2

6.98

7.28

g/l

0.53

255

Other lesions of median nerve

343

1.51

2.05

1.2

2.1

7.90

7.47

g/l

0.78

300

Non-small cell lung cancer, squamous, helper endpoint

721

0.67

2.05

1.8

2.4

8.45

7.40

g/l

3.40

634

Brain meningioma

619

1.37

2.05

2.2

1.4

7.21

7.49

g/l

0.77

539

Other predominantly sexually transmitted diseases, not elsewhere classified

179

1454

1.24

2.04

2.1

2.0

7.05

7.23

g/l

0.89

161

1354

Diseases of appendix

1252

10441

1.08

2.04

2.5

2.2

7.27

7.33

g/l

0.54

1134

9480

Pedestrian injured in transport accident

105

800

1.32

2.04

1.5

2.3

7.39

7.36

g/l

0.06

731

Graves ophthalmopathy

271

1.58

2.04

1.2

1.8

7.65

7.44

g/l

0.33

252

Recurrent dislocation of patella

270

1.57

2.03

1.5

1.8

7.58

7.08

g/l

1.64

256

Dislocation of lens

178

1.72

2.02

2.7

2.6

7.54

7.55

g/l

0.02

165

Amyloidosis of skin

5.18

2.02

3.2

1.0

6.74

8.39

g/l

—

Use of disulfiram, acamprosate or naltrexone

121

941

1.30

2.02

1.6

2.3

7.51

7.19

g/l

1.38

104

878

Hepatocellular carcinoma

272

1.57

2.02

2.4

1.4

7.70

7.47

g/l

0.34

233

Varicose veins of other sites

751

1.33

1.99

2.5

2.4

6.81

7.24

g/l

1.59

690

Macular cyst

412

1.46

1.99

2.4

2.9

7.59

7.50

g/l

0.16

374

Crohn disease (strict definition, all UC cases excluded)

469

1.42

1.99

1.6

2.2

7.10

7.26

g/l

0.37

435

HSIL lesion of the cervix uteri

178

1450

1.23

1.99

1.9

2.0

7.25

7.21

g/l

0.14

163

1347

Otitis media, unspecified

116

826

1.30

1.98

2.8

2.1

7.26

7.37

g/l

0.34

111

763

Other sideroblastic anaemias

2.57

1.98

1.1

1.5

7.04

7.81

g/l

0.75

Thyroiditis, unspecified

164

1.74

1.98

1.3

1.7

7.30

7.50

g/l

0.21

153

Other acquired deformities of musculoskeletal system and connective tissue

529

1.40

1.98

2.4

2.3

7.63

7.30

g/l

0.74

483

Alzheimer’s disease (Atypical or mixed)

145

1790

0.80

1.96

1.7

2.2

7.54

7.58

g/l

0.09

116

1550

Lifestyle-related condition

120

1.88

1.96

4.1

1.6

7.45

7.34

g/l

0.08

110

Benign neoplasm of eye and adnexa

178

1456

1.23

1.95

1.7

2.4

7.23

7.44

g/l

0.97

157

1320

Other strabismus

288

2450

1.18

1.95

2.2

7.08

7.37

g/l

2.27

263

2241

Brain meningioma, including Hilmo

651

1.35

1.94

2.1

1.4

7.22

7.52

g/l

0.85

563

Embedded teeth, including avohilmo

607

1.36

1.93

2.7

1.8

7.14

7.30

g/l

0.37

569

Procedures for purposes other than remedying health state

243

1.59

1.92

2.3

1.5

6.95

7.31

g/l

0.78

229

Perforation of tympanic membrane

157

1270

1.25

1.91

2.2

2.3

7.09

7.42

g/l

1.99

143

1150

Degeneration of nervous system due to alcohol

276

1.55

1.91

1.2

2.7

7.25

7.21

g/l

0.06

249

Cytomegaloviral hepatitis

3.02

1.91

1.8

2.1

6.76

7.85

g/l

—

Retrobulbar neuritis in diseases classified elsewhere

3.29

1.90

5.4

1.0

7.04

7.33

g/l

—

Acute nasopharyngitis (common cold)

154

1234

1.25

1.90

1.8

1.9

7.06

7.24

g/l

0.63

143

1145

Acute appendicitis

1144

9893

1.08

1.90

2.5

2.2

7.26

7.32

g/l

0.62

1040

8987

Benign neoplasm: Liver

228

1.60

1.90

2.5

1.9

7.19

7.36

g/l

0.25

212

Tonsillectomy and adenotomy

544

4240

0.89

1.90

1.8

2.0

7.15

7.17

g/l

0.08

500

3945

Acute appendicitis, no complications

846

7698

1.10

1.89

2.5

2.2

7.20

7.29

g/l

0.90

771

7046

Injuries involving multiple body regions

374

1.46

1.89

2.3

7.45

7.23

g/l

0.41

343

Dystonia

654

1.34

1.89

1.2

2.4

6.93

7.38

g/l

2.67

602

conjunctival haemorrhage

139

1112

1.26

1.89

2.6

2.3

7.25

7.43

g/l

0.64

127

1004

Graves disease, strict definition

136

1084

1.26

1.88

2.4

2.2

7.44

7.40

g/l

0.08

123

997

Pregnancy, childbirth and the puerperium

405

2414

0.87

1.88

1.8

2.1

7.70

7.63

g/l

0.36

364

2072

Tuberculosis, IBD comorbidity

132

1050

1.27

1.88

2.2

7.80

7.45

g/l

1.31

108

931

Malignant neoplasm of breast, including Hilmo

651

3796

1.11

1.87

2.0

1.4

7.61

7.48

g/l

0.98

571

3358

Transient acantholytic dermatosis [Grover]

2.99

1.86

1.3

2.7

7.34

7.06

g/l

—

Disorders of endocrine glands in diseases classified elsewhere

4.41

1.86

1.0

6.78

7.69

g/l

—

Other disorders of breast

182

1500

1.22

1.86

2.2

7.06

7.51

g/l

3.06

156

1352

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

425

3704

1.14

1.85

2.9

1.4

8.16

7.46

g/l

9.56

381

3289

Nonsuppurative otitis media

256

1879

1.18

1.85

1.9

2.0

7.39

7.32

g/l

0.25

237

1720

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

575

0.65

1.85

1.9

2.1

7.27

7.57

g/l

0.62

531

Hereditary lymphedema

3.25

1.85

1.0

1.3

6.69

7.71

g/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

238

1.58

1.85

1.7

2.4

8.04

7.42

g/l

1.08

209

Other mental disorders due to brain damage and dysfunction and to physical disease

225

1895

1.20

1.84

2.7

2.4

7.43

7.46

g/l

0.10

184

1706

Malignant neoplasm of breast, ER-positive, including Hilmo

510

3504

1.13

1.84

2.0

1.4

7.68

7.52

g/l

1.13

439

3083

Congenital obstruction of the pelviureteric junction

2.06

1.83

3.9

2.3

7.33

7.59

g/l

0.22

Malignant neoplasm of breast, HER2-negative, including Hilmo

650

3796

1.11

1.83

2.0

1.4

7.60

7.48

g/l

0.95

570

3358

Degeneration of the brain due to alcohol

279

1.53

1.83

1.2

2.7

7.25

7.29

g/l

0.06

252

Other specified disorders of external ear

487

1.39

1.82

1.9

2.7

7.37

7.28

g/l

0.14

447

Cysts of oral region, not elsewhere classified

676

1.33

1.81

2.6

2.5

7.35

7.25

g/l

0.24

620

Vascular dementia (mixed)

272

1.54

1.81

2.1

2.0

7.48

7.59

g/l

0.17

239

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

445

1.40

1.80

2.7

1.8

7.02

7.33

g/l

0.96

416

Bitten or struck by other mammals

144

1162

1.25

1.80

2.6

2.4

7.29

7.28

g/l

0.02

135

1071

Pyoderma

200

1.63

1.80

2.0

2.3

7.63

7.37

g/l

0.31

185

Other disorders of skin and subcutaneous tissue related to radiation

3.58

1.79

1.2

1.1

7.77

8.28

g/l

—

Congenital malformations of genital organs

699

1.31

1.77

1.6

1.9

7.10

7.35

g/l

0.83

659

Other and unspecified acute skin changes due to ultraviolet radiation

322

1.48

1.77

1.9

2.4

7.06

7.47

g/l

1.46

287

Conductive hearing loss, unspecified

129

1032

1.26

1.76

2.0

2.3

7.50

7.39

g/l

0.30

115

943

Chromophobe cell carcinoma of kidney

2.22

1.76

2.2

1.1

7.23

7.56

g/l

0.29

Diseases of middle ear and mastoid

828

6203

1.09

1.76

2.4

2.1

7.28

7.30

g/l

0.15

759

5623

Glaucoma

1157

9250

1.08

1.75

2.2

2.3

7.45

7.47

g/l

0.10

1018

8220

Systemic sclerosis,strict definition

103

1.90

1.75

1.2

1.7

7.53

7.57

g/l

0.04

Amblyopia ex anopsia

355

1.45

1.75

1.4

2.1

7.67

7.38

g/l

0.43

328

Congenital varicose veins

2.75

1.74

2.4

2.0

7.47

7.69

g/l

—

Lesion of radial nerve

398

1.42

1.73

2.0

2.3

7.83

7.31

g/l

1.16

358

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

217

1834

1.19

1.72

2.4

2.3

7.36

7.37

g/l

0.04

194

1680

Postpartum hemorraghe, parous women as controls

157

1628

0.82

1.72

1.9

2.0

6.89

7.15

g/l

1.74

142

1529

Appendicitis, broad definition

1229

10359

1.07

1.72

2.5

2.2

7.26

7.33

g/l

0.68

1115

9405

Pleural plaque without asbestos

605

1.34

1.72

1.7

2.4

7.98

7.43

g/l

1.51

537

Benign lipomatous neoplasm

505

4529

1.12

1.71

2.5

2.3

7.32

7.40

g/l

0.49

459

4085

Leiomyoma of uterus

1008

5274

1.09

1.71

2.1

2.2

7.54

7.47

g/l

0.58

880

4709

Other fall from one level to another

327

2853

1.15

1.70

2.2

2.3

7.29

7.34

g/l

0.21

297

2604

Other sexually transmitted chlamydial diseases

307

1.47

1.70

1.4

1.3

7.03

7.08

g/l

0.07

293

Orthopaedic devices associated with adverse incidents

260

1.53

1.70

1.2

2.4

7.42

7.49

g/l

0.08

232

Granuloma annulare

149

1.71

1.69

2.0

1.8

7.08

7.61

g/l

1.42

139

Pedal cyclist injured in noncollision transport accidents

158

1298

1.22

1.69

1.7

2.3

6.88

7.37

g/l

3.28

136

1199

Corneal degeneration

196

1.61

1.69

1.2

2.0

7.57

7.48

g/l

0.09

176

Other disorders of Eustachian tube

317

1.47

1.69

1.4

2.1

7.35

7.36

g/l

0.01

293

Examination and encounter for administrative purposes

468

1.38

1.68

2.7

2.6

7.56

7.42

g/l

0.31

426

Use of peginterferon beta-1a

2.89

1.67

2.0

1.1

6.51

7.20

g/l

—

Other acute skin changes due to ultraviolet radiation

427

1.40

1.67

1.7

2.2

7.16

7.47

g/l

1.00

385

Maze procedure for atrial fibrillation

2.16

1.65

1.3

1.7

7.08

7.61

g/l

0.21

Postpartum hemorraghe, all women as controls

157

1870

0.82

1.65

1.9

6.89

7.17

g/l

1.94

142

1756

Moderate visual impairment, binocular

386

1.42

1.64

1.7

2.2

7.74

7.64

g/l

0.15

343

Other diseases of peritoneum

566

1.34

1.63

1.6

2.5

7.66

7.41

g/l

0.47

513

Contraceptive management

419

3304

0.89

1.63

2.2

2.1

7.04

7.25

g/l

1.74

388

3073

Other sexually transmitted chlamydial diseases

470

1.37

1.63

1.3

1.5

7.05

7.10

g/l

0.08

447

Tuberculosis, wide

136

1107

1.24

1.62

2.2

2.4

7.77

7.46

g/l

1.16

111

984

Tooth eruption problems

107

824

1.27

1.62

2.3

1.8

7.28

7.27

g/l

0.02

772

Other infective (teno)synovitis

2.41

1.62

1.2

1.3

6.95

7.21

g/l

—

Malignant neoplasm of breast

636

3767

1.10

1.62

2.0

1.4

7.63

7.49

g/l

1.15

555

3329

Abnormal findings in secretions and smears from cervix uteri vagina vulva

616

4223

1.10

1.62

2.2

2.1

7.27

7.35

g/l

0.69

563

3824

Malignant neoplasm of liver and intrahepatic bile ducts

371

1.42

1.61

1.9

1.4

7.75

7.44

g/l

0.46

321

Other and unspecified disease of Bartholin gland

346

1.44

1.60

1.3

2.4

7.61

7.52

g/l

0.16

320

Benign neoplasm: Skin of other and unspecified parts of face

188

1582

1.20

1.60

3.4

2.4

7.30

7.45

g/l

0.58

162

1427

Other and unspecified degenerative diseases of nervous system

372

1.42

1.59

1.6

2.6

7.44

7.52

g/l

0.13

333

Endometriosis of pelvic peritoneum

191

1532

1.19

1.59

1.4

2.2

7.22

7.40

g/l

0.84

168

1389

Dementia, including avohilmo

1020

6511

1.08

1.58

2.0

2.4

7.52

g/l

0.01

827

5780

Parkinson's disease, including avohilmo

313

2744

1.15

1.58

1.8

2.3

7.32

7.47

g/l

0.89

264

2425

Neovascular glaucoma

526

1.35

1.58

2.3

2.4

7.92

7.39

g/l

2.08

469

Papillary adenocarcinoma of thyroid gland

570

1.33

1.56

2.0

1.3

7.22

7.39

g/l

0.43

512

Dentofacial anomalies [including malocclusion]

1016

7580

1.08

1.56

2.1

2.2

7.18

7.32

g/l

2.04

913

6914

Alzheimer’s disease (Early onset), excluding more controls

476

0.67

1.56

1.2

2.2

7.74

7.55

g/l

0.21

417

Obstructed labour due to malposition and malpresentation of fetus

149

1679

0.83

1.55

1.5

1.9

7.02

7.19

g/l

0.92

143

1571

Use of galantamine

107

1333

0.80

1.55

1.3

2.3

7.58

7.59

g/l

0.02

1156

Cerebral aneurysm, nonruptured

139

1141

1.23

1.54

1.8

2.4

7.33

7.43

g/l

0.29

124

1037

Benign neoplasm: Lip

266

1.49

1.54

3.4

2.2

7.64

7.34

g/l

0.36

236

Injury of muscle and tendon at shoulder and upper arm level

641

5858

1.10

1.54

2.3

7.44

7.37

g/l

0.40

583

5320

Glaucoma-related operations

109

873

1.26

1.53

2.6

7.57

7.52

g/l

0.12

779

Malignant neoplasm of stomach, including Hilmo

783

1.27

1.53

1.3

1.4

7.67

7.50

g/l

0.46

680

Use of rivastigmine

242

2788

0.86

1.53

2.0

2.3

7.45

7.61

g/l

0.69

196

2402

Benign neoplasm: other/unspecified salivary gland

350

1.42

1.52

1.6

2.5

7.50

7.53

g/l

0.04

314

Other peripheral vertigo

158

1316

1.21

1.52

1.7

2.5

7.37

7.42

g/l

0.16

136

1193

Malignant neoplasm of hypopharynx, including Hilmo

2.00

1.52

3.4

1.2

7.84

7.76

g/l

0.05

Sequelae of injuries of upper limb

140

1152

1.22

1.52

2.5

7.44

7.30

g/l

0.36

123

1058

Malignant neoplasm of breast, HER-positive

495

3481

1.11

1.50

2.0

1.4

7.68

7.52

g/l

1.12

424

3062

Maternal care related to the fetus and amniotic cavity and possible delivery problems

409

2689

0.89

1.49

2.5

2.0

7.14

7.30

g/l

1.22

385

2472

Other female pelvic inflammatory diseases

231

1990

1.17

1.49

1.7

2.3

7.56

7.49

g/l

0.18

185

1790

Other drug-induced secondary parkinsonism

117

1.75

1.48

1.9

2.1

7.13

7.56

g/l

0.49

105

Unspecified mental disorder

587

5352

1.10

1.47

1.9

2.2

7.28

7.31

g/l

0.18

525

4870

Malignant neoplasm of breast, HER2-negative

627

3745

1.10

1.46

2.0

1.4

7.63

7.49

g/l

1.08

545

3307

Alcohol withdrawal state with delirium

110

887

1.25

1.46

1.3

2.3

7.21

7.25

g/l

0.09

819

Other congenital malformations of the digestive system

451

1.35

1.46

1.4

2.5

7.29

7.34

g/l

0.10

411

Ulcerative rectosigmoiditis

109

878

1.25

1.45

2.0

2.4

7.08

7.28

g/l

0.59

813

Endometriosis of ovary

227

1909

1.16

1.45

1.7

2.2

7.24

7.51

g/l

1.90

198

1720

Malignant neoplasm of endocrine gland

102

817

1.26

1.44

2.3

1.4

7.29

7.42

g/l

0.34

721

Vascular dementia (undefined)

616

1.30

1.43

2.1

8.02

7.69

g/l

0.72

530

Maternal care for other known or suspected fetal problems

131

1009

0.82

1.43

1.5

1.8

7.06

g/l

0.01

126

952

Benign mammary dysplasia

230

1991

1.16

1.42

2.4

2.2

7.38

7.62

g/l

1.35

201

1768

Presbycusis

296

2584

1.14

1.41

2.3

2.2

7.42

7.63

g/l

1.41

245

2254

Unspecified jaundice

624

1.29

1.41

1.6

2.5

7.11

7.38

g/l

0.64

559

Vertigo of central origin

198

1.54

1.40

1.6

2.6

7.36

7.48

g/l

0.21

175

Malignant neoplasm of stomach

651

1.29

1.40

1.2

1.4

7.56

7.59

g/l

0.06

566

Aneurysms, operations, SAH

281

2470

1.14

1.40

1.9

2.2

7.43

7.44

g/l

0.06

244

2219

Benign neoplasm: Endocrine pancreas

1.89

1.39

1.8

2.5

6.85

7.42

g/l

1.25

L01XE Protein kinase inhibitors

777

1.26

1.39

3.0

2.6

7.93

7.39

g/l

1.57

710

Colorectal neuroendocrine tumor and carcinoma

127

1.68

1.39

3.5

1.4

6.84

7.52

g/l

1.55

117

Glaucoma secondary to other eye disorders

538

1.31

1.39

2.3

2.7

7.92

7.42

g/l

1.90

482

Pilonidal cyst

714

1.27

1.37

1.9

2.1

7.43

7.16

g/l

0.78

672

Benign neoplasm of male genital organs

265

1.46

1.37

2.0

2.8

6.93

7.14

g/l

0.33

238

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.98

1.37

1.5

2.3

7.18

7.41

g/l

0.17

Oral lichen planus, including avohilmo , including avohilmo

107

868

1.24

1.37

2.3

2.5

7.41

7.43

g/l

0.06

787

Melanocytic naevi of lip

1.82

1.35

1.3

2.0

6.97

7.48

g/l

0.74

Benign neoplasm: Other parts of oropharynx

113

1.72

1.35

3.1

1.8

6.85

7.45

g/l

1.06

103

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

350

1.39

1.34

1.6

2.2

6.77

7.31

g/l

1.46

327

Other and unspecified abdominal hernia

541

1.31

1.34

1.3

2.1

7.47

7.53

g/l

0.12

491

Benign neoplasm: Larynx

402

1.36

1.34

2.6

2.5

6.99

7.29

g/l

0.81

363

Acute alcohol intoxication

416

3753

1.11

1.34

1.4

2.4

7.50

7.25

g/l

2.20

368

3431

Other vitreous opacities

498

1.32

1.33

3.3

2.7

7.07

7.35

g/l

0.91

451

Outcome of delivery

138

707

1.21

1.33

1.7

1.9

6.80

7.22

g/l

2.53

131

669

Recurrent and persistent haematuria

1.80

1.31

1.4

2.3

7.26

7.48

g/l

0.25

Contact with other hot metals

137

1.63

1.31

1.0

2.5

8.03

7.20

g/l

0.91

123

Other acantholytic disorders

2.15

1.31

1.4

2.7

7.09

7.16

g/l

—

Other and unspecified disorders of orbit

2.07

1.30

1.3

2.7

7.82

7.28

g/l

0.56

Reduction defects of lower limb

2.87

1.30

4.0

2.6

7.54

7.29

g/l

—

Nontoxic single thyroid nodule

113

928

1.23

1.30

2.4

2.3

7.25

7.46

g/l

0.73

103

842

Separation of retinal layers (serosa)

465

1.32

1.29

2.3

2.5

7.34

7.33

g/l

0.02

428

Foreign body or object entering through skin

632

1.27

1.29

2.8

2.4

6.96

7.28

g/l

1.20

585

Parkinson's disease, strict definition

278

2460

1.14

1.28

1.8

2.3

7.28

7.48

g/l

1.18

238

2178

Acute otitis externa, noninfective

178

1.54

1.28

1.2

2.1

7.60

7.44

g/l

0.13

163

Renal cell carcinoma of kidney

414

1.34

1.28

1.9

1.5

7.68

7.55

g/l

0.18

353

Other maternal disorders predominantly related to pregnancy

626

4263

0.92

1.28

2.1

2.2

7.41

7.33

g/l

0.59

573

3894

Use of levodopa decarboxylase inhibitor

270

2386

1.14

1.27

2.0

2.4

7.20

7.47

g/l

2.07

228

2106

Contact urticaria

2.47

1.26

1.5

7.88

7.72

g/l

—

Tuberculosis of other organs, strict

338

1.38

1.26

2.7

2.5

7.81

7.58

g/l

0.35

298

Erythema intertrigo

270

1.43

1.25

2.1

2.9

7.60

7.41

g/l

0.28

244

Macular hole

109

897

1.23

1.25

1.9

2.6

7.63

7.44

g/l

0.61

808

Convalescence

582

1.28

1.25

2.1

2.0

7.22

7.33

g/l

0.24

529

Struck by thrown, projected or falling objec

494

1.30

1.24

1.2

2.5

7.29

7.20

g/l

0.12

458

Antepartum haemorrhage, not elsewhere classified

573

1.28

1.24

2.2

1.8

6.90

7.14

g/l

0.80

544

Peritonsillar abscess

260

2295

1.14

1.23

2.7

2.2

7.33

7.27

g/l

0.22

241

2108

Parkinson's disease

295

2628

1.13

1.23

1.9

2.3

7.31

7.47

g/l

0.98

251

2331

Erectile dysfunction

152

1293

1.18

1.22

2.4

7.16

7.33

g/l

0.61

138

1158

Other intracranial haemorrhages

435

1.33

1.22

1.7

2.5

7.45

7.44

g/l

0.01

384

Chondromalacia

314

1.38

1.22

1.4

2.1

7.91

7.36

g/l

0.90

298

Occupational exposure to risk-factors

419

0.68

1.22

3.8

2.7

6.89

7.19

g/l

0.52

384

Benign neoplasm of other and unspecified female genital organs

558

0.73

1.21

2.0

2.3

7.56

7.60

g/l

0.05

508

Carcinoma in situ of skin of lip

2.10

1.21

1.1

1.5

7.57

7.77

g/l

—

Dysplasia of cervi uteri

283

1817

1.13

1.20

2.2

2.0

7.29

7.40

g/l

0.53

259

1641

Malignant neoplasm of head and neck

129

1083

1.20

2.3

1.4

7.36

7.44

g/l

0.19

117

954

Malignant neoplasm of bronchus and lung, including Hilmo

390

2954

1.11

1.20

2.1

1.4

8.11

7.48

g/l

9.02

350

2603

Cauda equina syndrome

133

1.61

1.19

2.1

1.7

7.18

7.37

g/l

0.20

125

Other rupture of muscle

1.97

1.19

1.0

1.8

7.94

6.95

g/l

0.79

Colorectal cancer

404

3588

1.10

1.18

2.3

1.4

7.52

7.50

g/l

0.06

352

3155

Residual foreign body in soft tissue

481

1.30

1.17

2.0

2.3

7.11

7.33

g/l

0.46

442

Dementia in other diseases classified elsewhere

687

1.25

1.17

1.6

2.4

6.98

7.50

g/l

1.80

614

Undefined dementia

173

1844

0.86

1.17

1.8

2.2

7.69

7.58

g/l

0.35

147

1571

Viral haemorrhagic fevers, not elsewhere classified/unspecified

980

0.80

1.16

2.9

2.3

7.04

7.30

g/l

0.97

902

Vascular dementia (other)

103

1.70

1.16

1.8

2.6

7.51

7.69

g/l

0.13

Inflammatory diseases of prostate (prostatitis)

206

1803

1.15

2.1

2.5

7.23

7.33

g/l

0.37

190

1623

All dysplastic lesions of the vulva

475

1.30

1.14

1.3

2.2

7.63

7.53

g/l

0.19

443

Hereditary corneal dystrophies

458

1.30

1.14

1.4

2.6

7.60

7.40

g/l

0.36

415

Disorders of adrenal gland, other and/or unspecified

2.02

1.13

1.2

2.3

6.33

7.88

g/l

—

Dislocation, sprain and strain of joints and ligaments of knee

876

7572

1.07

1.13

1.9

2.2

7.29

7.28

g/l

0.07

788

6937

Malignant neoplasm of thyroid gland

762

1.23

1.13

2.4

1.4

7.20

7.41

g/l

0.61

674

Pedal cyclist injured in transport accident

314

2823

1.12

1.13

2.0

2.2

7.16

7.38

g/l

1.58

278

2584

Other noninflammatory disorders of vagina

107

889

1.21

1.13

2.6

2.1

7.53

7.52

g/l

0.04

798

Vasomotor rhinitis (mode)

108

899

1.21

1.12

2.1

2.6

7.09

7.34

g/l

0.89

820

Foreign body in alimentary tract

646

1.25

1.11

1.4

2.4

7.49

7.31

g/l

0.50

592

Chalazion

163

1406

1.16

1.11

2.8

2.4

7.20

7.39

g/l

0.84

145

1285

Other diseases of biliary tract

148

1268

1.17

1.11

2.2

2.3

7.36

7.46

g/l

0.32

134

1131

Non-small cell lung cancer, including Hilmo

270

2270

1.13

1.11

2.0

1.4

8.18

7.49

g/l

6.97

242

1988

Alzheimer disease

613

4832

0.93

1.10

1.9

2.2

7.69

7.54

g/l

1.20

484

4218

Dronedarone medication

355

1.34

1.10

1.9

2.4

7.35

7.43

g/l

0.11

315

Acute poliomyelitis

162

0.55

1.10

1.3

2.1

7.86

7.56

g/l

—

147

Disturbances of smell and taste

514

1.28

1.09

3.1

2.9

6.84

7.42

g/l

1.81

469

Oligomenorrhoea

295

1.37

1.08

1.6

2.2

7.44

7.43

g/l

0.00

270

Right side

1.76

1.08

1.3

1.8

7.85

7.62

g/l

0.34

Colon adenocarcinoma

200

1756

1.14

1.08

2.4

1.4

7.66

7.52

g/l

0.51

172

1518

Car occupant injured in other and unspecified transport accidents

238

2113

1.13

1.07

2.0

2.2

7.27

7.34

g/l

0.31

213

1941

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

2.07

1.07

1.1

1.2

6.98

7.54

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

104

1241

0.83

1.06

3.1

2.4

7.36

7.33

g/l

0.06

1139

Alzheimer disease, including avohilmo

720

5421

0.93

1.06

1.9

2.3

7.65

7.54

g/l

0.95

581

4744

Benign lipomatous neoplasm of other sites/unspecified

148

1275

1.17

1.05

2.9

2.3

7.37

7.44

g/l

0.21

140

1151

Effects of foreign body entering through natural orifice

353

3208

1.10

1.05

2.2

2.3

7.26

7.29

g/l

0.13

323

2944

Tuberculosis of other organs

289

1.37

1.05

2.6

2.4

7.81

7.62

g/l

0.25

254

Benign neoplasm: Orbit, unspecified

1.78

1.05

2.8

1.9

7.65

7.43

g/l

0.16

Fractures involving multiple body regions

2.35

1.05

1.2

8.62

7.82

g/l

—

Lack of expected normal physiological development

2.12

1.05

1.0

1.1

6.91

7.66

g/l

—

Abrasion of teeth

513

4742

1.08

1.04

2.4

2.3

7.08

7.37

g/l

3.85

461

4301

2.33

1.04

3.0

2.8

7.10

6.89

g/l

—

Transient global amnesia

124

1453

0.85

1.04

2.5

2.3

7.27

7.54

g/l

1.04

106

1313

Benign neoplasm of bone and articular cartilage

110

926

1.19

1.03

1.5

2.4

7.00

7.30

g/l

1.40

852

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

120

1407

0.85

1.02

2.7

1.4

7.35

7.46

g/l

0.30

1237

Benign neoplasm of brain and other parts of central nervous system

809

1.21

1.01

2.0

2.5

7.14

7.37

g/l

0.68

736

Unspecific neurodegenerative disorder

838

6081

0.94

1.01

1.9

2.3

7.57

7.52

g/l

0.33

660

5380

Perforation of oesophagus

1.79

0.99

1.1

2.4

7.33

7.32

g/l

0.01

Benign neoplasm: Choroid

103

868

1.20

0.98

1.6

2.5

7.00

7.38

g/l

1.68

790

Whooping cough

1.97

0.98

1.0

3.3

6.33

7.04

g/l

—

Schizoaffective disorder

739

1.21

0.98

1.7

2.2

7.56

7.28

g/l

0.98

689

Other problems related to primary support group, including family circumstances

101

826

1.19

0.96

1.9

2.1

7.21

7.29

g/l

0.20

771

Bacterial meningitis

381

1.30

0.96

3.6

2.6

7.25

7.22

g/l

0.05

351

Dementia due to Parkinsons disease, excluding more controls

259

1.37

0.96

1.3

2.4

6.81

7.48

g/l

1.12

230

Lichen sclerosus et atrophicus

157

1370

1.15

0.96

2.1

7.49

7.59

g/l

0.32

142

1208

Small plaque parapsoriasis

1.96

0.96

1.6

2.2

7.43

7.76

g/l

—

684

1.22

0.96

1.9

2.3

7.37

7.55

g/l

0.46

581

Gonococcal infection

346

1.31

0.96

2.2

1.8

7.95

7.36

g/l

1.31

322

Contact with other hot fluids

259

1.36

0.96

1.3

2.2

7.55

7.23

g/l

0.39

241

Varus deformity, not elsewhere classified

117

1.56

0.95

1.4

2.1

7.26

7.22

g/l

0.04

107

Labour and delivery complicated by fetal stress [distress]

138

1046

0.86

0.95

1.6

1.7

7.07

7.03

g/l

0.13

132

984

Inguinal hernia, bilateral

185

1635

1.14

0.94

2.8

2.2

7.10

7.35

g/l

1.27

164

1469

Malignant neoplasm of ovary, including Hilmo

800

0.81

0.94

3.0

1.4

7.36

7.62

g/l

0.72

695

Persistent delusional disorders

974

0.83

0.93

2.1

2.3

7.42

7.37

g/l

0.09

879

Secondary parkinsonism+Parkinsonism in other disease

357

1.30

0.93

2.6

2.7

7.24

7.41

g/l

0.32

322

Endometriosis diagnosis and infertility diagnosis occurring together

104

881

1.18

0.93

1.6

2.1

7.27

7.28

g/l

0.03

828

Specific developmental disorder of motor function

2.18

0.92

1.0

2.1

7.63

7.38

g/l

—

Pregnancy with abortive outcome

1008

4984

1.06

0.92

1.8

2.3

7.61

7.45

g/l

1.90

903

4420

Presbyopia

708

1.21

0.92

1.5

2.2

6.96

7.31

g/l

1.05

657

FESS (DNB20)

133

1533

0.86

0.92

2.4

2.3

7.24

7.35

g/l

0.31

119

1412

Caught, crushed, jammed or pinched in or between objects

473

1.25

0.91

1.5

2.3

7.22

7.19

g/l

0.05

438

Medicines for HER+ breast cancer

531

5395

0.93

0.91

2.1

2.3

7.65

7.52

g/l

0.88

459

4780

Personal history of certain other diseases

102

1.58

0.91

1.2

1.6

7.29

7.34

g/l

0.04

Maternal care for known or suspected abnormality of pelvic organs

186

1430

0.88

0.91

2.6

2.0

7.08

7.21

g/l

0.54

172

1334

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

2.13

0.91

1.0

1.4

7.88

7.76

g/l

—

Malignant neoplasm of nasal cavity and sinuses

1.73

0.90

6.6

1.3

6.42

7.73

g/l

4.20

Adenocarcinoma and papilloma adenocarcinoma of rectum

116

1347

0.86

0.90

2.7

1.4

7.38

7.48

g/l

0.26

1183

Pterygium

395

1.28

0.89

2.1

2.6

6.85

7.37

g/l

1.35

359

Any dementia

854

5612

1.06

0.89

2.0

2.2

7.62

7.53

g/l

0.77

700

4940

Contact with machinery

126

1453

0.86

0.89

2.2

2.3

7.06

7.28

g/l

0.74

113

1335

Fistulae involving female genital tract

203

1.40

0.89

2.0

2.2

8.49

7.56

g/l

1.30

184

Malignant neoplasm of rectum

118

1366

0.86

0.88

2.4

1.4

7.21

7.47

g/l

1.00

1200

Ovarian dysfunction, other/unspecified

1.89

0.88

2.3

2.2

7.31

7.57

g/l

—

Reduction defects of lower limb

2.05

0.88

3.7

3.5

7.35

7.48

g/l

—

Foreign body entering into or through eye or natural orifice

105

896

1.18

0.88

2.6

2.3

7.29

7.26

g/l

0.07

828

Disorders of globe

334

1.30

0.87

2.4

2.6

7.76

7.36

g/l

0.73

297

Mixed conductive and sensorineural hearing loss

215

1929

1.12

0.87

2.6

2.2

7.56

7.54

g/l

0.07

183

1727

Malignant neoplasm of hypopharynx

1.87

0.87

1.0

1.1

8.46

7.51

g/l

—

Motor disorders

2.00

0.86

1.0

2.0

7.63

7.42

g/l

—

Pleural plaque

188

1677

1.13

0.86

2.2

7.56

7.34

g/l

0.83

165

1483

Benign neoplasm: Scrotum

1.82

0.86

1.3

1.4

7.24

7.08

g/l

—

Endometriosis ASRM stages 1,2

197

1761

1.12

0.85

1.4

2.0

7.24

7.38

g/l

0.62

172

1621

Unspecified dementia

172

1741

0.88

0.85

1.8

2.3

7.71

7.55

g/l

0.62

146

1524

Inguinal or femoral hernia, bilateral

187

1668

1.13

0.85

2.8

2.2

7.10

7.36

g/l

1.35

166

1497

Alzheimer’s disease, strict definition

469

4147

0.93

0.85

1.9

2.2

7.67

7.55

g/l

0.73

374

3617

Aggressive periodontitis

231

1.36

0.84

2.3

2.7

7.38

7.33

g/l

0.05

213

Von Willebrand disease

113

1.52

0.83

2.3

2.0

6.81

7.43

g/l

0.77

107

LSIL lesion of the cervix uteri, vagina or vulva

144

1265

1.14

0.83

2.6

2.0

7.23

7.31

g/l

0.25

134

1172

Gonococcal infection

337

1.29

0.82

2.2

1.8

8.07

7.36

g/l

1.66

315

Universal erythroderma, KELA reimbursement

155

1.44

0.82

1.3

2.3

7.13

7.38

g/l

0.21

141

Arthropathy in Crohn disease

1.59

0.82

1.1

2.2

7.34

7.26

g/l

0.05

L02BG Aromatase inhibitors

442

4738

0.93

0.82

2.2

2.3

7.74

7.55

g/l

1.31

383

4187

Malignant neoplasm of respiratory system and intrathoracic organs

369

2836

1.09

0.82

2.0

1.4

8.06

7.47

g/l

7.04

326

2497

Divergent concomitant strabismus

794

1.18

0.79

1.8

2.2

7.09

7.32

g/l

0.72

728

Discharge from other and unspecified firearms

0.00

0.79

0.0

2.4

—

7.02

—

Exposure to other specified electric current

175

0.62

0.79

2.0

6.93

7.27

g/l

0.48

165

Carcinoma in situ of other and unspecified sites

548

1.22

0.78

3.3

2.6

7.53

7.33

g/l

0.34

495

Pregnancy hypertension

468

3914

1.07

0.78

2.3

2.1

7.36

7.31

g/l

0.30

438

3566

Secondary parkinsonism

349

1.27

0.78

2.6

2.5

7.21

7.41

g/l

0.40

315

Changes in corneal membranes

1.81

0.77

1.5

2.4

7.42

7.46

g/l

—

All dysplastic lesions of the vagina

270

1.31

0.77

2.7

1.9

7.49

g/l

0.01

253

Other congenital malformations of respiratory system

2.17

0.76

1.0

1.3

9.64

7.60

g/l

—

Other contact dermatitis

103

891

1.16

0.76

1.7

2.4

7.23

7.40

g/l

0.55

808

Hypermetropia

705

1.18

0.75

2.4

2.3

7.63

7.40

g/l

0.54

645

Gastrointestinal stromal tumor and sarcoma

133

1.45

0.75

1.3

1.4

7.00

7.60

g/l

0.48

118

Embolic stroke

670

1.19

0.74

2.0

2.5

7.48

7.49

g/l

0.02

596

Abnormalities of forces of labour

837

1.16

0.74

1.4

2.0

7.02

7.27

g/l

1.18

798

Pathological resorption of teeth

370

1.25

0.74

1.1

2.4

7.13

7.28

g/l

0.23

344

Necrobiosis lipoidica, not elsewhere classified

1.63

0.73

4.0

2.4

7.67

7.49

g/l

—

Long labour

186

1766

0.90

0.73

2.3

2.0

7.10

7.21

g/l

0.44

176

1644

Mild mental retardation

195

0.66

0.73

2.1

7.44

7.21

g/l

0.25

186

Non-small cell lung cancer, squamous

599

0.81

0.72

1.8

1.4

8.45

7.47

g/l

3.06

520

Malignant neoplasm of oral cavity, including Hilmo

536

1.20

0.70

2.4

1.4

7.50

7.45

g/l

0.10

473

Accidental poisoning by and exposure to alcohol

142

0.63

0.70

1.7

2.8

7.09

7.14

g/l

—

132

Hypertrophy of breast in women and men

248

2275

1.09

0.69

1.8

2.3

7.42

7.36

g/l

0.19

222

2080

Seminoma of testis, including Hilmo

1.66

0.69

1.6

1.4

7.37

7.04

g/l

—

Use of rasagiline

365

1.25

0.69

1.4

2.9

6.86

7.39

g/l

1.88

330

Acute drug-induced interstitial lung disorder

102

1.50

0.69

9.7

2.0

6.89

7.47

g/l

0.86

Motorcycle rider injured in noncollision transport accidents

231

1.31

0.68

1.8

6.66

7.09

g/l

0.90

217

Kela-code for behavioural disturbances in mental retardation

0.54

0.68

1.8

1.9

6.08

7.27

g/l

—

Neuroendocrine tumor and carcinoma of rectum

1.66

0.68

4.0

1.1

6.87

7.62

g/l

—

Fall on and from ladder

118

1042

1.14

0.68

3.7

2.5

7.07

7.32

g/l

0.85

108

955

Benign neoplasm: Bladder

119

1.45

0.68

1.9

2.9

7.59

7.44

g/l

0.13

106

Communicating hydrocephalus

267

1.29

0.68

1.5

2.8

7.18

7.41

g/l

0.23

242

Injury of nerves at forearm level

119

1.44

0.67

1.2

2.3

7.29

7.16

g/l

0.14

111

Single delivery by caesarean section

136

877

0.89

0.66

2.0

1.5

7.29

7.23

g/l

0.16

129

824

Postmenopausal atrophic vaginitis

435

2249

1.07

0.66

2.2

7.19

7.61

g/l

6.57

390

2004

Thromboangiitis obliterans

1.62

0.66

1.0

2.9

6.77

7.54

g/l

—

Typhoid and paratyphoid fevers

1.64

0.66

1.2

1.5

7.86

7.48

g/l

—

Contact with other and unspecified heat and hot substances

1.64

0.66

5.4

1.7

8.20

7.17

g/l

—

Oral leukoplakia, including avohilmo

340

1.25

0.66

1.2

2.4

7.46

7.37

g/l

0.09

312

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

1.62

0.66

3.3

1.1

6.83

7.75

g/l

—

Uterine polyps

134

1196

1.12

0.65

1.9

2.1

7.42

7.52

g/l

0.35

125

1075

Other complications of labour and delivery, not elsewhere classified

564

0.83

0.65

1.3

1.5

6.64

7.11

g/l

2.32

530

Acute and transient psychotic disorders

143

1282

1.12

0.64

2.1

2.3

7.42

7.32

g/l

0.37

124

1187

Deep bite

110

851

1.14

0.63

2.0

2.3

7.50

7.33

g/l

0.50

794

Calcaneal spur

121

1.42

0.63

1.2

1.7

7.22

7.45

g/l

0.30

109

Burn and corrosion confined to eye and adnexa

199

1.32

0.63

1.9

2.3

7.87

7.13

g/l

1.05

189

Carcinoma in situ, bladder

489

1.20

0.62

3.6

2.7

7.48

7.30

g/l

0.29

443

Other and unspecified heterotropia

1.70

0.62

1.8

1.1

7.08

7.48

g/l

—

Family history of malignant neoplasm

104

1176

0.88

0.61

3.0

2.0

7.18

7.39

g/l

0.62

1078

Non-small cell lung cancer, adenocarcinoma

100

883

1.14

0.60

1.9

1.4

7.86

7.45

g/l

1.30

770

Use of dimethyl fumarate

1.55

0.60

1.0

2.3

6.09

6.90

g/l

—

Unattended death

114

0.61

0.59

5.0

1.8

7.24

7.40

g/l

—

100

Dislocation, sprain and strain of joints and ligaments of head

345

1.22

0.59

1.3

1.9

7.17

7.33

g/l

0.25

319

Radial styloid tenosynovitis [de Quervain]

538

1.18

0.59

2.5

2.1

7.47

7.32

g/l

0.31

502

Acquired stenosis of external ear canal

115

1.41

0.57

1.6

1.9

7.48

7.21

g/l

0.17

104

Burns and corrosions confined to eye and internal organs

238

1.27

0.57

1.8

2.2

7.89

7.15

g/l

1.15

224

Seminoma of testis

1.47

0.56

1.8

1.4

7.24

7.06

g/l

—

Interstitial cystitis (chronic), drug-induced

1.65

0.56

1.0

1.7

7.12

7.89

g/l

—

Open bite that required surgery (Lefort1 or BSSO)

1.46

0.56

1.0

1.7

6.50

7.13

g/l

—

Malignant neoplasm of nasal cavity and middle ear

1.56

0.56

5.9

1.3

6.26

7.69

g/l

—

Benign neoplasm: Conjunctiva

385

1.20

0.55

1.3

2.7

7.42

7.38

g/l

0.06

356

Convergence insufficiency and excess

1.43

0.54

1.4

1.8

6.74

7.27

g/l

0.92

Unequal limb length (acquired)

1.59

0.54

1.2

2.2

7.65

7.09

g/l

—

Ethmoidectomy

145

1593

0.91

0.54

2.8

2.3

7.21

7.33

g/l

0.39

131

1466

Vestibular neuronitis

135

1224

1.11

0.53

2.1

2.4

7.32

7.35

g/l

0.05

122

1115

Cyst of Bartholin Gland

359

1.20

0.53

2.4

2.1

7.28

7.47

g/l

0.36

338

Infections of genitourinary tract in pregnancy

927

0.88

0.51

2.2

7.34

7.46

g/l

0.30

849

Erosion and ectropion of cervix uteri

371

1.19

0.50

3.3

2.2

7.92

7.73

g/l

0.31

334

Gestational diabetes (for exclusion)

265

1971

0.93

0.50

1.8

7.30

7.07

g/l

1.51

244

1857

Lesion of sciatic nerve

637

0.86

0.50

1.3

2.4

7.26

7.43

g/l

0.41

561

Torsion of ovary, ovarian pedicle and fallopian tube

189

1.28

0.50

1.3

2.1

7.42

7.38

g/l

0.06

175

Dementia

931

6185

1.04

0.49

2.0

2.3

7.56

7.51

g/l

0.35

749

5482

Other benign neoplasms of connective and other soft tissue

139

1269

1.10

0.49

2.5

2.4

7.33

7.38

g/l

0.14

121

1154

Malignant neoplasm of accessory sinuses, including Hilmo

1.54

0.49

5.0

1.3

7.46

7.66

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

119

1079

1.11

0.49

2.0

2.5

7.20

7.38

g/l

0.51

110

984

Non-allergic asthma

117

1059

1.11

0.48

2.1

2.5

7.45

7.41

g/l

0.11

108

961

Myocardial infarction, unclassifiable

396

3722

0.95

0.48

1.8

2.2

7.70

7.48

g/l

1.70

348

3250

Alzheimer’s disease (Late onset)

442

3904

0.95

0.48

2.0

2.2

7.70

7.56

g/l

0.87

349

3396

Embedded and impacted teeth

201

1539

1.08

0.47

2.0

1.9

7.06

7.16

g/l

0.35

188

1440

Gender identity disorders

1.50

0.47

1.0

1.7

7.66

7.19

g/l

—

Other appendicitis

110

995

1.11

0.47

2.9

2.4

7.28

7.34

g/l

0.13

918

Malignant neoplasm of eye and adnexa

1.40

0.46

1.2

7.75

7.58

g/l

0.16

Malignant neoplasm of nasopharynx, including Hilmo

1.45

0.46

1.3

1.2

6.33

7.48

g/l

—

Pedal cyclist injured in other and unspecified transport accidents

143

1312

1.09

0.46

2.1

2.3

7.37

7.34

g/l

0.06

128

1208

Other and unspecified disorders of skin and subcutaneous tissue

807

1.12

0.46

1.7

2.4

7.77

7.41

g/l

0.92

737

Other articular cartilage disorders

246

1.23

0.46

2.5

2.2

7.35

7.10

g/l

0.34

225

Frontotemporal dementia

1.42

0.45

2.4

2.0

7.20

7.61

g/l

—

Vertical strabismus

357

1.18

0.45

1.8

2.5

7.27

7.36

g/l

0.13

324

Frontotemporal dementia, wide, incl. Pick's disease

1.39

0.44

2.3

2.0

7.26

7.56

g/l

—

Other benign neoplasm of uterus: Other parts/unspecified

649

1.13

0.44

2.7

2.2

7.97

7.80

g/l

0.38

556

Supervision of high-risk pregnancy

169

941

1.08

0.43

1.7

1.8

7.09

7.26

g/l

0.78

159

887

Toxic effects of substances chiefly nonmedicinal as to source

116

1269

0.91

0.43

1.7

2.3

7.03

7.34

g/l

1.19

106

1169

Other specified and unspecified disorders of lens

140

1.30

0.43

1.7

2.8

6.52

7.70

g/l

2.25

128

Deep endometriosis

1091

0.91

0.43

1.5

2.2

7.35

7.57

g/l

0.65

984

Malignant neoplasm of gallbladder

1.42

0.43

1.1

7.59

7.70

g/l

—

Short Achilles tendon (acquired)

262

0.80

0.42

3.1

2.4

7.10

7.41

g/l

0.52

243

Obstructed labour due to maternal pelvic abnormality

166

1787

0.93

0.42

2.3

2.2

7.40

7.45

g/l

0.15

151

1629

Female infertility

327

1881

1.06

0.42

1.9

2.1

7.44

7.38

g/l

0.24

300

1709

Sequelae of infectious and parasitic diseases

889

1.11

0.42

2.9

2.1

7.70

7.39

g/l

0.81

806

Mental and behavioural disorders due to use of volatile solvents

0.00

0.41

0.0

3.0

—

7.05

—

Obstetric embolism

0.00

0.41

0.0

1.1

—

8.24

—

Other benign neoplasms of uterus

805

1.11

0.41

3.0

2.1

7.74

7.73

g/l

0.02

698

Malignant neoplasm of other and ill-defined sites, including Hilmo

186

1.25

0.41

1.4

1.3

7.78

7.72

g/l

0.04

160

Heterophoria

796

1.11

0.40

2.9

2.3

6.97

7.39

g/l

1.74

734

Wilms' tumor, including Hilmo

1.43

0.40

1.0

1.2

8.46

7.69

g/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

539

4508

1.04

0.39

2.2

2.1

7.44

7.32

g/l

0.89

502

4087

Other obstructed labour

739

0.89

0.39

1.9

2.1

7.69

7.42

g/l

0.85

695

Respiratory tuberculosis

789

1.11

0.39

2.1

2.5

7.77

7.42

g/l

0.98

702

Respiratory tuberculosis, confirmed and not-confirmed

789

1.11

0.39

2.1

2.5

7.77

7.42

g/l

0.98

702

Malignant neoplasm of other and ill-defined digestive organs

1.36

0.38

1.3

8.62

7.92

g/l

0.72

LSIL lesion of the cervix uteri

904

1.10

0.38

3.2

2.1

7.14

7.29

g/l

0.53

852

Persons encountering health services in circumstances related to reproduction

705

4907

0.97

0.38

2.1

2.2

7.03

7.31

g/l

4.17

658

4530

Other disorders of binocular vision

1.33

0.37

5.7

2.2

6.38

7.18

g/l

2.38

Acute appendicitis, with complications

298

2835

1.05

0.37

2.4

2.2

7.44

7.35

g/l

0.37

269

2588

Mumps

268

0.82

0.37

1.4

2.2

7.73

7.29

g/l

0.66

245

Postpartum haemorrhage due to retained placenta

810

0.90

0.37

2.0

1.8

6.88

7.13

g/l

0.89

767

Pedestrian injured in collision with car, pick-up truck or van

262

1.19

0.37

1.5

2.3

7.23

7.48

g/l

0.39

238

Stenosis and insufficiency of lacrimal passages

143

1330

1.08

0.37

2.2

2.5

7.49

7.52

g/l

0.07

125

1186

Other and unspecified injuries of shoulder and upper arm

318

1.17

0.37

1.4

2.6

7.93

7.35

g/l

0.96

287

Malignant neoplasm of other and unspecified urinary organs

1.49

0.37

1.0

1.2

6.65

7.75

g/l

—

Benign neoplasm: Skin of trunk

497

1.13

0.36

3.0

2.4

6.88

7.37

g/l

1.82

454

Malignant neoplasm of adrenal gland, including Hilmo

1.28

0.36

2.2

1.2

8.30

7.50

g/l

—

Hydatidiform mole

125

0.72

0.35

5.7

2.0

6.81

7.38

g/l

—

119

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.39

0.35

1.6

2.1

7.00

7.40

g/l

—

Complications predominantly related to the puerperium

264

2510

1.05

0.35

2.0

2.1

7.23

7.31

g/l

0.38

247

2310

Malignant neoplasm of breast, HER-negative

261

2691

0.95

0.34

1.9

1.4

7.66

7.61

g/l

0.16

225

2338

Carcinoma in situ of cervix uteri

710

1.10

0.33

2.2

2.1

7.25

7.36

g/l

0.25

666

Disorders of acoustic nerve

350

1.15

0.33

2.8

2.3

7.44

7.46

g/l

0.02

315

Foreign body in respiratory tract

568

1.11

0.33

2.5

2.3

7.16

7.34

g/l

0.35

518

Intermittent heterotropia

444

1.13

0.32

2.1

2.0

6.62

7.42

g/l

2.73

408

Maltreatment syndromes

369

1.14

0.32

2.1

1.8

7.19

7.21

g/l

0.05

352

Other abnormal products of conception

276

1741

1.05

0.32

1.8

2.0

7.15

7.19

g/l

0.18

262

1630

Subarachnoid haemorrhage

160

1504

1.07

0.32

1.9

2.3

7.47

g/l

0.01

137

1341

malignant neoplasm of female genital organs

200

2099

0.95

0.32

1.7

1.4

7.76

7.66

g/l

0.33

178

1819

Congenital malformations of aortic and mitral valves

398

1.13

0.32

1.9

2.3

7.00

7.22

g/l

0.38

370

Calculus of lower urinary tract

790

1.09

0.32

2.0

2.5

7.62

7.35

g/l

0.70

713

Malignant neoplasm of pancreas, including Hilmo

112

1204

0.93

0.31

2.1

1.4

7.47

7.51

g/l

0.08

103

1056

Injury of muscle and tendon at wrist and hand level

184

1740

1.06

0.31

1.9

2.3

7.36

7.35

g/l

0.02

174

1596

Malignant neoplasm of base of tongue, including Hilmo

0.72

0.31

3.9

1.2

6.94

7.51

g/l

—

Pedal cyclist injured in collision with motor vehicle

294

0.85

0.31

1.2

2.1

7.62

7.29

g/l

0.49

275

Female infertility, cervical, vaginal, other or unspecified origin

295

1835

1.05

0.30

2.0

2.1

7.44

7.36

g/l

0.35

272

1667

Cholesteatoma of middle ear

714

0.91

0.30

2.1

2.5

7.34

7.45

g/l

0.19

643

Generalized epilepsy, strict definition

166

1.21

0.30

1.4

2.1

6.61

7.26

g/l

1.33

157

Glaucoma suspect

624

6417

0.97

0.29

2.2

2.3

7.46

7.49

g/l

0.17

555

5692

Follow-up care involving plastic surgery

402

1.12

0.28

1.5

1.9

7.54

7.28

g/l

0.47

365

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

121

1.25

0.28

1.4

2.0

7.24

7.04

g/l

0.27

110

Tuberculosis

101

940

1.08

0.28

2.0

2.4

7.84

7.45

g/l

1.29

829

Excessive vomiting in pregnancy

660

1.09

0.28

2.3

2.2

7.14

7.37

g/l

0.59

619

Congenital malformations of breast

112

1.25

0.28

1.4

2.0

6.94

7.21

g/l

0.36

107

Malignant neoplasm of bronchus and lung

310

2473

1.04

0.28

1.9

1.4

8.16

7.50

g/l

7.55

273

2165

Infliximab

103

1.27

0.28

1.1

1.7

7.49

7.01

g/l

0.57

Mental retardation, excluding more controls

244

1.16

0.28

1.7

2.4

7.43

7.25

g/l

0.27

225

Haemorrhage in early pregnancy

295

2758

1.04

0.28

2.1

7.26

7.27

g/l

0.05

274

2526

Carcinoma in situ of middle ear and respiratory system

1.26

0.28

2.0

3.1

6.67

7.39

g/l

—

Ectopic pregnancy

172

1813

0.95

0.28

1.5

2.4

7.56

7.35

g/l

0.77

155

1674

Hypertrophy of breast

199

1896

1.05

0.27

1.4

2.2

7.38

7.42

g/l

0.12

178

1736

Bicuspidal aortic valve syndrome

366

1.12

0.27

2.0

2.4

7.02

7.18

g/l

0.22

341

Use of ropinirole

500

1.10

0.27

2.2

2.9

7.31

7.37

g/l

0.08

454

Malignant neoplasm of renal pelvis

1.20

0.26

1.0

1.3

9.48

7.55

g/l

—

Disorders of pituitary gland, other and/or unspecified

0.70

0.26

1.2

1.8

7.18

7.60

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

104

973

1.07

0.26

1.8

2.1

7.93

7.42

g/l

2.02

890

Mucinous and mucinous cystic tumor, including Hilmo

0.67

0.26

9.0

1.3

7.74

7.68

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

871

0.93

0.25

3.0

2.4

7.59

7.35

g/l

0.73

794

Other specified and unspecified strabismus

105

1.25

0.25

2.1

2.2

7.41

7.28

g/l

0.07

Pleural plaque with presence of asbestos

121

1282

0.94

0.25

2.5

2.4

7.40

7.32

g/l

0.17

105

1134

L02BB Anti-androgens

153

1610

0.95

0.25

1.7

2.3

7.81

7.33

g/l

2.37

136

1416

Drug-induced tremor

1.29

0.24

1.4

2.3

7.47

7.38

g/l

—

Endometriosis of rectovaginal septum and vagina

952

0.93

0.24

1.5

2.1

7.48

7.57

g/l

0.19

857

Use of selegiline

648

1.08

0.24

2.1

2.5

6.86

7.45

g/l

2.90

583

Nontraumatic intracranial haemmorrhage

345

3341

1.03

0.23

2.4

2.2

7.47

7.44

g/l

0.09

306

2960

Other congenital malformations of limb(s)

1.32

0.23

1.0

1.7

8.42

7.25

g/l

—

Hypothermia

209

1.15

0.23

1.2

3.0

7.68

7.25

g/l

0.59

187

Serous carcinoma of ovary

0.76

0.23

1.3

7.23

7.72

g/l

—

Diabetes mellitus in pregnancy

229

1525

0.96

0.22

1.5

1.8

7.41

7.03

g/l

2.85

212

1438

Impacted teeth

123

1036

1.06

0.22

1.4

1.8

7.14

7.12

g/l

0.05

116

971

Glanders and melioidosis

0.00

0.22

0.0

1.0

—

7.77

—

Medullary carcinoma of thyroid gland

0.00

0.22

0.0

1.0

—

7.88

—

Ascariasis

0.00

0.22

0.0

1.3

—

7.99

—

Malignant neoplasm of placenta, including Hilmo

0.00

0.21

0.0

1.0

—

7.63

—

Congenital malformation of optic disc

0.00

0.21

0.0

1.0

—

8.32

—

Congenital malformations of breast

107

1.22

0.21

1.4

1.5

6.98

7.28

g/l

0.36

102

Underdevelopment of the second kidney

0.00

0.21

0.0

4.2

—

7.60

—

Toxic effect of pesticides

0.00

0.21

0.0

1.1

—

8.15

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

8.01

—

Anomalies of dental arch relationship, including avohilmo

194

1679

1.04

0.21

1.9

2.2

7.38

7.30

g/l

0.25

168

1559

Unicornuate uterus

0.00

0.21

0.0

1.0

—

6.82

—

Birth injury to peripheral nervous system

0.00

0.21

0.0

3.3

—

6.79

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

7.84

—

Traumatic ischaemia of muscle

126

1.20

0.21

2.3

2.0

7.54

7.40

g/l

0.17

118

Other osteochondropathies

711

1.07

0.21

2.3

2.2

7.56

7.33

g/l

0.58

655

Other congenital malformations of spinal cord

0.00

0.21

0.0

1.2

—

7.72

—

Gestational [pregnancy-induced] hypertension

241

2321

1.04

0.21

2.5

2.0

7.30

7.25

g/l

0.21

232

2121

Female genital prolapse

434

2388

1.03

0.21

2.3

2.2

7.59

g/l

0.02

388

2126

Crossbite

425

1.09

0.20

1.1

2.0

7.09

7.28

g/l

0.28

404

Disorder of visual pathways, unspecified

0.00

0.20

0.0

1.6

—

7.58

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

136

1032

1.05

0.20

1.7

2.3

7.52

7.68

g/l

0.41

110

905

Benign neoplasm: Pineal gland

0.00

0.20

0.0

1.1

—

6.85

—

Other congenital musculoskeletal deformities

0.00

0.20

0.0

1.0

—

7.64

—

Antenatal screening

186

1002

1.04

0.20

2.0

1.8

7.04

7.27

g/l

1.23

181

947

Fourth [trochlear] nerve palsy

260

0.88

0.19

1.5

2.6

7.54

7.33

g/l

0.18

235

Benign neoplasm of thyroid gland

406

0.91

0.19

2.4

2.2

7.66

7.42

g/l

0.37

374

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

802

6460

0.98

0.19

2.2

7.30

7.33

g/l

0.23

736

5836

Medical treatment for female infertility

138

1433

0.96

0.19

1.7

7.22

7.06

g/l

0.54

130

1348

Postpartum care and examination

551

0.94

0.18

1.6

7.07

7.22

g/l

0.39

518

Use of levodopa decarbox-comt-inhibitor

473

1.08

0.18

1.1

2.8

6.95

7.45

g/l

1.53

429

Benign leiomyoma with endometriosis

234

2266

1.03

0.18

2.1

2.2

7.54

7.58

g/l

0.14

200

2024

False labour

222

1432

0.97

0.18

1.7

1.8

6.86

7.17

g/l

2.73

214

1353

Malignant neoplasm of penis, including Hilmo

1.19

0.18

3.6

1.4

8.03

7.51

g/l

—

Degenerative diseases of the nervous system

716

5350

0.98

0.17

1.8

2.2

7.61

7.53

g/l

0.61

576

4686

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS